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Appendix 1. Search terms for EED articles of interest. 
Search terms for EED alone are in gray, malnutrition outcomes are in pink. A combined 
strategy, denoted in yellow was utilized for searches in the smaller WHO databases. 
 
 
PubMed TE/ED  
completed April 1, 2010 (24156 Citations) 
Step 1 (24875 Citations) 
("Viruses" [Mesh] OR "Bacteria" [Mesh] OR "Parasites" [Mesh]) AND "Intestinal Diseases" 
[Mesh] 
Step 2 (2789652 Citations) 
("malnutrition" OR "undernutrition" OR "micronutrient" OR "nutritional deficiency" OR "Nutrition 
Disorders" [Mesh] OR "child development" [Mesh ] OR environmental OR recurrent OR 
recurring OR persistent OR chronic OR "Communicable Disease Control" [Mesh] OR 
handwashing OR "hand washing" OR toilet* OR sanitation OR hygiene OR drinking) 
Step 3 (478234 Citations) 
(enteropathy OR enteropathies OR diarrhea OR diarrhoea OR diarrhoeal OR diarrheal OR 
"Malabsorption Syndromes" [Mesh]) 
Step 2 AND 3 combined (93491 Citations) 
Step 4 (759 Citations) 
("Diarrhea" [Mesh] AND "chronic disease" [Mesh]) 1, 378 
Step 5 
("environmental enteropathies" OR "environmental enteropathy" OR "tropical enteropathy" OR 
"tropical enteropathies" OR "sprue, tropical " [MeSH] OR "tropical sprue" OR " Idiopathic 
Tropical Malabsorption Syndromes" OR " Idiopathic Tropical Malabsorption Syndrome") 
Step 6 (37074 Citations) 
"Intestinal Absorption" [Mesh] 
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Step 1 OR (Step 2 AND 3) OR Step 4 OR Step 5 OR Step6 (148353 Citations ) 
Step 7 (1826934 Citations ) 
"Child" [Mesh] OR "Maternal-Child Health Centers" [Mesh] OR "Child Nutrition Sciences" [Mesh] 
OR "Child Health Services" [Mesh] OR "Child Nutritional Physiological Phenomena" [Mesh] OR 
"Child Nutrition Disorders" [Mesh] OR "Child Mortality" [Mesh] OR "Child Welfare" [Mesh] OR 
"Child Care" [Mesh] OR "Child Reactive Disorders" [Mesh] OR "Child Guidance" [Mesh] OR 
"Child Reactive Disorders" [Mesh] OR "Child Behavior Disorders" [Mesh] OR "Child, Orphaned" 
[Mesh] OR "Child, Institutionalized" [Mesh] OR "Child, Hospitalized" [Mesh] OR "Child 
Development" [Mesh] OR "Child Behavior" [Mesh] OR "Developmental Disabilities" [Mesh] OR 
"Mental Disorders Diagnosed in Childhood" [Mesh] OR "Disabled Children" [Mesh] OR 
"children" [TIAB] OR "newborn*" [TIAB] OR "childhood" [TIAB] OR "baby" [TIAB] OR "babies" 
[TIAB] OR "toddler" [TIAB] OR "toddlers" [TIAB] OR "infants" [TIAB] OR "infant" [TIAB] OR 
"infantile" [TIAB] OR "young patient" [TIAB] OR "young patients" [TIAB] OR "Pediatric Nursing" 
[Mesh] OR "Pediatric Assistants" [Mesh] OR "Hospitals, Pediatric" [Mesh] OR "Intensive Care 
Units, Pediatric" [Mesh] OR "Pediatrics" [Mesh] OR "Pediatricians" [TIAB] OR "paediatricians" 
[TIAB] OR "Pediatrician" [TIAB] OR "paediatrician" [TIAB] OR "Pediatrics" [TIAB] OR 
"paediatrics" [TIAB] OR "Pediatric" [TIAB] OR "paediatric" [TIAB] 
Step 1 OR (Step 2 AND 3) OR Step 4 OR Step 5 OR Step6 AND Step7 (24156 Citations)  
 
EMBASE TE/ED  
completed April 1, 2010 (20052 Citations) 
Step 1 (39771 Citations)  
'gastroenteritis'/exp OR 'gastroenteritis' OR 'protein losing gastroenteropathy'/exp OR 'protein 
losing gastroenteropathy' OR 'celiac disease'/exp OR 'celiac disease' OR 'tropical sprue'/exp 
OR 'tropical sprue' OR 'infantile gastroenteritis'/exp OR 'infantile gastroenteritis' OR 'acute 
gastroenteritis'/exp OR 'acute gastroenteritis' OR 'viral gastroenteritis'/exp OR 'viral 
gastroenteritis' OR 'persistent diarrhea' OR 'persistent diarrhoea' OR 'recurrent diarrhea' OR 
'recurrent diarrhoea' 
 Step 2 (4062 Citations) 
'intestine mucosa permeability'/exp OR 'small intestine absorption'/exp 
Step 3 (745 Citations)  
'environmental enteropathies' OR 'environmental enteropathy' OR 'tropical enteropathy' OR 
'tropical enteropathies' OR 'tropical sprue'/exp OR 'tropical sprue' OR 'idiopathic tropical 
malabsorption syndromes' OR 'idiopathic tropical malabsorption syndrome' 
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OR  
Step 4 (3611 citations)  
('chronic disease'/exp AND 'diarrhea'/exp) OR 'chronic diarrhea'/exp 
Step 5 (3156573 Citations) 
'child'/exp OR 'child' OR 'children'/exp OR 'children' OR 'youth'/exp OR 'youth' OR youth* OR 
newborn* OR 'newborn'/exp OR 'newborn' OR 'new born' OR 'childhood disease'/exp OR 
'childhood disease' OR 'baby'/exp OR 'baby' OR babies OR 'infant'/exp OR 'infant' OR infant* 
OR childhood* OR toddler* OR kid OR kids OR 'young patient' OR boy* OR girl* OR 'young age' 
OR pediatr* OR paediatr* OR 'child death'/exp OR 'child death' OR 'child health'/exp OR 'child 
health' OR 'child care'/exp OR 'child care' OR 'childhood mortality'/exp OR 'childhood mortality' 
OR 'child hospitalization'/exp OR 'child hospitalization' OR 'pediatric hospital'/exp OR 'pediatric 
hospital' OR child* 
(Step 1 OR Step 2 OR Step 3 OR Step 4) AND Step 5 (20052 Citations)  
 
Global Health TE/ED  
completed June 1, 2010 (7825 citations) 
Step 1 (232244 Citations) 
(child or children or newborn$ or childhood or baby or babies or toddler or toddlers or infants or 
infant or infantile or "young patients" or "young patient" or pediatrics or pediatric or paediatric or 
paediatrics or girls or sons or daughters or "child welfare" or "rearing practices" or unicef or 
paediatr$ or "child development" or "child nutrition" or "child health" or kid or kids or 
pediatricians or paediatricians).af. 
Step 2 (4555 Citations)  
(enteropathy or scouring).id. OR ("chronic infections" and diarrhoea).de. OR (diarrhea and 
"nutritional status").id. OR ("tropical sprue$" or "tropical enteropath$" or "environmental 
enteropath$" or "persistent diarrhea$" or "Persistent diarrhoea$" or "chronic diarrhoea$" 
or "chronic diarrhea$" or "intestinal inflamm*" or "intestinal permeability").af.  
        
Step 3 (620850 Citations) 
(undernutrition or "tropical countries" or "tropical zones" or "parasitic infections").id. or (tropics or 
"bacterial diseases").de. or (vv600 or vv210 or hh600 or ll822 or vv130).cc.  
Step 4 (28447 Citations) 
290
"("intestinal mucosa" or "small intestine" or "gastroenteritis" or intestines or "intestinal diseases" 
or "intestinal absorption").de. or (Intestines or "gastrointestinal tract").id. 
Step 1 AND (Step 2 OR (Step 3 AND Step 4)) (10242 Citations) 
Step 5 (*Journals indexed by PubMed and Embase removed) (2417 Citations) 
"Journal of Pediatric Gastroenterology and Nutrition" [Journals] OR Journal of Clinical 
Microbiology" [Journals] OR"Archives of Disease in Childhood" [Journals] OR"Pediatric 
Infectious Disease Journal" [Journals] OR"Journal of Infectious Diseases" [Journals] 
OR"Journal of Pediatrics" [Journals] OR 
"Clinical Infectious Diseases" [Journals] OR"Infection and Immunity" [Journals] OR 
"Journal of Medical Virology" [Journals] OR"Transactions of the Royal Society of Tropical 
Medicine and Hygiene" [Journals] OR"Journal of Nutrition" [Journals] OR "East African Medical 
Journal" [Journals] 
"BMC Infectious Diseases" [Journals] OR"American Journal of Tropical Medicine and Hygiene" 
[Journals] OR"Pediatric Research" [Journals] OR"Archives de Pediatrie" [Journals] OR 
"Journal of Paediatrics and Child Health" [Journals] OR"Asian Pacific Journal of Allergy and 
Immunology" [Journals] OR"Journal of Tropical Pediatrics" [Journals] 
Step 1 AND (Step 2 OR (Step 3 AND Step 4) NOT Step 5 (7825 Citations)  
 
PubMed Malnutrition  
completed April 19, 2010 (23238 Citations) 
Step 1 (2540333 Citations)          
"developing country" [tiab] OR "developing countries" [tiab] OR "developing nation" [tiab] OR 
"developing nations" [tiab] OR "developing population" [tiab] OR "developing populations" [tiab] 
OR "developing world" [tiab] OR "less developed country" [tiab] OR "less developed countries" 
[tiab] OR "less developed nation" [tiab] OR "less developed nations" [tiab] OR "less developed 
population" [tiab] OR "less developed populations" [tiab] OR "less developed world" [tiab] OR 
"lesser developed country" [tiab] OR "lesser developed countries" [tiab] OR "lesser developed 
nation" [tiab] OR "lesser developed nations" [tiab] OR "lesser developed population" [tiab] OR 
"lesser developed populations" [tiab] OR "lesser developed world" [tiab] OR "under developed 
country" [tiab] OR "under developed countries" [tiab] OR "under developed nation" [tiab] OR 
"under developed nations" [tiab] OR "under developed population" [tiab] OR "under developed 
populations" [tiab] OR "under developed world" [tiab] OR "underdeveloped country" [tiab] OR 
"underdeveloped countries" [tiab] OR "underdeveloped nation" [tiab] OR "underdeveloped 
nations" [tiab] OR "underdeveloped population" [tiab] OR "underdeveloped populations" [tiab] 
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OR "underdeveloped world" [tiab] OR "middle income country" [tiab] OR "middle income 
countries" [tiab] OR "middle income nation" [tiab] OR "middle income nations" [tiab] OR "middle 
income population" [tiab] OR "middle income populations" [tiab] OR "low income country" [tiab] 
OR "low income countries" [tiab] OR "low income nation" [tiab] OR "low income nations" [tiab] 
OR "low income population" [tiab] OR "low income populations" [tiab] OR "lower income 
country" [tiab] OR "lower income countries" [tiab] OR "lower income nation" [tiab] OR "lower 
income nations" [tiab] OR "lower income population" [tiab] OR "lower income populations" [tiab] 
OR "underserved country" [tiab] OR "underserved countries" [tiab] OR "underserved nation" 
[tiab] OR "underserved nations" [tiab] OR "underserved population" [tiab] OR "underserved 
populations" [tiab] OR "underserved world" [tiab] OR "under served country" [tiab] OR "under 
served countries" [tiab] OR "under served nation" [tiab] OR "under served nations" [tiab] OR 
"under served population" [tiab] OR "under served populations" [tiab] OR "under served world" 
[tiab] OR "deprived country" [tiab] OR "deprived countries" [tiab] OR "deprived nation" [tiab] OR 
"deprived nations" [tiab] OR "deprived population" [tiab] OR "deprived populations" [tiab] OR 
"deprived world" [tiab] OR "poor country" [tiab] OR "poor countries" [tiab] OR "poor nation" [tiab] 
OR "poor nations" [tiab] OR "poor population" [tiab] OR "poor populations" [tiab] OR "poor 
world" [tiab] OR "poorer country" [tiab] OR "poorer countries" [tiab] OR "poorer nation" [tiab] OR 
"poorer nations" [tiab] OR "poorer population" [tiab] OR "poorer populations" [tiab] OR "poorer 
world" [tiab] OR "developing economy" [tiab] OR "developing economies" [tiab] OR "less 
developed economy" [tiab] OR "less developed economies" [tiab] OR "lesser developed 
economy" [tiab] OR "lesser developed economies" [tiab] OR "under developed economy" [tiab] 
OR "under developed economies" [tiab] OR "underdeveloped economy" [tiab] OR 
"underdeveloped economies" [tiab] OR "middle income economy" [tiab] OR "middle income 
economies" [tiab] OR "low income economy" [tiab] OR "low income economies" [tiab] OR "lower 
income economy" [tiab] OR "lower income economies" [tiab] OR "low gdp" [tiab] OR "low gnp" 
[tiab] OR "low gross domestic" [tiab] OR "low gross national" [tiab] OR "lower gdp" [tiab] OR 
"lower gnp" [tiab] OR "lower gross domestic" [tiab] OR "lower gross national" [tiab] OR lmic [tiab] 
OR lmics [tiab] OR "third world" [tiab] OR "lami country" [tiab] OR "lami countries" [tiab] OR 
"transitional country" [tiab] OR "transitional countries" [tiab] OR "developing country" [ot] OR 
"developing countries" [ot] OR "developing nation" [ot] OR "developing nations" [ot] OR 
"developing population" [ot] OR "developing populations" [ot] OR "developing world" [ot] OR 
"less developed country" [ot] OR "less developed countries" [ot] OR "less developed nation" [ot] 
OR "less developed nations" [ot] OR "less developed population" [ot] OR "less developed 
populations" [ot] OR "less developed world" [ot] OR "lesser developed country" [ot] OR "lesser 
developed countries" [ot] OR "lesser developed nation" [ot] OR "lesser developed nations" [ot] 
OR "lesser developed population" [ot] OR "lesser developed populations" [ot] OR "lesser 
developed world" [ot] OR "under developed country" [ot] OR "under developed countries" [ot] 
OR "under developed nation" [ot] OR "under developed nations" [ot] OR "under developed 
population" [ot] OR "under developed populations" [ot] OR "under developed world" [ot] OR 
"underdeveloped country" [ot] OR "underdeveloped countries" [ot] OR "underdeveloped nation" 
[ot] OR "underdeveloped nations" [ot] OR "underdeveloped population" [ot] OR 
"underdeveloped populations" [ot] OR "underdeveloped world" [ot] OR "middle income country" 
[ot] OR "middle income countries" [ot] OR "middle income nation" [ot] OR "middle income 
nations" [ot] OR "middle income population" [ot] OR "middle income populations" [ot] OR "low 
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income country" [ot] OR "low income countries" [ot] OR "low income nation" [ot] OR "low income 
nations" [ot] OR "low income population" [ot] OR "low income populations" [ot] OR "lower 
income country" [ot] OR "lower income countries" [ot] OR "lower income nation" [ot] OR "lower 
income nations" [ot] OR "lower income population" [ot] OR "lower income populations" [ot] OR 
"underserved country" [ot] OR "underserved countries" [ot] OR "underserved nation" [ot] OR 
"underserved nations" [ot] OR "underserved population" [ot] OR "underserved populations" [ot] 
OR "underserved world" [ot] OR "under served country" [ot] OR "under served countries" [ot] 
OR "under served nation" [ot] OR "under served nations" [ot] OR "under served population" [ot] 
OR "under served populations" [ot] OR "under served world" [ot] OR "deprived country" [ot] OR 
"deprived countries" [ot] OR "deprived nation" [ot] OR "deprived nations" [ot] OR "deprived 
population" [ot] OR "deprived populations" [ot] OR "deprived world" [ot] OR "poor country" [ot] 
OR "poor countries" [ot] OR "poor nation" [ot] OR "poor nations" [ot] OR "poor population" [ot] 
OR "poor populations" [ot] OR "poor world" [ot] OR "poorer country" [ot] OR "poorer countries" 
[ot] OR "poorer nation" [ot] OR "poorer nations" [ot] OR "poorer population" [ot] OR "poorer 
populations" [ot] OR "poorer world" [ot] OR "developing economy" [ot] OR "developing 
economies" [ot] OR "less developed economy" [ot] OR "less developed economies" [ot] OR 
"lesser developed economy" [ot] OR "lesser developed economies" [ot] OR "under developed 
economy" [ot] OR "under developed economies" [ot] OR "underdeveloped economy" [ot] OR 
"underdeveloped economies" [ot] OR "middle income economy" [ot] OR "middle income 
economies" [ot] OR "low income economy" [ot] OR "low income economies" [ot] OR "lower 
income economy" [ot] OR "lower income economies" [ot] OR "low gdp" [ot] OR "low gnp" [ot] 
OR "low gross domestic" [ot] OR "low gross national" [ot] OR "lower gdp" [ot] OR "lower gnp" 
[ot] OR "lower gross domestic" [ot] OR "lower gross national" [ot] OR lmic [ot] OR lmics [ot] OR 
"third world" [ot] OR "lami country" [ot] OR "lami countries" [ot] OR "transitional country" [ot] OR 
"transitional countries" [ot] OR Africa [pl] OR Asia [pl] OR Caribbean [pl] OR West Indies [pl] OR 
South America [pl] OR Latin America [pl] OR Central America [pl] OR Afghanistan [pl] OR 
Albania [pl] OR Algeria [pl] OR Angola [pl] OR Antigua [pl] OR Barbuda [pl] OR Argentina [pl] 
OR Armenia [pl] OR Armenian [pl] OR Aruba [pl] OR Azerbaijan [pl] OR Bahrain [pl] OR 
Bangladesh [pl] OR Barbados [pl] OR Benin [pl] OR Byelarus [pl] OR Byelorussian [pl] OR 
Belarus [pl] OR Belorussian [pl] OR Belorussia [pl] OR Belize [pl] OR Bhutan [pl] OR Bolivia [pl] 
OR Bosnia [pl] OR Herzegovina [pl] OR Hercegovina [pl] OR Botswana [pl] OR Brazil [pl] OR 
Bulgaria [pl] OR Burkina Faso [pl] OR Burkina Fasso [pl] OR Upper Volta [pl] OR Burundi [pl] 
OR Urundi [pl] OR Cambodia [pl] OR Khmer Republic [pl] OR Kampuchea [pl] OR Cameroon 
[pl] OR Cameroons [pl] OR Cameron [pl] OR Camerons [pl] OR Cape Verde [pl] OR Central 
African Republic [pl] OR Chad [pl] OR Chile [pl] OR China [pl] OR Colombia [pl] OR Comoros 
[pl] OR Comoro Islands [pl] OR Comores [pl] OR Mayotte [pl] OR Congo [pl] OR Zaire [pl] OR 
Costa Rica [pl] OR Cote d'Ivoire [pl] OR Ivory Coast [pl] OR Croatia [pl] OR Cuba [pl] OR 
Cyprus [pl] OR Czechoslovakia [pl] OR Czech Republic [pl] OR Slovakia [pl] OR Slovak 
Republic [pl] OR Djibouti [pl] OR French Somaliland [pl] OR Dominica [pl] OR Dominican 
Republic [pl] OR East Timor [pl] OR East Timur [pl] OR Timor Leste [pl] OR Ecuador [pl] OR 
Egypt [pl] OR United Arab Republic [pl] OR El Salvador [pl] OR Eritrea [pl] OR Estonia [pl] OR 
Ethiopia [pl] OR Fiji [pl] OR Gabon [pl] OR Gabonese Republic [pl] OR Gambia [pl] OR Gaza [pl] 
OR Georgia Republic [pl] OR Georgian Republic [pl] OR Ghana [pl] OR Gold Coast [pl] OR 
Greece [pl] OR Grenada [pl] OR Guatemala [pl] OR Guinea [pl] OR Guam [pl] OR Guiana [pl] 
293
OR Guyana [pl] OR Haiti [pl] OR Honduras [pl] OR Hungary [pl] OR India [pl] OR Maldives [pl] 
OR Indonesia [pl] OR Iran [pl] OR Iraq [pl] OR Isle of Man [pl] OR Jamaica [pl] OR Jordan [pl] 
OR Kazakhstan [pl] OR Kazakh [pl] OR Kenya [pl] OR Kiribati [pl] OR Korea [pl] OR Kosovo [pl] 
OR Kyrgyzstan [pl] OR Kirghizia [pl] OR Kyrgyz Republic [pl] OR Kirghiz [pl] OR Kirgizstan [pl] 
OR "Lao PDR" [pl] OR Laos [pl] OR Latvia [pl] OR Lebanon [pl] OR Lesotho [pl] OR Basutoland 
[pl] OR Liberia [pl] OR Libya [pl] OR Lithuania [pl] OR Macedonia [pl] OR Madagascar [pl] OR 
Malagasy Republic [pl] OR Malaysia [pl] OR Malaya [pl] OR Malay [pl] OR Sabah [pl] OR 
Sarawak [pl] OR Malawi [pl] OR Nyasaland [pl] OR Mali [pl] OR Malta [pl] OR Marshall Islands 
[pl] OR Mauritania [pl] OR Mauritius [pl] OR Agalega Islands [pl] OR Mexico [pl] OR Micronesia 
[pl] OR Middle East [pl] OR Moldova [pl] OR Moldovia [pl] OR Moldovian [pl] OR Mongolia [pl] 
OR Montenegro [pl] OR Morocco [pl] OR Ifni [pl] OR Mozambique [pl] OR Myanmar [pl] OR 
Myanma [pl] OR Burma [pl] OR Namibia [pl] OR Nepal [pl] OR Netherlands Antilles [pl] OR New 
Caledonia [pl] OR Nicaragua [pl] OR Niger [pl] OR Nigeria [pl] OR Northern Mariana Islands [pl] 
OR Oman [pl] OR Muscat [pl] OR Pakistan [pl] OR Palau [pl] OR Palestine [pl] OR Panama [pl] 
OR Paraguay [pl] OR Peru [pl] OR Philippines [pl] OR Philipines [pl] OR Phillipines [pl] OR 
Phillippines [pl] OR Poland [pl] OR Portugal [pl] OR Puerto Rico [pl] OR Romania [pl] OR 
Rumania [pl] OR Roumania [pl] OR Russia [pl] OR Russian [pl] OR Rwanda [pl] OR Ruanda [pl] 
OR Saint Kitts [pl] OR St Kitts [pl] OR Nevis [pl] OR Saint Lucia [pl] OR St Lucia [pl] OR Saint 
Vincent [pl] OR St Vincent [pl] OR Grenadines [pl] OR Samoa [pl] OR Samoan Islands [pl] OR 
Navigator Island [pl] OR Navigator Islands [pl] OR Sao Tome [pl] OR Saudi Arabia [pl] OR 
Senegal [pl] OR Serbia [pl] OR Montenegro [pl] OR Seychelles [pl] OR Sierra Leone [pl] OR 
Slovenia [pl] OR Sri Lanka [pl] OR Ceylon [pl] OR Solomon Islands [pl] OR Somalia [pl] OR 
Sudan [pl] OR Suriname [pl] OR Surinam [pl] OR Swaziland [pl] OR Syria [pl] OR Tajikistan [pl] 
OR Tadzhikistan [pl] OR Tadjikistan [pl] OR Tadzhik [pl] OR Tanzania [pl] OR Thailand [pl] OR 
Togo [pl] OR Togolese Republic [pl] OR Tonga [pl] OR Trinidad [pl] OR Tobago [pl] OR Tunisia 
[pl] OR Turkey [pl] OR Turkmenistan [pl] OR Turkmen [pl] OR Uganda [pl] OR Ukraine [pl] OR 
Uruguay [pl] OR USSR [pl] OR Soviet Union [pl] OR Union of Soviet Socialist Republics [pl] OR 
Uzbekistan [pl] OR Uzbek OR Vanuatu [pl] OR New Hebrides [pl] OR Venezuela [pl] OR 
Vietnam [pl] OR Viet Nam [pl] OR West Bank [pl] OR Yemen [pl] OR Yugoslavia [pl] OR Zambia 
[pl] OR Zimbabwe [pl] OR Rhodesia [pl] OR Africa [tiab] OR Asia [tiab] OR Caribbean [tiab] OR 
West Indies [tiab] OR South America [tiab] OR Latin America [tiab] OR Central America [tiab] 
OR Afghanistan [tiab] OR Albania [tiab] OR Algeria [tiab] OR Angola [tiab] OR Antigua [tiab] OR 
Barbuda [tiab] OR Argentina [tiab] OR Armenia [tiab] OR Armenian [tiab] OR Aruba [tiab] OR 
Azerbaijan [tiab] OR Bahrain [tiab] OR Bangladesh [tiab] OR Barbados [tiab] OR Benin [tiab] OR 
Byelarus [tiab] OR Byelorussian [tiab] OR Belarus [tiab] OR Belorussian [tiab] OR Belorussia 
[tiab] OR Belize [tiab] OR Bhutan [tiab] OR Bolivia [tiab] OR Bosnia [tiab] OR Herzegovina [tiab] 
OR Hercegovina [tiab] OR Botswana [tiab] OR Brazil [tiab] OR Bulgaria [tiab] OR Burkina Faso 
[tiab] OR Burkina Fasso [tiab] OR Upper Volta [tiab] OR Burundi [tiab] OR Urundi [tiab] OR 
Cambodia [tiab] OR Khmer Republic [tiab] OR Kampuchea [tiab] OR Cameroon [tiab] OR 
Cameroons [tiab] OR Cameron [tiab] OR Camerons [tiab] OR Cape Verde [tiab] OR Central 
African Republic [tiab] OR Chad [tiab] OR Chile [tiab] OR China [tiab] OR Colombia [tiab] OR 
Comoros [tiab] OR Comoro Islands [tiab] OR Comores [tiab] OR Mayotte [tiab] OR Congo [tiab] 
OR Zaire [tiab] OR Costa Rica [tiab] OR Cote d'Ivoire [tiab] OR Ivory Coast [tiab] OR Croatia 
[tiab] OR Cuba [tiab] OR Cyprus [tiab] OR Czechoslovakia [tiab] OR Czech Republic [tiab] OR 
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Slovakia [tiab] OR Slovak Republic [tiab] OR Djibouti [tiab] OR French Somaliland [tiab] OR 
Dominica [tiab] OR Dominican Republic [tiab] OR East Timor [tiab] OR East Timur [tiab] OR 
Timor Leste [tiab] OR Ecuador [tiab] OR Egypt [tiab] OR United Arab Republic [tiab] OR El 
Salvador [tiab] OR Eritrea [tiab] OR Estonia [tiab] OR Ethiopia [tiab] OR Fiji [tiab] OR Gabon 
[tiab] OR Gabonese Republic [tiab] OR Gambia [tiab] OR Gaza [tiab] OR Georgia Republic 
[tiab] OR Georgian Republic [tiab] OR Ghana [tiab] OR Gold Coast [tiab] OR Greece [tiab] OR 
Grenada [tiab] OR Guatemala [tiab] OR Guinea [tiab] OR Guam [tiab] OR Guiana [tiab] OR 
Guyana [tiab] OR Haiti [tiab] OR Honduras [tiab] OR Hungary [tiab] OR India [tiab] OR Maldives 
[tiab] OR Indonesia [tiab] OR Iran [tiab] OR Iraq [tiab] OR Isle of Man [tiab] OR Jamaica [tiab] 
OR Jordan [tiab] OR Kazakhstan [tiab] OR Kazakh [tiab] OR Kenya [tiab] OR Kiribati [tiab] OR 
Korea [tiab] OR Kosovo [tiab] OR Kyrgyzstan [tiab] OR Kirghizia [tiab] OR Kyrgyz Republic [tiab] 
OR Kirghiz [tiab] OR Kirgizstan [tiab] OR "Lao PDR" [tiab] OR Laos [tiab] OR Latvia [tiab] OR 
Lebanon [tiab] OR Lesotho [tiab] OR Basutoland [tiab] OR Liberia [tiab] OR Libya [tiab] OR 
Lithuania [tiab] OR Macedonia [tiab] OR Madagascar [tiab] OR Malagasy Republic [tiab] OR 
Malaysia [tiab] OR Malaya [tiab] OR Malay [tiab] OR Sabah [tiab] OR Sarawak [tiab] OR Malawi 
[tiab] OR Nyasaland [tiab] OR Mali [tiab] OR Malta [tiab] OR Marshall Islands [tiab] OR 
Mauritania [tiab] OR Mauritius [tiab] OR Agalega Islands [tiab] OR Mexico [tiab] OR Micronesia 
[tiab] OR Middle East [tiab] OR Moldova [tiab] OR Moldovia [tiab] OR Moldovian [tiab] OR 
Mongolia [tiab] OR Montenegro [tiab] OR Morocco [tiab] OR Ifni [tiab] OR Mozambique [tiab] OR 
Myanmar [tiab] OR Myanma [tiab] OR Burma [tiab] OR Namibia [tiab] OR Nepal [tiab] OR 
Netherlands Antilles [tiab] OR New Caledonia [tiab] OR Nicaragua [tiab] OR Niger [tiab] OR 
Nigeria [tiab] OR Northern Mariana Islands [tiab] OR Oman [tiab] OR Muscat [tiab] OR Pakistan 
[tiab] OR Palau [tiab] OR Palestine [tiab] OR Panama [tiab] OR Paraguay [tiab] OR Peru [tiab] 
OR Philippines [tiab] OR Philipines [tiab] OR Phillipines [tiab] OR Phillippines [tiab] OR Poland 
[tiab] OR Portugal [tiab] OR Puerto Rico [tiab] OR Romania [tiab] OR Rumania [tiab] OR 
Roumania [tiab] OR Russia [tiab] OR Russian [tiab] OR Rwanda [tiab] OR Ruanda [tiab] OR 
Saint Kitts [tiab] OR St Kitts [tiab] OR Nevis [tiab] OR Saint Lucia [tiab] OR St Lucia [tiab] OR 
Saint Vincent [tiab] OR St Vincent [tiab] OR Grenadines [tiab] OR Samoa [tiab] OR Samoan 
Islands [tiab] OR Navigator Island [tiab] OR Navigator Islands [tiab] OR Sao Tome [tiab] OR 
Saudi Arabia [tiab] OR Senegal [tiab] OR Serbia [tiab] OR Montenegro [tiab] OR Seychelles 
[tiab] OR Sierra Leone [tiab] OR Slovenia [tiab] OR Sri Lanka [tiab] OR Ceylon [tiab] OR 
Solomon Islands [tiab] OR Somalia [tiab] OR Sudan [tiab] OR Suriname [tiab] OR Surinam [tiab] 
OR Swaziland [tiab] OR Syria [tiab] OR Tajikistan [tiab] OR Tadzhikistan [tiab] OR Tadjikistan 
[tiab] OR Tadzhik [tiab] OR Tanzania [tiab] OR Thailand [tiab] OR Togo [tiab] OR Togolese 
Republic [tiab] OR Tonga [tiab] OR Trinidad [tiab] OR Tobago [tiab] OR Tunisia [tiab] OR Turkey 
[tiab] OR Turkmenistan [tiab] OR Turkmen [tiab] OR Uganda [tiab] OR Ukraine [tiab] OR 
Uruguay [tiab] OR USSR [tiab] OR Soviet Union [tiab] OR Union of Soviet Socialist Republics 
[tiab] OR Uzbekistan [tiab] OR Uzbek OR Vanuatu [tiab] OR New Hebrides [tiab] OR Venezuela 
[tiab] OR Vietnam [tiab] OR Viet Nam [tiab] OR West Bank [tiab] OR Yemen [tiab] OR 
Yugoslavia [tiab] OR Zambia [tiab] OR Zimbabwe [tiab] OR Rhodesia [tiab] OR Africa [ot] OR 
Asia [ot] OR Caribbean [ot] OR West Indies [ot] OR South America [ot] OR Latin America [ot] 
OR Central America [ot] OR Afghanistan [ot] OR Albania [ot] OR Algeria [ot] OR Angola [ot] OR 
Antigua [ot] OR Barbuda [ot] OR Argentina [ot] OR Armenia [ot] OR Armenian [ot] OR Aruba [ot] 
OR Azerbaijan [ot] OR Bahrain [ot] OR Bangladesh [ot] OR Barbados [ot] OR Benin [ot] OR 
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Byelarus [ot] OR Byelorussian [ot] OR Belarus [ot] OR Belorussian [ot] OR Belorussia [ot] OR 
Belize [ot] OR Bhutan [ot] OR Bolivia [ot] OR Bosnia [ot] OR Herzegovina [ot] OR Hercegovina 
[ot] OR Botswana [ot] OR Brazil [ot] OR Bulgaria [ot] OR Burkina Faso [ot] OR Burkina Fasso 
[ot] OR Upper Volta [ot] OR Burundi [ot] OR Urundi [ot] OR Cambodia [ot] OR Khmer Republic 
[ot] OR Kampuchea [ot] OR Cameroon [ot] OR Cameroons [ot] OR Cameron [ot] OR Camerons 
[ot] OR Cape Verde [ot] OR Central African Republic [ot] OR Chad [ot] OR Chile [ot] OR China 
[ot] OR Colombia [ot] OR Comoros [ot] OR Comoro Islands [ot] OR Comores [ot] OR Mayotte 
[ot] OR Congo [ot] OR Zaire [ot] OR Costa Rica [ot] OR Cote d'Ivoire [ot] OR Ivory Coast [ot] OR 
Croatia [ot] OR Cuba [ot] OR Cyprus [ot] OR Czechoslovakia [ot] OR Czech Republic [ot] OR 
Slovakia [ot] OR Slovak Republic [ot] OR Djibouti [ot] OR French Somaliland [ot] OR Dominica 
[ot] OR Dominican Republic [ot] OR East Timor [ot] OR East Timur [ot] OR Timor Leste [ot] OR 
Ecuador [ot] OR Egypt [ot] OR United Arab Republic [ot] OR El Salvador [ot] OR Eritrea [ot] OR 
Estonia [ot] OR Ethiopia [ot] OR Fiji [ot] OR Gabon [ot] OR Gabonese Republic [ot] OR Gambia 
[ot] OR Gaza [ot] OR "Georgia Republic" [ot] OR "Georgian Republic" [ot] OR Ghana [ot] OR 
Gold Coast [ot] OR Greece [ot] OR Grenada [ot] OR Guatemala [ot] OR Guinea [ot] OR Guam 
[ot] OR Guiana [ot] OR Guyana [ot] OR Haiti [ot] OR Honduras [ot] OR Hungary [ot] OR India 
[ot] OR Maldives [ot] OR Indonesia [ot] OR Iran [ot] OR Iraq [ot] OR Isle of Man [ot] OR Jamaica 
[ot] OR Jordan [ot] OR Kazakhstan [ot] OR Kazakh [ot] OR Kenya [ot] OR Kiribati [ot] OR Korea 
[ot] OR Kosovo [ot] OR Kyrgyzstan [ot] OR Kirghizia [ot] OR Kyrgyz Republic [ot] OR Kirghiz [ot] 
OR Kirgizstan [ot] OR "Lao PDR" [ot] OR Laos [ot] OR Latvia [ot] OR Lebanon [ot] OR Lesotho 
[ot] OR Basutoland [ot] OR Liberia [ot] OR Libya [ot] OR Lithuania [ot] OR Macedonia [ot] OR 
Madagascar [ot] OR Malagasy Republic [ot] OR Malaysia [ot] OR Malaya [ot] OR Malay [ot] OR 
Sabah [ot] OR Sarawak [ot] OR Malawi [ot] OR Nyasaland [ot] OR Mali [ot] OR Malta [ot] OR 
Marshall Islands [ot] OR Mauritania [ot] OR Mauritius [ot] OR Agalega Islands [ot] OR Mexico 
[ot] OR Micronesia [ot] OR Middle East [ot] OR Moldova [ot] OR Moldovia [ot] OR Moldovian [ot] 
OR Mongolia [ot] OR Montenegro [ot] OR Morocco [ot] OR Ifni [ot] OR Mozambique [ot] OR 
Myanmar [ot] OR Myanma [ot] OR Burma [ot] OR Namibia [ot] OR Nepal [ot] OR Netherlands 
Antilles [ot] OR New Caledonia [ot] OR Nicaragua [ot] OR Niger [ot] OR Nigeria [ot] OR 
Northern Mariana Islands [ot] OR Oman [ot] OR Muscat [ot] OR Pakistan [ot] OR Palau [ot] OR 
Palestine [ot] OR Panama [ot] OR Paraguay [ot] OR Peru [ot] OR Philippines [ot] OR Philipines 
[ot] OR Phillipines [ot] OR Phillippines [ot] OR Poland [ot] OR Portugal [ot] OR Puerto Rico [ot] 
OR Romania [ot] OR Rumania [ot] OR Roumania [ot] OR Russia [ot] OR Russian [ot] OR 
Rwanda [ot] OR Ruanda [ot] OR Saint Kitts [ot] OR St Kitts [ot] OR Nevis [ot] OR Saint Lucia 
[ot] OR St Lucia [ot] OR Saint Vincent [ot] OR St Vincent [ot] OR Grenadines [ot] OR Samoa [ot] 
OR Samoan Islands [ot] OR Navigator Island [ot] OR Navigator Islands [ot] OR Sao Tome [ot] 
OR Saudi Arabia [ot] OR Senegal [ot] OR Serbia [ot] OR Montenegro [ot] OR Seychelles [ot] 
OR Sierra Leone [ot] OR Slovenia [ot] OR Sri Lanka [ot] OR Ceylon [ot] OR Solomon Islands 
[ot] OR Somalia [ot] OR Sudan [ot] OR Suriname [ot] OR Surinam [ot] OR Swaziland [ot] OR 
Syria [ot] OR Tajikistan [ot] OR Tadzhikistan [ot] OR Tadjikistan [ot] OR Tadzhik [ot] OR 
Tanzania [ot] OR Thailand [ot] OR Togo [ot] OR Togolese Republic [ot] OR Tonga [ot] OR 
Trinidad [ot] OR Tobago [ot] OR Tunisia [ot] OR Turkey [ot] OR Turkmenistan [ot] OR Turkmen 
[ot] OR Uganda [ot] OR Ukraine [ot] OR Uruguay [ot] OR USSR [ot] OR Soviet Union [ot] OR 
Union of Soviet Socialist Republics [ot] OR Uzbekistan [ot] OR Uzbek OR Vanuatu [ot] OR New 
Hebrides [ot] OR Venezuela [ot] OR Vietnam [ot] OR Viet Nam [ot] OR West Bank [ot] OR 
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Yemen [ot] OR Yugoslavia [ot] OR Zambia [ot] OR Zimbabwe [ot] OR Rhodesia [ot] OR 
Developing Countries [Mesh:noexp] OR Africa [Mesh:noexp] OR Africa, Northern [Mesh:noexp] 
OR Africa South of the Sahara [Mesh:noexp] OR Africa, Central [Mesh:noexp] OR Africa, 
Eastern [Mesh:noexp] OR Africa, Southern [Mesh:noexp] OR Africa, Western [Mesh:noexp] OR 
Asia [Mesh:noexp] OR Asia, Central [Mesh:noexp] OR Asia, Southeastern [Mesh:noexp] OR 
Asia, Western [Mesh:noexp] OR Caribbean Region [Mesh:noexp] OR West Indies [Mesh:noexp] 
OR South America [Mesh:noexp] OR Latin America [Mesh:noexp] OR Central America 
[Mesh:noexp] OR Afghanistan [Mesh:noexp] OR Albania [Mesh:noexp] OR Algeria 
[Mesh:noexp] OR American Samoa [Mesh:noexp] OR Angola [Mesh:noexp] OR "Antigua and 
Barbuda" [Mesh:noexp] OR Argentina [Mesh:noexp] OR Armenia [Mesh:noexp] OR Azerbaijan 
[Mesh:noexp] OR Bahrain [Mesh:noexp] OR Bangladesh [Mesh:noexp] OR Barbados 
[Mesh:noexp] OR Benin [Mesh:noexp] OR Byelarus [Mesh:noexp] OR Belize [Mesh:noexp] OR 
Bhutan [Mesh:noexp] OR Bolivia [Mesh:noexp] OR Bosnia-Herzegovina [Mesh:noexp] OR 
Botswana [Mesh:noexp] OR Brazil [Mesh:noexp] OR Bulgaria [Mesh:noexp] OR Burkina Faso 
[Mesh:noexp] OR Burundi [Mesh:noexp] OR Cambodia [Mesh:noexp] OR Cameroon 
[Mesh:noexp] OR Cape Verde [Mesh:noexp] OR Central African Republic [Mesh:noexp] OR 
Chad [Mesh:noexp] OR Chile [Mesh:noexp] OR China [Mesh:noexp] OR Colombia 
[Mesh:noexp] OR Comoros [Mesh:noexp] OR Congo [Mesh:noexp] OR Costa Rica 
[Mesh:noexp] OR Cote d'Ivoire [Mesh:noexp] OR Croatia [Mesh:noexp] OR Cuba [Mesh:noexp] 
OR Cyprus [Mesh:noexp] OR Czechoslovakia [Mesh:noexp] OR Czech Republic [Mesh:noexp] 
OR Slovakia [Mesh:noexp] OR Djibouti [Mesh:noexp] OR "Democratic Republic of the Congo" 
[Mesh:noexp] OR Dominica [Mesh:noexp] OR Dominican Republic [Mesh:noexp] OR East 
Timor [Mesh:noexp] OR Ecuador [Mesh:noexp] OR Egypt [Mesh:noexp] OR El Salvador 
[Mesh:noexp] OR Eritrea [Mesh:noexp] OR Estonia [Mesh:noexp] OR Ethiopia [Mesh:noexp] 
OR Fiji [Mesh:noexp] OR Gabon [Mesh:noexp] OR Gambia [Mesh:noexp] OR "Georgia 
(Republic)" [Mesh:noexp] OR Ghana [Mesh:noexp] OR Greece [Mesh:noexp] OR Grenada 
[Mesh:noexp] OR Guatemala [Mesh:noexp] OR Guinea [Mesh:noexp] OR Guinea-Bissau 
[Mesh:noexp] OR Guam [Mesh:noexp] OR Guyana [Mesh:noexp] OR Haiti [Mesh:noexp] OR 
Honduras [Mesh:noexp] OR Hungary [Mesh:noexp] OR India [Mesh:noexp] OR Indonesia 
[Mesh:noexp] OR Iran [Mesh:noexp] OR Iraq [Mesh:noexp] OR Jamaica [Mesh:noexp] OR 
Jordan [Mesh:noexp] OR Kazakhstan [Mesh:noexp] OR Kenya [Mesh:noexp] OR Korea 
[Mesh:noexp] OR Kosovo [Mesh:noexp] OR Kyrgyzstan [Mesh:noexp] OR Laos [Mesh:noexp] 
OR Latvia [Mesh:noexp] OR Lebanon [Mesh:noexp] OR Lesotho [Mesh:noexp] OR Liberia 
[Mesh:noexp] OR Libya [Mesh:noexp] OR Lithuania [Mesh:noexp] OR Macedonia [Mesh:noexp] 
OR Madagascar [Mesh:noexp] OR Malaysia [Mesh:noexp] OR Malawi [Mesh:noexp] OR Mali 
[Mesh:noexp] OR Malta [Mesh:noexp] OR Mauritania [Mesh:noexp] OR Mauritius [Mesh:noexp] 
OR Mexico [Mesh:noexp] OR Micronesia [Mesh:noexp] OR Middle East [Mesh:noexp] OR 
Moldova [Mesh:noexp] OR Mongolia [Mesh:noexp] OR Montenegro [Mesh:noexp] OR Morocco 
[Mesh:noexp] OR Mozambique [Mesh:noexp] OR Myanmar [Mesh:noexp] OR Namibia 
[Mesh:noexp] OR Nepal [Mesh:noexp] OR Netherlands Antilles [Mesh:noexp] OR New 
Caledonia [Mesh:noexp] OR Nicaragua [Mesh:noexp] OR Niger [Mesh:noexp] OR Nigeria 
[Mesh:noexp] OR Oman [Mesh:noexp] OR Pakistan [Mesh:noexp] OR Palau [Mesh:noexp] OR 
Panama [Mesh:noexp] OR Papua New Guinea [Mesh:noexp] OR Paraguay [Mesh:noexp] OR 
Peru [Mesh:noexp] OR Philippines [Mesh:noexp] OR Poland [Mesh:noexp] OR Portugal 
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[Mesh:noexp] OR Puerto Rico [Mesh:noexp] OR Romania [Mesh:noexp] OR Russia 
[Mesh:noexp] OR "Russia (Pre-1917)" [Mesh:noexp] OR Rwanda [Mesh:noexp] OR "Saint Kitts 
and Nevis" [Mesh:noexp] OR Saint Lucia [Mesh:noexp] OR "Saint Vincent and the Grenadines" 
[Mesh:noexp] OR Samoa [Mesh:noexp] OR Saudi Arabia [Mesh:noexp] OR Senegal 
[Mesh:noexp] OR Serbia [Mesh:noexp] OR Montenegro [Mesh:noexp] OR Seychelles 
[Mesh:noexp] OR Sierra Leone [Mesh:noexp] OR Slovenia [Mesh:noexp] OR Sri Lanka 
[Mesh:noexp] OR Somalia [Mesh:noexp] OR South Africa [Mesh:noexp] OR Sudan 
[Mesh:noexp] OR Suriname [Mesh:noexp] OR Swaziland [Mesh:noexp] OR Syria [Mesh:noexp] 
OR Tajikistan [Mesh:noexp] OR Tanzania [Mesh:noexp] OR Thailand [Mesh:noexp] OR Togo 
[Mesh:noexp] OR Tonga [Mesh:noexp] OR "Trinidad and Tobago" [Mesh:noexp] OR Tunisia 
[Mesh:noexp] OR Turkey [Mesh:noexp] OR Turkmenistan [Mesh:noexp] OR Uganda 
[Mesh:noexp] OR Ukraine [Mesh:noexp] OR Uruguay [Mesh:noexp] OR USSR [Mesh:noexp] 
OR Uzbekistan [Mesh:noexp] OR Vanuatu [Mesh:noexp] OR Venezuela [Mesh:noexp] OR 
Vietnam [Mesh:noexp] OR Yemen [Mesh:noexp] OR Yugoslavia [Mesh:noexp] OR Zambia 
[Mesh:noexp] OR Zimbabwe [Mesh:noexp] OR "tropical climate" OR "tropical climate" [MeSH] 
OR "Vulnerable Populations" [Mesh] OR "American Native Continental Ancestry Group" [Mesh] 
OR "Oceanic Ancestry Group" [Mesh] OR "aboriginals" [all fields] OR "aboriginals" [all fields] OR 
"native americans" [all fields] OR "native american" [all fields] OR "first nations" [all fields] OR 
inuit [all fields] OR eskimo [all fields] OR eskimos [all fields] OR maori [all fields] OR "Health 
Services, Indigenous" [MeSH] 
Step 2 (53847 Citations)  
"Growth Disorders" [Mesh:NoExp] OR "Body Weight Changes" [Mesh] OR "Child Nutrition 
Disorders" [Mesh] OR "Infant Nutrition Disorders" [Mesh] 
Step 1 AND Step 2 (7592 Citations) 
Step 3 (73672 Citations) 
"Failure to Thrive" [Mesh] OR "Body Height" [Mesh]OR "Thinness" [Mesh] OR "Starvation" 
[Mesh] OR "Protein Deficiency" [Mesh] OR "Malnutrition" [Mesh] OR "Malnutrition" 
[Mesh] or "stunting" [all fields] OR "stunted" [all fields] OR "wasted" [TIAB] OR "wasting" 
[TIAB] OR "height for age" [all fields] OR "weight for age" [all fields] OR "weight for 
height" [all fields] OR "growth faltering" [all fields] OR "underweight" [all fields] OR "under 
weight" [all fields] OR "short stature" [all fields] 
(Step 1 AND Step 2) OR Step 3 (79085 Citations) 
Step 4 (1848948 Citations) 
'Child' [Mesh] OR 'Maternal-Child Health Centers' [Mesh] OR 'Child Nutrition Sciences' [Mesh] 
OR 'Child Health Services' [Mesh] OR 'Child Nutritional Physiological Phenomena' [Mesh] OR 
'Child Nutrition Disorders' [Mesh] OR 'Child Mortality' [Mesh] OR 'Child Welfare' [Mesh] OR 
'Child Care' [Mesh] OR 'Child Reactive Disorders' [Mesh] OR 'Child Guidance' [Mesh] OR 'Child 
Reactive Disorders' [Mesh] OR 'Child Behavior Disorders' [Mesh] OR 'Child, Orphaned' [Mesh] 
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OR 'Child, Institutionalized' [Mesh] OR 'Child, Hospitalized' [Mesh] OR 'Child Development' 
[Mesh] OR 'Child Behavior' [Mesh] OR 'Developmental Disabilities' [Mesh] OR 'Mental Disorders 
Diagnosed in Childhood' [Mesh] OR 'Disabled Children' [Mesh] OR 'children' [TIAB] OR 
'newborn*' [TIAB] OR 'childhood' [TIAB] OR 'baby' [TIAB] OR 'babies' [TIAB] OR 'toddler' [TIAB] 
OR 'toddlers' [TIAB] OR 'infants' [TIAB] OR 'infant' [TIAB] OR 'infantile' [TIAB] OR 'young patient' 
[TIAB] OR 'young patients' [TIAB] OR 'Pediatric Nursing' [Mesh] OR 'Pediatric Assistants' 
[Mesh] OR 'Hospitals, Pediatric' [Mesh] OR 'Intensive Care Units, Pediatric' [Mesh] OR 
'Pediatrics' [Mesh] OR 'Pediatricians' [TIAB] OR 'paediatricians' [TIAB] OR 'Pediatrician' [TIAB] 
OR 'paediatrician' [TIAB] OR 'Pediatrics' [TIAB] OR 'paediatrics' [TIAB] OR 'Pediatric' [TIAB] OR 
'paediatric' [TIAB]  
Step 4 AND ((Step 1 AND Step 2) OR Step 3(34445 Citations)) 
Step 5 (2329420 Citations) 
"Congenital Abnormalities" [Mesh] OR "Genetic Diseases, Inborn" [Mesh] OR "Endocrine 
System Diseases" [Mesh]OR "Hormones, Hormone Substitutes, and Hormone Antagonists" 
[Mesh] OR "Kidney Diseases" [Mesh] 
(Step 4 AND ((Step 1 AND Step 2) OR Step 3)) NOT Step 5 23238 Citations 
  
 
EMBASE Malnutrition  
completed April 19, 2010 (17,634 Citations) 
Step 1 (3,164,283 citations) 
'child'/exp OR 'child' OR 'children'/exp OR 'children' OR 'youth'/exp OR 'youth' OR youth* OR 
newborn* OR 'newborn'/exp OR 'newborn' OR 'new born' OR 'childhood disease'/exp OR 
'childhood disease' OR 'baby'/exp OR 'baby' OR babies OR 'infant'/exp OR 'infant' OR infant* 
OR childhood* OR toddler* OR kid OR kids OR 'young patient' OR boy* OR girl* OR 'young age' 
OR pediatr* OR paediatr* OR 'child death'/exp OR 'child death' OR 'child health'/exp OR 'child 
health' OR 'child care'/exp OR 'child care' OR 'childhood mortality'/exp OR 'childhood mortality' 
OR 'child hospitalization'/exp OR 'child hospitalization' OR 'pediatric hospital'/exp OR 'pediatric 
hospital' OR child* 
 Step 2 (4,437,122 Citations) 
Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or Armenia or 
Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or Byelarus or 
Byelorussian or Belarus or Belorussian or Belorussia or Belize or Bhutan or Bolivia or Bosnia or 
Herzegovina or Hercegovina or Botswana or Brazil or Bulgaria or 'Burkina Faso' or 'Burkina 
Fasso' or 'Upper Volta' or Burundi or Urundi or Cambodia or 'Khmer Republic' or Kampuchea or 
Cameroon or Cameroons or Cameron or Camerons or 'Cape Verde' or 'Central African 
299
Republic' or Chad or Chile or China or Colombia or Comoros or 'Comoro Islands' or Comores or 
Mayotte or Congo or Zaire or 'Costa Rica' or 'Cote d Ivoire' or 'Ivory Coast' or Croatia or Cuba or 
Cyprus or Czechoslovakia or 'Czech Republic' or Slovakia or 'Slovak Republic' or Djibouti or 
'French Somaliland' or Dominica or 'Dominican Republic' or 'East Timor' or 'East Timur' or 
'Timor Leste' or Ecuador or Egypt or 'United Arab Republic' or 'El Salvador' or Eritrea or Estonia 
or Ethiopia or Fiji or Gabon or 'Gabonese Republic' or Gambia or Gaza or 'Georgia Republic' or 
'Georgian Republic' or Ghana or 'Gold Coast' or Greece or Grenada or Guatemala or Guinea or 
Guam or Guiana or Guyana or Haiti or Honduras or Hungary or India or Maldives or Indonesia 
or Iran or Iraq or Jamaica or Jordan or Kazakhstan or Kazakh or Kenya or Kiribati or Korea or 
Kosovo or Kyrgyzstan or Kirghizia or Kyrgyz or Kirghiz or Kirgizstan or 'Lao PDR' or Laos or 
Latvia or Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania or Macedonia or 
Madagascar or Malagasy or Malaysia or Malaya or Malay or Sabah or Sarawak or Malawi or 
Nyasaland or Mali or Malta or 'Marshall Islands' or Mauritania or Mauritius or 'Agalega Islands' 
or Mexico or Micronesia or 'Middle East' or Moldova or Moldovia or Moldovian or Mongolia or 
Montenegro or Morocco or Ifni or Mozambique or Myanmar or Myanma or Burma or Namibia or 
Nepal or 'Netherlands Antilles' or 'New Caledonia' or Nicaragua or Niger or Nigeria or 'Mariana 
Islands' or Oman or Muscat or Pakistan or Palau or Palestine or Panama or Paraguay or Peru 
or Philippines or Philipines or Phillipines or Phillippines or Poland or Portugal or 'Puerto Rico' or 
Romania or Rumania or Roumania or Russia or Russian or Rwanda or Ruanda or 'Saint Kitts' 
or 'St Kitts' or Nevis or 'Saint Lucia' or 'St Lucia' or 'Saint Vincent' or 'St Vincent' or Grenadines 
or Samoa or 'Samoan Islands' or 'Navigator Island' or 'Navigator Islands' or 'Sao Tome' or 
'Saudi Arabia' or Senegal or Serbia or Montenegro or Seychelles or 'Sierra Leone' or Slovenia 
or 'Sri Lanka' or Ceylon or 'Solomon Islands' or Somalia or Sudan or Suriname or Surinam or 
Swaziland or Syria or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or Tanzania or 
Thailand or Togo or Togolese or Tonga or Trinidad or Tobago or Tunisia or Turkey or 
Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay or USSR or 'Soviet Union' or 'Union 
of Soviet Socialist Republics' or Uzbekistan or Uzbek or Vanuatu or 'New Hebrides' or 
Venezuela or Vietnam or 'Viet Nam' or 'West Bank' or Yemen or Yugoslavia or Zambia or 
Zimbabwe or Rhodesia OR ((developing or 'less developed' or 'under developed' or 
underdeveloped or 'middle income' or 'low income' or 'lower income' or underserved or 'under 
served' or deprived or poor*) and (countr* or nation* or population* or world)) OR ((developing 
or 'less developed' or 'lesser developed' or 'under developed' or underdeveloped or middle 
income or 'lower income' or 'lower income') AND (economy or economies)) OR (low* NEAR 
(gdp or gnp or gross domestic or gross national )) OR ( low NEAR/3 middle ) OR (lmic OR lmics 
OR third AND world OR 'lami countries' OR 'lami country') OR ( transitional AND countr*) OR 
'tropic climate'/exp OR 'aborigine'/exp OR 'American Indian'/exp OR 'Eskimo'/exp OR 
'Maori'/exp OR 'indigenous people'/exp 
Step 3 (141,231 Citations) 
'thinness' OR 'stunted' OR 'stunting' OR 'growth faltering' OR 'wasted' OR 'height for age' OR 
'weight for age' OR 'weight for height' OR 'underweight' OR 'under weight' OR 'growth failure' 
OR 'protein deficiency'/exp OR 'starvation'/exp OR 'underweight'/exp OR 'lean body weight'/exp 
OR 'weight change'/exp OR 'growth curve'/exp OR 'growth inhibition'/exp OR 'growth rate'/exp 
OR 'postnatal growth'/exp OR 'failure to thrive'/exp OR 'wasting syndrome'/exp OR 
'malnutrition'/de or 'developmental, age and growth parameters'/de OR 'growth disorder'/de OR 
'body height'/exp OR 'body height'/exp 
Step 1 AND Step 2 AND Step 3 (24,575 Citations) 
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Step 4  
'genetic and familial disorders'/exp OR 'congenital disorder'/exp OR 'endocrine disease'/exp OR 
'hormones and agents acting on the endocrine system'/exp OR 'urogenital tract disease'/exp OR 
'neoplasm'/exp 
 (Step 1 AND Step 2 AND Step 3) NOT Step 4 (16,833 Citations) 
Step 5 (13,130 Citations) 
'growth retardation'/exp 
    
Step 1 and Step 2 and Step 5 (2,321 Citations) 
Step 6 (5,6000,005) 
'genetic and familial disorders'/exp OR 'congenital disorder'/exp OR 'hormones and agents 
acting on the endocrine system'/exp OR 'urogenital tract disease'/exp OR 'neoplasm'/exp 
(Step 1 and Step 2 and Step 3) NOT Step 6 (801 Citations) 
 
 ((Step 1 AND Step 2 AND Step 3) NOT Step 4) OR ((Step 1 and Step 2 and Step 5) NOT Step 
6) (17,634 Citations)  
 
WHO LILACS Database (TE/ED and Malnutrition)  
completed June 17, 2010 (1617 Citations) 
("tropical sprue" OR "tropical enteropathy" OR "environmental enteropathy" OR "persistent 
diarrhea" OR "Persistent diarrhoea" or "chronic diarrhoea" or "chronic diarrhea" OR "tropical 
malabsorption syndrome" OR Stunting OR wasting OR underweight OR "height for age" OR 
"weight for height" OR "weight for age" OR malnutrition) and ( Child OR Children OR newborn 
OR childhood OR baby OR babies OR toddler OR toddlers OR infants OR infant OR infantile 
OR young patient OR young patients OR Pediatricians OR paediatricians OR Pediatrician OR 
paediatrician OR Pediatrics OR paediatrics OR Pediatric OR paediatric )  
 
WHO SE Asia Database (IMSEAR) (TE/ED and Malnutrition)  
completed June 17, 2010 (1335 Citations) 
(("tropical sprue" OR "tropical enteropathy" OR "environmental enteropathy" OR "persistent 
diarrhea" OR "Persistent diarrhoea" or "chronic diarrhoea" or "chronic diarrhea" OR "tropical 
malabsorption syndrome" OR Stunting OR wasting OR underweight OR "height for age" OR 
"weight for height" OR "weight for age" OR malnutrition) AND (Child OR Children OR newborn 
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OR childhood OR baby OR babies OR toddler OR toddlers OR infants OR infant OR infantile 
OR young patient OR young patients OR Pediatricians OR paediatricians OR Pediatrician OR 
paediatrician OR Pediatrics OR paediatrics OR Pediatric OR paediatric)) 
 
 
WHO Western Pacific Region Index Medicus (WPRIM) (TE/ED and Malnutrition)  
completed June 17, 2010 (685 Citations) 
"tropical sprue" OR "tropical enteropathy" OR "environmental enteropathy" OR "persistent 
diarrhea" OR "Persistent diarrhoea" or "chronic diarrhoea" or "chronic diarrhea" OR "tropical 
malabsorption syndrome" OR Stunting OR wasting OR underweight OR "height for age" OR 
"weight for height" OR "weight for age" OR malnutrition  
 
WHO EMRO (IMEMR) (TE/ED and Malnutrition)  
completed June 17, 2010 (459 Citations) 
Child OR Children OR newborn OR childhood OR baby OR babies OR toddler OR toddlers OR 
infants OR infant OR infantile OR young patient OR young patients OR Pediatricians OR 
paediatricians OR Pediatrician OR paediatrician OR Pediatrics OR paediatrics OR Pediatric OR 
paediatric [KeyWords] and "tropical sprue" OR "tropical enteropathy" OR "environmental 
enteropathy" OR "persistent diarrhea" OR "Persistent diarrhoea" or "chronic diarrhoea" or 
"chronic diarrhea" OR "tropical malabsorption syndrome" OR Stunting OR wasting OR 
underweight OR "height for age" OR "weight for height" OR "weight for age" OR malnutrition 
[KeyWords]  
 
WHO African Index Medicus (TE/ED and Malnutrition)  
completed June 17, 2010 (70 Citations) 
"tropical sprue" OR "tropical enteropathy" OR "environmental enteropathy" OR "persistent 
diarrhea" OR "Persistent diarrhoea" or "chronic diarrhoea" or "chronic diarrhea" OR "tropical 
malabsorption syndrome" OR Stunting OR wasting OR underweight OR "height for age" OR 
"weight for height" OR "weight for age" OR malnutrition 
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Appendix 2. References used to test systematic search. 
These papers were used to confirm inclusiveness in search criteria, and to confirm that filters do 
not inadvertently exclude relevant work. 
Reference Setting and why selected 
Brown KH, Khatun M, Ahmed G. Relationship of the xylose 
absorption status of children in Bangladesh to their 
absorption of macronutrients from local diets. Am J Clin Nut. 
1981;34(8):1540-7. 
Setting: Bangladesh 
Reason for selection: Biomarker and 
physiologic test studied 
Fagundes-Neto U, Viaro T, Wehba J, Patrício FR, Machado 
NL. Tropical enteropathy (environmental enteropathy) in 
early childhood: a syndrome caused by contaminated 
environment. J Trop Pediatr. 1984;30(4):204-9. 
Setting: Brazil 
Reason for selection: Biomarkers, 
pathophysiologic correlates 
Solomons NW, Mazariegos M, Brown KH, Klasing K. The 
underprivileged, developing country child: environmental 
contamination and growth failure revisited. Nutr Rev 
1993;51(11):327-32. 
Setting: Review 
Reason for selection: Addresses 
pathophysiology and epidemiology 
Fagundes-Neto U, Martins MC, Lima FL, Patricio FR, Toledo 
MR. Asymptomatic environmental enteropathy among slum-
dwelling infants. J Am Coll Nutr 1994;13(1):51-6. 
Setting: Brazil 
Reason for selection: Pathophysiology 
Bhutta ZA, Hendricks KM. Nutritional management of 
persistent diarrhea in childhood: a perspective from the 
developing world. J Pediatr Gastroenterol Nutr 
1996;22(1):17-37. 
Setting: Review 
Reason for selection: Therapy and 
epidemiology 
Menzies IS, Zuckerman MJ, Nukajam WS, Somasundaram 
SG, Murphy B, Jenkins AP, et al. Geography of intestinal 
permeability and absorption. Gut 1999;44(4):483-91. 
Setting: Qatar  
Reason for selection: Pathophysiology 
Campbell DI, Elia M, Lunn PG. Growth faltering in rural 
Gambian infants is associated with impaired small intestinal 
barrier function, leading to endotoxemia and systemic 
inflammation. J Nutr. 2003;133(5):1332-8. 
Setting: Gambia 
Reason for selection: Biomarkers related to 
stunting 
Kukuruzovic R, Brewster DR, Gray E, Anstey NM. Increased 
nitric oxide production in acute diarrhoea is associated with 
abnormal gut permeability, hypokalaemia and malnutrition in 
tropical Australian aboriginal children. Trans R Soc Trop Med 
Hyg. 2003;97(1):115-20. 
Setting: Australian Aboriginal children  
Reason for selection: Relates a relevant 
biomarker (NO production) to 
lactulose/rhamnose test of intestinal 
permeability  
Solomons NW. Environmental contamination and chronic 
inflammation influence human growth potential. J Nutr 
2003;133(5):12372. 
Setting: Commentary 
Reason for selection: Risk factors 
1 The reference was not captured in the umbrella search of multiple databases with both TE/ED and stunting search 
terms (i.e., PubMed + EMBASE + GH—TE/ED + stunting). 
2 The reference was captured in the PubMed stunting search but lost when the child filter was added. 
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Reference Setting and why selected 
Campbell DI, McPhail G, Lunn PG, Elia M, Jeffries DJ. 
Intestinal inflammation measured by fecal neopterin in 
Gambian children with enteropathy: association with growth 
failure, Giardia lamblia, and intestinal permeability. J Pediatr 
Gastroenterol Nutr. 2004;39(2):153-7.  
Setting: Gambia 
Reason for selection: Marker of gut 
inflammation in children and inflammation is 
related to another biomarker 
(lactulose:mannitol ratio) and growth of 
children in study 
Salazar-Lindo E, Allen S, Brewster DR, Elliott EJ, Fasano A, 
Phillips AD, et al. Intestinal infections and environmental 
enteropathy: Working Group report of the second World 
Congress of Pediatric Gastroenterology, Hepatology, and 
Nutrition. J Pediatr Gastroenterol Nutr 2004;39 Suppl 
2:S662-9. 
Setting: Review 
Reason for selection: Broadly inclusive of 
topics of interest 
Lima AA, Brito LF, Ribeiro HB, Martins MC, Lustosa AP, 
Rocha EM, et al. Intestinal barrier function and weight gain in 
malnourished children taking glutamine supplemented 
enteral formula. J Pediatr Gastroenterol Nutr 2005;40(1):28-
35. 
Setting: Brazil 
Reason for selection: Pathophysiology and 
treatment 
Bhutta ZA. Effect of infections and environmental factors on 
growth and nutritional status in developing countries. J 
Pediatr Gastroenterol Nutr 2006;43 Suppl 3:S13-213. 
Setting: Review 
Reason for selection: Epidemiology and 
causative factors 
Bhutta ZA, Nelson EA, Lee WS, Tarr PI, Zablah R, Phua KB, 
et al. Recent advances and evidence gaps in persistent 
diarrhea. J Pediatr Gastroenterol Nutr 2008;47(2):260-5. 
Setting: Review 
Reason for selection: Broadly inclusive data 
Botero-Garcés JH, García-Montoya GM, Grisales-Patiño D, 
Aguirre-Acevedo DC, Alvarez-Uribe MC. Giardia intestinalis 
and nutritional status in children participating in the 
complementary nutrition program, Antioquia, Colombia, May 
to October 2006.Rev Inst Med Trop Sao Paulo. 
2009;51(5):155-62.  
Setting: Colombia 
Reason for selection: Studies relation 
between a specific agent and nutritional 
status  
Goto R, Mascie-Taylor CG, Lunn PG. Impact of intestinal 
permeability, inflammation status and parasitic infections on 
infant growth faltering in rural Bangladesh 2009:Br J Nutr. 
2009;101(10):1509-16.  
Setting: Rural Bangladesh 
Reason for selection: Biomarkers 
associated with stunting  
Humphrey JH. Child undernutrition, tropical enteropathy, 
toilets, and handwashing. Lancet 2009;374(9694):1032-5. 
Setting: Review 
Reason for selection: Environmental factors 
Ritchie BK, Brewster DR, Davidson GP, Tran CD, McNeil Y, 
Hawkes JS, et al. 13C-sucrose breath test: novel use of a 
noninvasive biomarker of environmental gut health. 
Pediatrics. 2009;124(2):620-6.  
Setting: Australian Aboriginal children 
Reason for selection: Novel biomarker 




3 The reference was captured in the search with only the stunting term. 
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Appendix 3. Summary of sampled references published between 1990-1999. 
Method: An index of records determined to be relevant to this systematic review was sorted by 
year. From this ordering, every 10th article was sampled. 
 
1. Khoshoo V, Bhan MK, Jain R, Jayashree S, Bhandari N, Sazawal S, et al. Intestinal glucoamylase and 
other disaccharidases in children with protracted diarrhoea. Indian J Med Res. 1990;92:1-4. 
Sample size: 42 (all < 5 years of age) 
Subjects: Persistent or chronic diarrhea and malnutrition 
Markers: Jejunal biopsy, brush border disaccharidase activity, and correlation of latter with degree of 
mucosal injury 
Relevance to 2000-2010 set: Disaccharidase activity was investigated in one study from the previous 
decade; this study adds assessment of its relationship with histology. 
 
2. Saavedra JM, Brown KH. Nonabsorbable marker and single, random stool samples used for 
measuring intestinal absorption of macronutrients in infants and children. Am J Clin Nutr. 1991;53(3):790-
94. 
Sample size: 21 (all < 5 years of age) 
Subjects: Malnourished 
Markers: Fecal excretion of polyethylene glycol as a marker of intestinal absorption and in comparison to 
standard balance test 
Relevance to 2000-2010 set: These tests of absorption were not included in the previous decade article 
set.  
 
3. Sullivan PB, Lunn PG, Northrop-Clewes C, Crowe PT, Marsh MN, Neale G. Persistent diarrhea and 
malnutrition--the impact of treatment on small bowel structure and permeability. J Pediatr Gastroenterol 
Nutr. 1992;14(2):208-15. 
Sample size: 20 (all < 5 years of age) 
Subjects: Persistent or chronic diarrhea, most also malnourished 
Markers: Lactulose and mannitol fractional excretion, L:M, and jejunal biopsy; compared L:M with biopsy 
results  
Relevance to 2000-2010 set: The L:M test was reported in 25 studies in later decade, but none compared 
it to histology. 
 
4. Baqui AH, Sack RB, Black RE, Chowdhury HR, Yunus M, Siddique AK. Cell-mediated immune 
deficiency and malnutrition are independent risk factors for persistent diarrhea in Bangladeshi children. 
Am J Clin Nutr. 1993;58(4):543-48. 
Sample size: 705 (all < 5 years of age) 
Subjects: Persistent diarrhea, malnutrition, or asymptomatic 
Markers: Cell-mediated immune response with multiple-antigen skin test  
Relevance to 2000-2010 set: A similar study was published in the 2000-2010 publication set. 
 
5. Roy SK, Akramuzzaman SM, Haider R, Khatun M, Akbar MS, Eeckels R. Persistent diarrhoea: efficacy 
of a rice-based diet and role of nutritional status in recovery and nutrient absorption. Br J Nutr. 
1994;71(1):123-34. 
Sample size: 51 (all < 5 years of age) 
Subjects: Persistent diarrhea (many also malnourished) and controls with previous history of acute 
diarrhea 
Markers: Comparison of nutrient absorption in cases and controls determined by 72-hour balance study 
and recovery of cases following rice-based diet therapy 




6. Kallas MR, Patricio FR, Fagundes-Neto U. [Morphometrics of the small intestine in children with 
diarrhea due to classical enteropathogenic Escherichia coli and to environmental asymptomatic 
enteropathy]. Rev Assoc Med Bras. 1995;41(3):162-166. Portuguese. 
Sample size: 46 (likely most or all subjects < 5 years of age; mean age was under 7 months) 
Subjects: Acute or persistent diarrhea with stool culture positive for EPEC (cases) or asymptomatic 
children negative for EPEC (controls) 
Markers: Small intestine biopsy and morphometry 
Relevance to 2000-2010 set: Histology was examined in 18 studies in the 2000-2010 set with one study 
also using morphometric assessment.  
 
7. Cooper ES, Ramdath DD, Whyte-Alleng C, Howell S, Serjeant BE. Plasma proteins in children with 
trichuris dysentery syndrome. J Clin Pathol. 1997;50(3):236-240. 
Sample size: 89 (many older than 5 years of age) 
Subjects: Chronic diarrhea with and without Trichuris dysentery syndrome and healthy controls 
Markers: Blood markers: alpha-1-antitrypsin, ceruloplasmin, albumin, globulin, fibrinogen, fibronectin, 
ferritin, transferrin, plasma viscosity, hemoglobin, leukocytes, and CRP 
Relevance to 2000-2010 set: Primarily assessed markers of systemic inflammation that were reviewed in 
assessments of articles from the previous decade. The remaining markers are primarily assessments of 
hepatic function and were not assessed in the 2000-2010 set. 
 
8. Brooks SE, Reid WA. Scanning electron microscopy of the jejunum in children with protein-energy 
malnutrition. West Indian Med J. 1997;46(1):15-21. 
Sample size: 7 (all < 5 years of age) 
Subjects: Fatal severe kwashiorkor or marasmic kwashiorkor 
Markers: Scanning electron microscopy (SEM) and light microscopy on jejunal biopsy sections taken by 
autopsy and fixed within 75 minutes after death 
Relevance to 2000-2010 set: In the later decade publications, SEM and light microscopy were used in 
one study to investigate jejunal morphology in 16 infants with persistent diarrhea, many of whom also had 
small bowel bacterial overgrowth (as measured by jejunal secretion) and/or exhibited some degree of 
malnutrition. 
 
9. Abbas KA, Bilal R, Sajjad MI, Latif Z, Mirza NH. Fat absorption in persistent diarrhoea using 13C-
labelled trioctanoin breath test. J Trop Pediatr. 1999;45(2):87-94. 
Sample size: 10 (all < 5 years of age) 
Subjects: Persistent diarrhea (some with malnutrition) and asymptomatic controls 
Markers: Fat absorption by breath test after 13C-labelled trioctanoin administration 
Relevance to 2000-2010 set: 2 studies in the 1990-1999 publication set assessed fat absorption although 
not by breath test with this specific medium chain fatty acid. 
 
10. Taniguchi K, Rikimaru T, Yartey JE, Akpedonu P, Armar-Klemesu MA, Nkrumah FK, et al. 
Immunological background in children with persistent diarrhea in Ghana. Pediatr Int. 1999;41(2):162-167. 
Sample size: 85 (all < 5 years of age) 
Subjects: Persistent or acute diarrhea 
Markers: A variety of serum markers of systemic inflammation and immune response were compared 
between persistent and acute diarrhea cases, including: albumin, pre-albumin, total protein, transferrin, 
IgA & IgG subclass fractions, natural killer cells, lymphocyte immunophenotypes, and T-cell activation.  
Relevance to 2000-2010 set: Many of these systemic markers were examined in the 2000-2010 set, 
although some were not.  
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Appendix 5. Highly considered but excluded references. 
Reference Country Reason for exclusion 
Altuntas B, Filik B, Ensari A, Zorlu 
P, Teziç T. Can zinc deficiency be 
used as a marker for the diagnosis 
of celiac disease in Turkish 
children with short stature? Pediatr 
Int. 2000;42(6):682-684. 
Turkey Biopsy data were the same as previously reported 
in a 1998 publication1 that was included in this 
review. This 2000 publication adds no new data of 
relevance to this review. 
Bahia M, Rabello A, Brasileiro 
Filho G, Penna FJ. Serum 
antigliadin antibody levels as a 
screening criterion before jejunal 
biopsy indication for celiac disease 
in a developing country. Braz J 
Med Biol Res. 2001;34(11):1415-
1420. 
Brazil The only outcomes of interest to this review that 
were reported on for subjects of interest (controls 
that did not have celiac disease) were that their 
jejunal biopsy results were “normal,” and no other 
data or specific information was reported that 
pertained to this review. 
Bay A, Oner AF, Celebi V, Uner A. 
Evaluation of vitamin K deficiency 
in children with acute and 
intractable diarrhea. Adv Ther. 
2006;23(3):469-474. 
Turkey Outcomes were primarily related to micronutrient 
(vitamin K) deficiency or malabsorption. 
Cooke ML, Goddard EA, Brown 
RA. Endoscopy findings in HIV-
infected children from sub-




Most subjects had upper gastrointestinal 
conditions that were not of interest to this review. 
Only 3 subjects had diarrhea, and it was unlikely 
that they were all under 5 yr. 
Kelly P, Musuku J, Kafwembe E, 
Libby G, Zulu I, Murphy J, et al. 
Impaired bioavailability of vitamin 
A in adults and children with 
persistent diarrhoea in Zambia. 
Aliment Pharmacol Ther. 
2001;15(7):973-979. 
Zambia Change in serum retinol status was assessed 
following administration of oral vitamin A to adult 
cases (males hospitalized with persistent diarrhea 
(PD)) (n=15), controls (males hospitalized with 
conditions other than PD) (n=24) and cases under 
2 yr hospitalized with PD and malnutrition (n=11). 
While the children with PD did have similar 
degrees of change in serum retinol after vitamin A 
administration compared to the adult controls, the 
study did not include childhood controls. Without 
childhood controls and with limited sample size of 
children, interpretation and generalization of 
findings to childhood enteric function is limited. 
Kukuruzovic R, Robins-Browne 
RM, Anstey NM, Brewster DR. 
Enteric pathogens, intestinal 
permeability and nitric oxide 
Australia Data on outcomes of interest to this review were 
not reported.  
1 Altuntas B, Kansu A, Ensari A, Girgin N. Celiac disease in Turkish short-statured children and the value 
of antigliadin antibody in diagnosis. Acta Paediatr Jpn. 1998;40(5):457-460. 
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Reference Country Reason for exclusion 
production in acute gastroenteritis. 
Pediatr Infect Dis J. 
2002;21(8):730-739. 
Kumar R, Marwaha N, Marwaha 
RK, Garewal G. Vitamin K 
deficiency in diarrhoea. Indian J 
Pediatr. 2001;68(3):235-238. 
India Outcomes were primarily related to micronutrient 
(vitamin K) deficiency or malnutrition. 
Manary MJ, Hotz C, Krebs NF, 
Gibson RS, Westcott JE, Arnold T, 
et al. Dietary phytate reduction 
improves zinc absorption in 
Malawian children recovering from 
tuberculosis but not in well 
children. J Nutr. 
2000;130(12):2959-2964. 
Malawi Subjects ranged in age from 3-13 yr, but based on 
the group means and standard deviations for age, 
there were likely to be few subjects under age 5 
years. 
 
Thacher TD, Obadofin MO, 
O'Brien KO, Abrams SA. The 
effect of vitamin D2 and vitamin D3 
on intestinal calcium absorption in 
Nigerian children with rickets. J 
Clin Endocrinol Metab. 
2009;94(9):3314-3321. 
 Nigeria Study assessed differences in calcium uptake with 
varying vitamin D preparations and was not an 
assessment of intestinal function.  
Ukarapol N, Lertprasertsuk N, 
Fuchs GJ, Wongsawasdi L, 
Sirisanthana V. Impact of 
gastrointestinal endoscopy on HIV-
infected children. Dig Endosc. 
2004;16(1):26-29. 
Thailand Study described 13 colonoscopy or 
sigmoidoscopy and 10 gastroduodenoscopy 
sessions for 14 patients resulting in 7 possible 
assessments of the small intestine. However 
results were aggregated across gastrointestinal 
anatomical sites, and it was difficult to extract 
results of interest to this review.  
Walkowiak J, Herzig KH. Fecal 
elastase-1 is decreased in villous 
atrophy regardless of the 
underlying disease. Eur J Clin 
Invest. 2001;31(5):425-430. 
Poland The age range of all subjects (n=54) was 2-16 yr 
with a mean of 7.0 yr, SE=0.5. The sample size of 
children of any age with presentations of interest 
to this review was n=18. The high mean age of 
subjects coupled with small sample size suggest 
that few children with presentations meeting 
inclusion criteria were likely under 5 yr. In addition, 
it was unclear if the study setting met developing 
country setting inclusion criteria. 
Yachha SK, Aggarwal R, Srinivas 
S, Srivastava A, Somani SK, Itha 
S. Antibody testing in Indian 
children with celiac disease. Indian 
J Gastroenterol. 2006;25(3):132-
135. 
India While some subjects in this study were under 5 yr 
of age, the subjects of interest to this review (i.e., 
the children without celiac disease who had small 
intestinal biopsies) were all aged >5 yr. 
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Appendix 6. Review articles with information of relevance to the systematic review. 
Bhatnagar S. Laboratory diagnosis of persistent and chronic diarrhea. IJPP. 2003;5(2):125-132. 
Bhutta ZA, Nelson EA, Lee WS, Tarr PI, Zablah R, Phua KB, et al. Recent advances and evidence 
gaps in persistent diarrhea. J Pediatr Gastroenterol and Nutr. 2008;47(2):260-265.  
Bhutta ZA. Effect of infections and environmental factors on growth and nutritional status in 
developing countries. J Pediatr Gastroenterol Nutr. 2006 Dec;43: Suppl 3:S13-21. 
Bickler SW. Tropical enteropathy protects against Western diseases in environments of poor 
sanitation. Med Hypotheses. 2006;67(1):146-150. 
Brewster DR. Critical appraisal of the management of severe malnutrition: 3. Complications. J 
Paediatr Child Health. 2006;42(10):583-593. 
Brewster DR, Manary MJ, Menzies IS, O'Loughlin EV, Henry RL. Intestinal permeability in 
kwashiorkor. Arch Dis Child. 1997; Mar;76(3):236-41. 
Butler RN. Non-invasive tests in animal models and humans: a new paradigm for assessing efficacy 
of biologics including prebiotics and probiotics. Curr Pharm Des. 2008;14(14):1341-50. 
Davidson G, Kritas S, Butler R. Stressed mucosa. Nestle Nutr Workshop Ser Pediatr Program. 
2007;59:133-142; discussion 143-146. 
Gibbons T, Fuchs GJ. Chronic enteropathy: clinical aspects. Nestle Nutr Workshop Ser Pediatr 
Program. 2007;59:89-101; discussion 102-104. 
Guerrant RL, Oriá RB, Moore SR, Oriá MO, Lima AA. Malnutrition as an enteric infectious disease 
with long-term effects on child development. Nutr Rev. 2008;66(9):487-505. 
Humphrey JH. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet. 
2009;374(9694):1032-35. 
Mehta S. Celiac disease in India. Indian J Gastroenterol. 2008;27(1):43. 
Petri WA Jr, Miller M, Binder HJ, Levine MM, Dillingham R, Guerrant RL. Enteric infections, diarrhea, 
and their impact on function and development. J Clin Invest. 2008;118(4):1277-90. 
Prentice AM, Darboe MK, Growth and host-pathogen interactions. Nestle Nutr Workshop Ser Pediatr 
Program. 2007;61:197-210. 
Ramakrishna BS, Venkataraman S, Mukhopadhya A. Tropical malabsorption. Postgrad Med J. 2006; 
82(974):779-787. 
Solon JA, Morgan G, Prentice A. Mucosal immunity in severely malnourished Gambian children. J 
Pediatr. 2006; 149(5) Suppl:S100-S106. 
Sondheimer JM. Glutamine for childhood malnutrition: Probably not needed. J Pediatr Gastroenterol 
and Nutr. 2005;40(1):24-25. 
Sullivan PB. Studies of the small intestine in persistent diarrhea and malnutrition: the Gambian 
experience. J Pediatr Gastroenterol Nutr. 2002;34 Suppl 1:S11-13. 
Taren DL. Diarrhea and other gastrointestinal diseases. In: Gershwin ME, Nestel P, Keen CL, editors. 
Handbook of Nutrition and Immunity. Humana Press; 2004;287-302. 
Velasco-Benitez CA. Digestive, hepatic, and nutritional manifestations in Latin American children with 









Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
2003 
 












Fecal cytokines and 
lactoferrin as markers 
of intestinal 
inflammation among 








3-43 mo olds 
recruited from a 
shantytown 
community who 
were screened for 
enteric pathogens. 
 
There was a high 
prevalence of 
malnutrition 








these data were 







with C. parvum:  
• 4 with no 
diarrhea 
• 10 with AD 








HAZ and WAZ 
scores to cases 
 
Stool tests: 
• Lactoferrin  
(17 cases and 15 
controls tested) 
• IL-8  
(13 cases and 15 
controls tested) 
• TNF-α  
(10 cases and 0 






• 12/17 cases 
• 1/4 cases without 
diarrhea 
• 8/10 AD cases 
• 3/3 PD cases 
• 3/15 controls (p=0.006 
compared to cases) 
 
IL-8 detectable: 
• 3/13 all cases 
• 0/2 cases without 
diarrhea 
• 3/10 AD cases 
• 0/1 PD cases 
• 6/16 controls (p=0.435 
compared to cases) 
 
TNF-α detectable:  
• 0/10 cases 
 
The proportion of 
children who tested 
positive for fecal 
lactoferrin was 





diarrhea, than in 
uninfected controls, 
although 20% of 
the control group 
tested positive. 
 
Fecal IL-8 did not 
differ between 












stool tests were 











negative if there 
was no reaction 








Alves GM et al. 
 
Nutritional status and 
breath hydrogen test 
with lactose and 




breath test (HBT) as a 
marker of lactase 
activity, and lactulose 
HBT as a marker of 
Limão Verde and 
Córrego Seco, 
Mato Grosso du 
Sul, Brazil 
 
All children <10 yr 
old were recruited 


















• Lactose HBT 
(251 tested) 
• Lactulose HBT  
(252 tested) 
Lactose HBT: 
• Elevated: 27.1% among all 
subjects 
• Borderline: 43.0% among 
all subjects 
• 0% of subjects <4 yr had 
elevated or borderline 
results 
 
Lactulose HBT positive: 
• 11.5% of all subjects 
• 8.6% of subjects <4 yr 
The prevalence of 
lactase deficiency 
as measured by 
lactose HBT was 
>25%, but non-
existent among 
those <4 yr of age. 
 
Prevalence of 
SBBO as assessed 
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Target Population  
Design and 




Amadi B et al. 
 
Reduced production of 
sulfated 
glycosaminoglycans 
occurs in Zambian 
children with 





of intestinal markers in 
children with PD and 




12.2-19.8 mo olds 
with PD and 
malnutrition 
admitted to the 
malnutrition ward 







with PD and 
malnutrition:  
• 18 with 
marasmus 
• 8 with 
marasmic 
kwashiorkor 
• 15 with 




from UK  
 
 
* UK subjects 
are presented 




in the review. 
However we do 
not include 
these subjects 
in the sample 





• Densities in lamina 
propria and crypt 
epithelium: 







• Syndecan-1  
• Inflammatory cell 
markers: 
• CD3 IEL 
• Ki67 
• Human leukocyte 
antigen DR-1 
(HLA-DR) 
Biopsy findings among the 
Zambian compared to the UK 
children: 
• Villous height reduced 
• Crypt depth increased  
• ~50% reduction in 
crypt:villous ratio 
• Values for lamina propria 
cell densities were not 
reported for UK subjects 
 
No significant differences in 
crypt or villous measures or 
lamina propria cell densities 
were observed between 




• Inflammatory markers were 
seen in higher densities 
compared to the UK 
children. There were 
significant differences 
between the different 
nutritional groups in the 
specific types of 
inflammatory markers. 
• There was a significant 
reduction in GAGs and 
HSPG in the kwashiorkor 
group compared to UK 
children, but no significant 
differences between 
kwashiorkor and other 
presentations of 
malnutrition.  




compared to UK 










compared to UK 
children and 
showed different 












markers did not 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
epithelial syndecan-1 
protein expression between 
the malnutrition groups 




Azim T et al. 
 
Immune response of 
Bangladeshi children 






tests, as well as 
transferrin and 
albumin as markers of 
nutritional status 
among children with 




7-12 mo olds with 







Cases were those 
who went on to 
develop PD, 
controls were 
those who did not.  
 
An additional 
group of subjects 
without diarrhea 
were recruited 
from a nutrition 














• 85 with AD 























• Mononuclear cell 
proliferation, 
spontaneous and in 












and Trichophyton  
WBC total and differential, 
immunoglobulin subtypes, 
cytokines, transferrin, and 
albumin did not differ 
between cases with diarrhea 
or controls, nor did stool 
leukocyte or erythrocyte 
counts.  
 
The percentages of 
neutrophils that polarized in 
response to stimulation were 
significantly higher in subjects 
with AD or PD compared to 
those without diarrhea; there 
was no difference between 
the two diarrhea groups. 
 
Opsonization did not vary 
between any groups. 
 
Monocyte spontaneous 
proliferation counts were less 
than half among children with 
no diarrhea compared to 
those with AD (p<0.001) or 
with PD (p=0.011); there was 
no difference between the 
two diarrhea groups.  
 
Monocyte proliferation in 
response to stimulation did 
not differ between the 3 
groups.  
 
The proportion with DTH 











progression to PD 
was a negative 
DTH response to 
tuberculin antigen 
(odds ratio=3.8, CI: 
1.4, 9.9). This was 
calculated from a 
logistic regression 
analysis that only 
included children 
with diarrhea.  
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Target Population  
Design and 





• Red blood cells 
responses differed among the 
three groups only in response 
to tuberculin (p=0.021). More 
PD subjects had a negative 
tuberculin response than did 
subjects with AD (p=0.024).  
2005 
 
Bhatnagar S et al. 
 
Celiac disease with 
mild to moderate 
histological changes is 
a common cause of 


























antibodies were of 










70 had normal histology 
(defined as crypt:villous ratio 
1:2-3, absence of lymphoid 




37 had mild changes (defined 
as mild blunting of villi with 
crypt:villous ratio of 1:1*). A 
specific etiology was 
identified in only n=5: 
• 2 with giardiasis 
• 1 with lymphangiectasia 
• 2 with chronic pancreatitis 
 
Only children with CD had 
moderate or severe histologic 
changes. 
 
* Along with increased IEL 
and lymphocytic lamina 
propria infiltration. 
More than one 





at follow-up their 
growth had 






reached for 86% of 
subjects with 
abnormal histology 






Bitarakwate E et al. 
 
Serum zinc status of 
children with 
persistent diarrhea 
admitted to the 
diarrhea management 






6-36 mo olds with 

















• Total protein 
• Hemoglobin 
PD cases:  
• 47.9% low serum protein  
• 69.7% low serum albumin 
• Low mean hemoglobin 
(10.5 g/dL) 
 
For controls, means of all 
three laboratory values were 
within normal range; percent 
of subjects with abnormal 
values are not reported. 
Decreased 
albumin, serum 
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Target Population  
Design and 




children with and 
without PD 
 
All three test results were 
significantly lower in children 
with PD than in controls (p< 
0.01 for each comparison). 
2010 
 
Bukhari AS et al. 
 
DNA damage and 
plasma homocysteine 
concentrations are 
associated with serum 
metabolites and 
mineral constituents' 





levels of DNA damage 
among children with 




3-6 yr olds 
admitted to 


















• Total protein 
• Total cholesterol, 
HDL, LDL, 
triglycerides 
• AST, ALT 
• T3, T4 
• Total oxidant status 
(TOS), Total anti-




• DNA damage to 
lymphocytes 
Mean values significantly 
higher among PD cases than 





• DNA damage 
 
Mean values significantly 
lower among PD cases than 
in healthy controls:  












speculate that zinc 
deficiency, more 
commonly found in 
the children with 





play an important 
role in mediating 
DNA damage.  
Control 
recruitment 










gender in both 
the case and 
















Bushen OY et al. 
 
Heavy cryptosporidial 







All newborns from 
an urban 
shantytown were 












68.3% were lactoferrin- 
positive; there were no 
differences in positivity 
between subjects with C. 
hominis and C. parvum spp. 
 
67.9% of lactoferrin-positive 
subjects had very high titers. 
Lactoferrin was 
correlated with 
younger age and 
symptomatic 
infection among 
those infected with 
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Target Population  
Design and 






Fecal lactoferrin as a 




and followed for 
















Younger children were more 
often lactoferrin-positive 
(p=0.03). The difference was 
mediated by C. parvum; 
87.5% of ≤1 year olds 
compared to 40.0% of older 
children with C. parvum were 
lactoferrin-positive (p=0.04). 
There was no difference 
among those infected with C. 
hominis. 
 
Lactoferrin was correlated 
with symptomatic infection 
among those with C. parvum: 
78.6% of symptomatic 
children compared to no 
asymptomatic children had a 
positive test (r=0.67, 
p=0.0041).  
 
Lactoferrin was not correlated 
with degree of oocyst 
shedding (p=0.28). 
 
Lactoferrin was correlated 
with ∆HAZ score among 
those with C. parvum, 
although this observation was 













In contrast to C. 
parvum, there was 
no association 
between lactoferrin 







children with C. 
hominis had high 
fecal lactoferrin 





negative if there 
was no reaction 
at 1:50 and 
highly positive at 
>1:400. 
 
Data were part 






published by A. 
Kohli, et al. (also 
included in this 
review), using a 
slightly different 












status and found 








                                                          
1 Reported results were adjusted for confounding variables, unless otherwise noted. 
Appendix 7. Evidence table of all studies included in the review.




Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
2003 
 
Bustos M et al. 
 
Disaccharidase 




Jejunal biopsy and 
disaccharidase 
activities in children 
with PD and different 




3-34 mo old 
Amerindians 
hospitalized with 
PD and moderate 
or severe 





with PD and 
malnutrition: 
• 2 with 
kwashiorkor 
• 20 with 
marasmus 


























Histology was scored 
on a scale of 1 (normal) 
to 4 (severe 
morphological damage 
or flat mucosa). 
 
Most subjects had mild to 
moderate (score of 2-3) 
histological abnormalities, 
with one kwashiorkor patient 
having completely flat villi.  
 
Second biopsy showed a 
trend of improved mucosa, 
but difference was not 
significant based on histology 
score, intraepithelial 
lymphocyte density, or 
degree of infiltration of lamina 
propria. 
 
Percentages with enzymatic 
activity below normal at 
baseline, discharge:  
• Lactase: 64%, 59% 
• Sucrase-isomaltase: 97%, 
90% 
• Maltase: 45%, 52% 
All changes were statistically 
significant.  
 
Lactase recovery was 
associated with admission 
HAZ (p=0.05) and WAZ 
(p=0.03) scores.  
 
Despite continued high 
disaccharidase deficiency 
prevalence at discharge, all 
children tolerated the lactose-


































Authors did not 
report whether 














2 mo olds from 









Mean neopterin concentration 
was negatively correlated 
with long-term height (r=-
0.29, p<0.009) and weight 







overlap with that 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
Intestinal inflammation 
measured by fecal 




growth failure, Giardia 
lamblia, and intestinal 
permeability 
 
Fecal neopterin and 
L:M as markers of 
intestinal inflammation 
and permeability, 
respectively, and their 
correlation with growth 
status and Giardia 
recovery in the stool  












every 2 mo.  
Urine Tests: 





(r=-0.36, p<0.007) gain, but 
not with giardiasis. 
 
Mean3 L:M (CI): 0.31 (0.26, 
0.34). 
 
Mean excretion of lactulose 
(CI): 0.20 (0.18, 0.23).  
 
Mean excretion of mannitol 
(CI): 3.0 (2.8, 3.2).  
 
Mean L:M was negatively 
correlated with long-term 
height gain (r value not 
provided, p<0.0001), but was 
not correlated with presence 
of Giardia. 
 
L:M and fecal neopterin were 
not correlated (p=0.11). 
 
Mean L:M in the 
Gambian children 
was substantially 
higher than normal 
values in children 
in the UK. These 
high L:M ratios 
appear to be driven 
by mannitol 
excretion. 
of Campbell et 
al. also included 




Campbell DI et al. 
 
Growth faltering in 
rural Gambian infants 
is associated with 
impaired small 
intestinal barrier 









All 2-11 mo olds 
were recruited 
from this rural 
village and 
followed up to 14 


















• C-reactive  
protein (CRP) 
• IgA 
At 8 wk of age:  
• Mean5 L:M: 0.169 (CI: 
0.145, 0.198; range: 0.058-
0.657) 
• Mean lactulose recovery: 
0.202 (SD=0.159; range: 
0.009-0.640) 
• Mean mannitol recovery: 
3.80 (SD=2.35; range: 
0.52-8.58) 
 
L:M more than doubled 
between 12 wk-1 yr of age 
(r=0.44, p<0.001) and was 
driven by both increasing 
Mean L:M ratios 
were elevated at 8 
weeks of age, and 
more than doubled 
in the first year of 
life. 
 












blood smear at 







Authors did not 
report 
investigating 
                                                          
2 Lactulose and mannitol results were expressed as % of dose administered. 
3 Type of mean not specified. 
4 For lactulose and mannitol results, excretion measurement was not specified. 
5 Geometric mean. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
and its relationship 
with various 
inflammatory markers 
and endotoxin  
• IgM 
• IgG 
• Plasma endotoxin 
• IgG endotoxin-core 
antibody 
 
lactulose (r=0.18, p<0.001) 
and decreasing mannitol (r=-
0.14, p<0.01) excretion with 
age.  
 
WAZ and HAZ scores were 
negatively correlated with L:M 
(r=-0.41, p<0.001), and 
primarily driven by lactulose 
excretion (r=-0.39, p<0.001). 
 
Laboratory values were 
consistent with chronic, low 
level immunostimulation: 
• 50% of platelet and 39% of 
leukocyte counts were 
elevated, especially mean 
lymphocyte counts which 
were almost twice 
expected values [198]. 
• While the mean6 CRP was 
within the normal range, 
25% of values were above 
the upper limit of normal (5 
mg/L), and 17% were >10 
mg/L [198]. 
• Mean IgG, IgA and IgM 
concentrations were near 
normal at 8 wk of age, but 
increased rapidly; all three 
were elevated above 
expected values in all other 
age groups [198, 199]. 
• Mean7 free plasma 
endotoxin concentration 
was twice the upper limit of 
normal [200] and IgG 
endotoxin-core antibody 
concentrations were also 
Poor growth was 
significantly 
correlated with L:M 










ascribed to a gut 
source, endotoxin 
and its related core 
antibody are 
potentially a direct 
measure of 
intestinal 
inflammation due to 
gut gram negatives 
as a primary 




















with that of 
Campbell et al. 
2004 also 
included in this 
review [15]. 
                                                          
6 Geometric mean. 
7 Geometric mean. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
elevated [198]. 
• However, mean albumin 
concentrations (and 
concentrations within SD) 
were generally within 
normal range [198]. 
 
L:M was correlated with 
IgG and IgA (r=0.41 and 
0.41, respectively, p<0.001), 
and IgM (r=0.28, p<0.02). 
 
IgG and IgA were also 
correlated with lactulose 
recovery (r=0.26 and 0.25, 
respectively, p<0.02). 
 
IgG endotoxin core antibody 
concentration was correlated 
with L:M and driven by 
lactulose recovery, (r=0.35, 
p<0.005 for both).  
 
Endotoxin concentrations 
were correlated with lactulose 








in rural west African 
children: relationship 













• Group 1: n=4  
• Group 2: 
n=11 (7 with 
diarrhea) 
• Group 3: 
n=25 (18 
Endoscopic 





computer analysis*  
• Intestinal tissue 
cytokines and 
Crypt-hyperplasia and villous 
atrophy were observed 
among all Gambian subjects, 
and the degree of 
histopathology did not differ 
among cases with differing 
nutritional status, nor was 







and villous atrophy, 
and mean IELs >2 









(e.g. type of 
central tendency 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 




L:M as a marker of 
intestinal permeability, 






among rural Gambian 










nutritional status:  














with or without 
diarrhea 
3. Grade II PEM 
(WAZ score <-
4) with or 
without diarrhea  
 
Controls from UK* 
who were well 
nourished children 
with GI complaints 
other than 
diarrhea and with 
normal endoscopy 




* UK subjects are 










ivity tests:  
• Group 1: 
n=3 
• Group 2: 
n=8 




immune markers:  





















* Biopsy involved 
morphometric 
assessment by 
computer analysis of 
villous height, crypt 
depth, villous:crypt 
ratio, and intraepithelial 
lymphocyte (IEL) 
density (per 100 
epithelial cells).  
 
 
IEL9 means were ~3-fold 
higher in Gambian than UK 
children. 
 
Median CD3, CD4, CD8, 
CD19, and CD25 cell counts 
were significantly higher (2-5x 
higher) among each case 
group compared to the UK 
controls.  
 
IEL, γδ, syndecan-1, HLA-
DR, and perforin were 
detected among the Gambian 
children in varying degrees 
but were not reported for UK 
controls. Syndecan, CD3, 
and CD8 displayed a gradient 
proportional to malnutrition 
severity. 
 
All Gambian groups showed 
higher lamina propria 
cytokine-immunoreactive 
mononuclear cell density 
(~200-450/mm2) than UK 
controls (30-80/mm2). 
 
Among subjects with elevated 
cytokines, similar densities 
were seen for both pro-
inflammatory (IFN-γ and 
TNF-α) and putative 
regulatory (IL-10 and TGF-β) 
cytokines. Epithelial 
expression of TGF-β was 
also enhanced compared to 












present across the 





L:M ratios were 
elevated in all 
Gambian groups, 
without apparent 
correlation to host 


















y, and L:M 





                                                          
8 Lactulose and mannitol results were expressed as % of dose administered. 
9 These figures are presumed to represent IEL means; however, this was not explicitly stated. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
table due to 
comparisons of 
interest made in 
the review. 
However we do 
not include these 
subjects in the 




poorer nutritional status had 
lower densities of mucosal 
TGF-β+ cells, with median 
densities of 420 and 250 
cells/mm2 in the grade I and 
grade II PEM groups, 
respectively. 
 
L:M values10:  
• Group 1: 0.53 (0.4-1.3)  
• Group 2: 0.47 (0.02-2.20) 
• Group 3: 0.73 (0.14-2.2) 
• Not assessed among the 
UK controls 
 
Nutritional status was not 
associated with L:M, 
recoveries of lactulose or 
mannitol.  
 
L:M was correlated with 
mucosal B lymphocyte 
density (r=0.57, p<0.05), IEL 
(r=0.51, p<0.02), and 




Campbell DI et al. 
 
Age-related 
association of small 
intestinal mucosal 
enteropathy with 














<5 yr old:  
n=26 








Mean12 L:M (SE) in 2-5 yr old 
group: 0.353 (0.022).  
 
Mean lactulose and mannitol 
% recovery was ~0.45 and 
~0.65, respectively. 
  
L:M was highest in 2-5 yr age 
group and decreased with 
Mean L:M in 
asymptomatic 2 to 
5 yr olds was high 
and decreased 
significantly with 
increasing age, but 
never fell within 





symptoms for at 
least one week 




                                                          
10 Not clearly indicated if these figures represent mean (CI) or another measure of central tendency. 
11 Lactulose and mannitol results were expressed as % of dose administered. 
12 Type of mean not specified. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
rural Gambian children 
 
L:M and urinary 
lactulose and mannitol 
recovery as a marker 
of intestinal 
permeability and its 
association with 
nutritional status at 
varying ages. Also 
assessed correlation 
of change in L:M with 
nutritional status at 3.5 
mo re-visit. 
 
increasing age (up to age 20) 
(p<0.001), but never fell 
within referenced UK normal 
ranges [201]. 
 
Most of the improvement in 
L:M was driven by a 
reduction in lactulose 
excretion (p<0.001), which 
fell within expected UK 
ranges by age 10 yr. 
 
In contrast, although mannitol 
excretion slightly decreased 
with age, this trend did not 
reach statistical significance. 
In fact, excretion proportions 
were at all times ½ - ⅓ of 
expected UK values [201]. 
 
L:M was inversely correlated 
with HAZ score13 (r=-0.31, 
p<0.001), but not with WAZ 
or body mass index (BMI) Z 
scores. The correlation with 
HAZ score was mainly due to 
the higher lactulose excretion 
in subjects with poorer HAZ 
scores (r=-0.22, p=0.001) and 
held across all age groups.  
 
There was a small 
improvement in mean L:M 
(SE) between the two study 
time points from 0.198 
(0.018) to 0.172 (0.010) 
(p=0.026 for change in L:M), 
driven by an improvement in 
mannitol recovery with no 
change in lactulose excretion.  
 





tests conducted 3.5 
months apart.  
 
Among all age 
groups, L:M was 
significantly 
inversely correlated 
with HAZ score, 
primarily driven by 





mean L:M of the 









                                                          
13 Reported results were adjusted for age, sex, and visit. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
 
Indices of intestinal 
permeability within subjects 
showed a high degree of 
correlation between the two 
visits:  
• Lactulose: r=0.55, p<0.001 
• Mannitol: r=0.24, p<0.05 
• L:M: r=0.66, p<0.001 
 
Change in measures 
between visits (analysis not 
stratified by age): 
• Mean L:M (SD):  
• Visit 1: -1.62 (0.66) 
• Visit 2: -1.76 (0.55), 
(p=0.026) 
• Mean mannitol recovery 
(SD): 
• Visit 1: 5.25 (2.69) 
• Visit 2: 6.28 (3.03), 
(p=0.006) 
• Mean lactulose recovery 
(SD):  
• Visit 1: 0.28 (0.20)  
• Visit 2: 0.29 (0.18),  




Chen P et al. 
 
Association of vitamin 
A and zinc status with 
altered intestinal 
permeability: analyses 




Fortaleza, Brazil  
 
2-97 mo olds 
recruited from an 







L:M and retinol 
concentrations 
measured: 









Baseline mean (SD): 
• L:M15: 0.29 (0.16) 
• Lactulose: 0.54 (0.29) 
• Mannitol: 2.07 (0.88) 
 
L:M was not correlated with 
age. L:M was inversely 
correlated with retinol (r=-
0.55, p<0.0005), including 
after adjustment for zinc 
Supplementation of 




L:M among the 
cohort of children 
with a history of PD 
or low WAZ score 
who received post-
Longitudinal 









                                                          
14 For lactulose and mannitol results, excretion measurement was not specified. 
15 Type of mean not specified. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
 
L:M as a marker of 
intestinal permeability 
pre- and post-vitamin 
A and zinc 
supplementation 
among children with 











history of PD 








dose of vitamin 
A and a 2-wk 





stratification on retinol 
concentrations.  
 
Retinol was correlated with 
mannitol (r=0.28, p=0.017) 
and lactulose (r=-0.22, 
p<0.063) excretion.  
 
Lactulose, mannitol and their 
combined ratio were not 
correlated with zinc 
concentrations.  
  
L:M improved after 
supplementation for the 
cohort of 20 children followed 
longitudinally with PD or low 
WAZ score: 
L:M mean (SD):  
• Pre-treatment: 0.28 (0.12) 
• Post-treatment: 0.19 (0.07) 
However, lactulose and 




than one-third of 




on L:M were not 
provided for the 
children with 
normal WAZ 
score or no 





the L:M testing 




L:M results in 










Clark TD et al. 
 
Risk factors and 
cumulative incidence 






Association of chronic 
diarrhea with 








until 36 mo of age.  
 











While chronic diarrhea was 
associated with moderate 
anemia in a univariate 
analysis (odds ratio=2.5, CI: 
1.0, 6.3), it was either not 
associated with moderate 
anemia (hemoglobin <9 g/dL) 
in a multivariate model or not 
included in the model 
  
While there was a 
high prevalence of 
anemia (<11 g/dL) 
and moderate 
anemia (<9 g/dL) 
(92% and 35% at 9 
months, 
respectively) 
among this cohort 
of HIV-infected 
children, chronic 
diarrhea appears to 
have not been 
associated with 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
analysis. However, 
the text did not 
specifically state 
whether chronic 
diarrhea was tested 




Darboe MK et al. 
 
Effectiveness of an 
early supplementation 
scheme of high-dose 
vitamin A versus 
standard WHO 
protocol in Gambian 




L:M as a marker of 
intestinal epithelial 
integrity among infants 
receiving high-dose 
vitamin A or standard 





at birth from rural 
community. Age 
range during 

























Mean16 L:M and proportion 
with values >0.30 among 
those receiving standard 
doses of vitamin A, by age: 
• 2 mo: 0.195, 12% 
• 5 mo: 0.197, 13% 
• 7 mo: 0.212, 22% 
• 9 mo: 0.286, 30% 
• 12 mo: 0.322, 34% 
 
Mean L:M differed between 
the two groups only at 7 mo 
(0.276 in high-dose vitamin A 
group, p=0.014), although 
there was no difference in 




L:M values rose by 
~50% from age 2 
mo to 1 yr and 
were not affected 
by dosing of 
vitamin A.  
The L:M normal 
cutoff was 
defined higher 
than for most 
other L:M 
studies, as 0.30. 
This was 
derived from the 
mean plus 2 SD 
from a study of 




Dini E et al. 
 
Sudan III and 
steatocrit in the 
detection of fecal fat in 
malnourished children 
 
Fecal fat by four 
different testing 




6 mo-9 yr olds 











• 30 with 
subclinical 
malnutrition 
• 34 with mild 
malnutrition  
• 30 with 
moderate 
Stool Test: 
Fecal fat, by method: 
• Sudan III classic 
• Sudan III 
modified 
• Steatocrit classic 




underwent testing for 
Proportions testing positive 
for fecal fat ranged from 33%-
41% overall, depending on 
test method used. 
 
The proportion testing 
positive varied by nutritional 
status across testing 
methods: 
• 80%-100% of severely 
malnourished subjects had 
a positive test 
A majority of 
children studied 
tested negative for 




positive was in 
those with severe 
malnutrition, 











positive for fecal 
fat by history of 
diarrhea (current 
                                                          
16 Geometric mean. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
of malabsorption 







• 5 with severe 
malnutrition  
 
n=30 controls  
 
all four methods. • Similar proportions of 
subjects with subclinical, 
mild or moderate 
malnutrition tested positive, 
ranging from 30%-47%  
• 13%-27% of controls tested 
positive 
These differences appeared 
to be significant, but 
statistical comparison results 
were not entirely clear. 
 
Fecal fat did not vary based 
on quantity of fat intake. 
  
By all four methods, a high 
percentage of children with 
parasites tested positive 
(~60%) compared to children 
without parasites (25%).  
 
Associations were observed 
between infection with 
Giardia lamblia or 
Blastocystis hominis and 
fecal fat (p<0.05); this held 
true across diagnostic 
methods.  
 
The presence of diarrhea at 
time of testing was positively 
associated with fecal fat by all 
test methods (p<0.02 for all 
except steatocrit classic, 
p=0.06).  
 
The relationship between 
fecal fat and history of 
diarrhea in the year prior to 
testing varied by test method:  
• Sudan III classic: p=0.134 
moderate 
malnutrition. 
Controls had the 
lowest percent 
testing positive.  
 
Subjects with 
enteric parasites or 
those experiencing 
diarrhea at time of 







difference was not 
reported.  
 
There was some 
variation between 
the different testing 
methods, for 
example their 
relationship with a 
history of diarrhea 









but did not 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
• Sudan III modified: p<0.001 
• Steatocrit classic: p=0.14 
• Steatocrit acid: p=0.015  
 
Agreement between all four 
methods was 72%. 
Agreement between at least 
three was 91.5%. 
2006 
 
El Mouzan MI et al. 
 
Endoscopic duodenal 
biopsy in children 
 
Duodenal biopsy 












78% of subjects 
were <12 yr old; 
results not 






• 102 with PD 
• 116 with 
unexplained 
short stature  
• 11 with 
refractory 
rickets 








• Gross endoscopic 
visualization 
• Histopathology 
14% had abnormalities on 
endoscopic visualization: 
• 1% had esophagitis 
• 6% had gastritis, 7 (47%) of 
which were H. pylori 
positive 
• 7% had duodenitis 
 
Biopsy results: 
• PD:  
• 26% normal 
• 29% chronic non-
specific duodenitis 
• 40% villous atrophy 
• 5% other* 
 
• Short stature: 
• 56% normal 
• 22% chronic non-
specific duodenitis 
• 22% villous atrophy 
 
• Rickets: 
• 55% normal 
• 36% chronic non-
specific duodenitis 
• 9% villous atrophy 
 
• Other: 
• 25% normal 
• 50% chronic non-
specific duodenitis 
Villous atrophy was 
identified not only 
among 40% of 
children with PD, 
but also among 
22%, 9%, and 17% 
of those with short 




Authors argue that 
endoscopic biopsy 




settings and allows 
for visualization of 




were not reported 
by condition nor in 
relation to 
histopathology 
results; it is difficult 
to assess the value 











For 27% of 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
• 17% villous atrophy 
• 8% other* 
 
* 3 lymphangiectasia, 2 
Giardia, 1 Mycobacterium 
avium intracellulare. Findings 




Fagundes-Neto U et 
al. 
 
Studies of the small 
bowel surface by 
scanning electron 






and light microscope 
(LM) analyses of small 
intestinal biopsy 
among infants with PD 
with and without 
SBBO 
 
Sao Paulo, Brazil 
 
2-10 mo olds with 




























68.7% had bacterial 
overgrowth (concentration 
>104 colonies/mL): 3 had 
enteropathogenic E. coli 
while the rest had colonic 
microflora. 
 
All small intestine specimens 
had morphological 
abnormalities on LM: 
• 43.7% moderate villous 
atrophy 
• 56.3% subtotal villous 
atrophy  
 
SEM revealed abnormalities 
of varying intensity:  
• Among the 11 with SBBO, 
villous atrophy ranged from 
Grade II (n=4), Grade III 
(n=2), to Grade IV (n=3).  
• For the 5 subjects without 
SBBO, villous atrophy 
ranged from Grade I (n=1) 
to Grade 2 (n=4).  
• A mucous-fibrinoid pseudo-
membrane over enterocytes 
was noted in 7 of the 11 
with SBBO and none of the 
others.  
 
Other abnormalities noted on 
SEM included:  
Histological 
abnormalities were 
noted in all 
subjects by LM and 
SEM.  
 
Degree of villous 
atrophy noted on 












consistent with a 
malabsorptive 
process, with the 
findings of fat 
droplets on 
enterocytes 
surfaces, and with 
the state of 







all subjects and 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
• Mucus and debris covered 
large areas of the villous 
surface 
• Derangement of the 
enterocytes (in some cases 
cell borders were not clearly 
defined)  
• Reduced height and 
number (or absence in 
some places) of microvilli  
• Lymphocytes and fat 
droplets were observed 
over the surface of 
enterocytes (18%)17 
 
10 subjects had colitis on 
rectal biopsy; this was not 
associated with SBBO or 
degree of small intestinal 
pathology on SEM.  
2001 
 
Filteau SM et al. 
 
The effect of antenatal 
vitamin A and (beta)-
carotene 
supplementation on 
gut integrity of infants 
of HIV-infected South 
African women 
 
L:M as a marker of 
intestinal permeability 







between 28-32 wk 
gestation recruited 
from antenatal 
clinic. Infants were 
followed until 14 


















• Lactulose18  





• 1 wk: 
• Treatment: n=104 
• Placebo: n=104 
• 6 wk: 
• Treatment: n=100 
• Placebo: n=105 
• 14 wk: 
• Treatment: n=99 
Mean L:M19 (CI) at 1 wk 
among infants without reports 
of illness was 0.12 (0.08, 
0.17). L:M did not change 
with increasing age and did 
not significantly increase with 
reported morbidity. 
 
While a history of ever having 
been breastfed was an 
important contributor to L:M 
at 1 wk (ΔR2=0.22, p=0.008), 
a significant effect was not 
seen at 6 and 14 weeks20. 
Current feeding status had a 
modest effect on L:M only at 
Mean L:M overall 
was within normal 
range. However, 
mean L:M for 
placebo-treated, 
HIV-infected infants 
by 14 weeks was 
significantly 
elevated to almost 
0.5.  
 
While HIV infection 
did not affect 
mannitol excretion, 












                                                          
17 These SEM results were not presented separately for those with and without SBBO. 
18 For lactulose and mannitol results, excretion measurement was not specified. 
19 Geometric mean. 
20 Reported results were adjusted for confounding variables, unless otherwise noted. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 











at delivery.  
• Placebo: n=95 
 
14 wk (ΔR2=0.06, p=0.04).  
 
Birth weight contributed 
significantly at 1 wk 
(ΔR2=0.07, p=0.02), but 
current weight did not 
contribute significantly to L:M 
at any time point.  
 
HIV infection status by 14 wk 
was the major factor 
contributing to L:M at 6 wk 
(ΔR2=0.22, p=0.008) and 14 
wk (ΔR2=0.21, p=0.01). 
 
Maternal HIV viral load during 
pregnancy was not 
consistently significantly 
correlated with infant L:M. 
Maternal lymphocyte counts 
and plasma retinol 
concentrations were not 
associated with infant L:M. 
 
While maternal vitamin A 
supplementation had no 
effect on L:M of uninfected 
infants, it appeared to prevent 
the increase in L:M of HIV-
infected infants21: 
Mean22 L:M (CI):  
• Uninfected: 
• Vitamin A group: 0.11 
(0.08, 0.15)  
• Placebo group: 0.09 





                                                          
21 Reported results were adjusted for confounding variables included an interaction with HIV infection. 
22 Geometric mean. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
• Vitamin A group: 0.17 
(0.13, 0.23) 
• Placebo group: 0.50 
(0.37, 0.68)  
  
Mannitol was not affected by 
vitamin A. HIV infection was 
not consistently significantly 
associated with mannitol 
across age groups. 
 
Lactulose also did not 
consistently differ between 
treatment groups or by HIV-
status, although vitamin A 
prevention of increase in 
lactulose among HIV-infected 
infants neared significance at 
14 wk (p=0.058)23.  
2005 
 
Galpin L et al. 
 
Effect of Lactobacillus 
GG on intestinal 
integrity in Malawian 
children at risk of 
tropical enteropathy 
 
L:M and sucrose: 
lactulose ratio (SUC:L) 
as markers of 




presumed at risk of 
Mwenye, Malawi  
 
36-60 mo olds 
recruited from a 
rural community, 
excluding children 






considered at risk 
for EED due to 
residence in a 
























• Sucrose (SUC) 





• 73% had L:M >0.10  
• 40% had L:M >0.20 
• Mean25 L:M (SD): 
• Treatment: 0.18 (0.16) 
• Placebo: 0.22 (0.20)  
• Mean lactulose (SD) in 
treatment group: 0.25 (0.17) 
• Mean mannitol (SD) in 
treatment group: 8.0 (4.5)  
• Mean SUC:L (SD):  
• Treatment: 0.58 (0.64)  
• Placebo: 0.60 (0.64) 
 
Mean excretion of sucrose 
(SD) increased from 0.057 
(0.042) to 0.078 (0.058) in the 
treatment group (p=0.01), but 
A high baseline 
prevalence of 
abnormal L:M was 






to UK norms) drove 
the abnormal L:M. 
 
There was little 
effect on SUC:L 
with intervention; 
sucrose excretion 






are limited data 
on laboratory 
values for these 
tests in young 
children. 
                                                          
23 P-values are from reported results that were adjusted for confounding variables. 
24 Lactulose, mannitol, and sucrose results were expressed as % of dose administered. 
25 Arithmetic mean. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
EED  
Presumed that if 








GG or placebo. 





similar results were observed 
in the placebo group. 
Otherwise there were no 
changes in lactulose, 
mannitol, L:M, or SUC:L after 
treatment or placebo.  
control groups.  
2001 
 
Gandolfi L et al. 
 
Antiendomysial 
antibody test reliability 
in children with 
frequent diarrhea and 
malnutrition: is it celiac 
disease 
 
Jejunal biopsy among 
children with PD 
and/or malnutrition  
Brasilia, Brazil 
 






seen at the 
pediatric 
gastroenterology 
service of a 
university hospital 







antibodies were of 











30/31 (96.8%) had abnormal 
histopathology: 
• Suggesting non-specific 
inflammatory abnormalities 
in 27 (87.1%) subjects. 
• Demonstrating grade 3 
mucosal abnormalities in all 
malnourished 1 yr olds 
negative for enteric 
parasites. 
 



























R. Goto, et al. 
 
Impact of anti-Giardia 
and anthelminthic 




3-15 mo olds from 
a rural area were 
enrolled and 












Blood Tests:  
• α-1-acid glycoprotein 
(AGP) 
Mean L:M26 (SD) at baseline 
was 0.18 (0.24) in treatment 
groups, with no significant 
difference in placebo group or 
in testing post-intervention. 
 
Proportion with elevated L:M 







High L:M ratios 
were defined as 
greater than the 




                                                          
26 Geometric mean. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
growth and intestinal 
permeability in rural 
Bangladesh: a 
randomised double-
blind controlled study 
 
L:M as a marker of 
intestinal permeability, 
IgG as a marker of 
chronic immune 
stimulation, and α-1-
acid glycoprotein as 











There was a high 
prevalence of 













* Those who 
fully 
participated 
and for whom 
data were 
analyzed are 







at any study time point varied 
between 58%-74%. >57% 
consistently elevated L:M 
ratios. 
 
Seasonal variation in L:M 
was observed (p <0.001), 
with highest mean values in 
the monsoon season.  
 
L:M was associated with 
∆WAZ and ∆WHZ scores at 
24 weeks (p=0.001 and 
p<0.001, respectively, point 
estimates not provided.) 
 
Serum immune marker 
values were similar in all 




AGP concentrations were 
negatively associated with 
∆WAZ score at 24 weeks 
(p=0.004, point estimate not 
provided), and were 
associated with ∆WHZ score 
at 12 weeks but not at 24 
weeks. 
Interventions did 






weight with better 
L:M values, the 
degree to which 
this occurred was 




reported by this 
group in another 
study also 




Goto R et al. 
 








3-15 mo olds from 
a rural area were 
enrolled and 





















Mean27 L:M: 0.15 
 
L:M showed a decreasing 
trend with age (p=0.003), and 
was associated with female 
gender (p=0.004), HAZ score 
(p=0.039), and WAZ score 
(p=0.019), but not with 
giardiasis or any of the serum 
Mean L:M was 
elevated. L:M was 
not associated with 
any of the tested 




IgG rose with 
Helminthiasis 
prevalence was 







                                                          
27 Geometric mean. 
Appendix 7. Evidence table of all studies included in the review.




Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
growth faltering in 
rural Bangladesh 
 
L:M as a marker of 
intestinal permeability, 
IgG as a marker of 
chronic immune 
stimulation, and α-1-
acid glycoprotein as 




with giardiasis and 
growth parameters.  
There was a high 
prevalence of 
















IgG, AGP, and albumin were 
associated with giardiasis, 
but hemoglobin was not. 
 
Mean circulating albumin 
concentration was normal for 
age [203]. Compared to UK 
age-matched reference [199], 
rate of rise in IgG with 
increasing age was similar, 
but concentrations were 
consistently ~3g/L higher.  
 
IgG was not associated with 
growth parameters. Albumin 
was associated with HAZ 
score only (p=0.016). AGP 
was inversely associated with 
HAZ (p=0.011) and WAZ 
(p=0.005) scores.  
increasing age at 
the rate expected 
(compared to UK 
norms) [199] but at 
higher 
concentrations 












reported by this 
group in another 
study also 







have not been 
determined for 
AGP. UK norms 
for 10 mo olds-
adults are 0.88 




Goto R et al. 
 
Poor intestinal 
permeability in mildly 
stunted Nepali 
children: Associations 
with weaning practices 
and Giardia lamblia 
infection 
 




0-5 yr olds (mean 
























• 92% had values >UK norms 
• Mean30 L:M (SD, range): 
0.26 (0.21, 0.04-1.71).  
• Giardia-infected versus 
uninfected means: 0.43 vs. 
0.25, p=0.014 
 
The duration of ingestion of 
solid foods (with or without 
concurrent breastfeeding) 
was not associated with L:M 
in multivariate analysis.  

















ratio >0.4.  
 
Specific L:M 
data by WAZ 





                                                          
28 Lactulose and mannitol results were expressed as % of dose administered. 
29 Lactose results were expressed in mg/L. 
30 Geometric mean. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
intestinal permeability, 





and growth status.  
respectively.   
L:M was correlated with 
longer duration of 
breastfeeding (r=0.27, 
p<0.019). Specifically, 
children who breastfed for >2 
yr had higher L:M ratios than 
children who breastfed for 
shorter times (data not 
provided).  
 
L:M was not associated with:  
• History of diarrhea in the 
week preceding testing 
• Helminthiasis 
• Age 
• WAZ or HAZ scores 
 
Lactulose excretion ranged 
from 0.02–15.00. Mannitol 
excretion ranged from 0.5–
15.00. 
 
47% showed low lactase 
activity. Lactose values and 
lactose:lactulose ratios 
decreased with age (R2=28%, 
p<0.0001), but were not 
associated with sex, ethnicity, 
and location nor were they 
associated with L:M.  
 
Mean31 urinary lactose 
concentrations (mg/L) by 
feeding mode: 
• Breastfed: 172.5  
• Non-breastfed: 44.5, 
p<0.0001 corrected for 







subjects than in 











not the timing of 
introduction of solid 
foods, was 
correlated with L:M, 
and the correlation 
was direct, not 
inverse. Authors 
speculate that this 
could be due to 
higher mean age of 
their cohort 
compared to 
another study that 
demonstrated 
beneficial effect of 
duration of 
breastfeeding on 
reduced L:M in 
Guatemala [205]. 





                                                          
31 Geometric mean. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
 
Mean32 lactose:lactulose ratio 
by feeding mode:  
• Breastfed: 2.76 
• Non-breastfed: 0.31,  
p<0.0001 corrected for 
infant age 
 
Mean L:M by feeding mode: 
• Breastfed: 0.23 
• Non-breastfed: 0.28, non-




Haase A et al. 
 
Dual sugar 




ratio (L:R) as a marker 
of intestinal 
permeability in 
children with or 
without diarrhea. Also 
directly compared 
blood and urine 
methods of L:R testing 





Cases were >4 
mo olds admitted 





GI illness.  
 






























• 24 had both blood 
and urine L:R 
• 98 had blood L:R only 
• 28 had urine L:R only 
  
Among controls: 
• 25 had both blood 
and urine L:R 
• 36 had blood L:R only 
• 53 had urine L:R only 
 
A total of 49 subjects 
were tested with both 
blood and urine L:R 
methods to allow direct 
Among the subset with both 
blood and urine specimens: 
• Urine L:R: 
• Mean33 (CI): 
• Cases: 12.4 (9.3, 
16.5) 
• Controls: 6.7 (5.0, 
8.8), p=0.004 
• Distribution across 
ratios:  
• Low: n=31 
• Intermediate: n=9 
• High: n=9 
• Blood L:R: 
• Mean34 (CI): 
• Cases: 9.4 (6.7, 13.1) 
• Controls: 5.9 (4.4, 
7.8), p=0.04  
• Distribution across 
ratios: 
• Low: n=27 
• Intermediate: n=11 




L:R ratios by both 
blood and urine 
testing compared 
with controls 





between urine and 
blood L:R tests in 
the same subjects. 
 
Urine has been an 
established 
substrate for sugar 
excretion 











for L:R ratios 
used in this 
study:  
• Blood L:R: 





• Urinary L:R: 
• Low= <10 
• Intermediat
e= 10-18 




                                                          
32 Geometric mean. 
33 Geometric mean. 
34 Geometric mean. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
comparison of values. 
 
 
Among subjects with only 
urine tested: 
Mean35 urine L:R (CI):  
• Cases: 15.7 (12.6, 19.6)  
• Controls: 6.7 (5.7, 8.0), 
p<0.0001  
 
Among subjects with only 
blood tested: 
Mean36 blood L:R (CI):  
• Cases: 12.8 (10.3, 16.0) 
• Controls: 3.7 (2.8, 4.9), 
p<0.0001   
 
Even though blood L:R was 
consistently lower than urine 
L:R by a geometric mean (CI) 
of 1.09 (1.02, 1.16), there 
was strong correlation 
between L:R ratios in blood 
and urine as measured by:  
• Concordance correlation 
coefficient for agreement 
(CI) of 0.76 (0.64, 0.88) 
• Kappa statistic (CI) of 0.71 
(0.51, 0.92) (when L:R 
ratios are divided into 3 
ordered categories) 
• Sensitivity and specificity of 
blood tests of 81% (25/31) 
and 89% (16/18), 
respectively, when using 
the urine testing as the 
standard. 
 
The failure rate* for serum 
However, timed 
collection of urine 









the much lower 
concentrations of 
probe sugars in 
blood compared to 
urine had posed a 
challenge to 
sensitive detection 




as used in this 
study, now provide 





The failure rate of 
L:R blood testing 
was significantly 
lower than that of 
urine testing.  
 
 














test failure rate 
calculations 







who had both 






those with and 
without diarrhea 
would have 
been of interest. 
One would 
expect children 
with diarrhea to 
have higher 
rates of urine 
                                                          
35 Geometric mean. 
36 Geometric mean. 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
L:R testing (20/197, 10%) 
was lower than for urine 




* Defined as emesis with 
rhamnose/lactulose oral 
challenge (same dose for 
urine and serum testing), 
urine leakage or 
contamination with stool, or 
plasma quantity from blood 
draw of insufficient quantity 
for analysis.  
test failure due 
to contamination 




analytes due to 




testing might be 
more feasible 
than timed urine 
collections, but 
HPLC might not 






report on the 
same population 
as two other 
studies in this 
review which 
also assessed 







Hafeez A et al. 
 







2 mo-12 yr olds 
referred from 
various hospitals 





• 28 with PD 
• 9 with FTT 










findings were identified in:  
• 21/28 with PD  
• 7/9 with FTT 
• 3/4 with short stature 
 
More abnormalities were 
found via histology than 
75% of the PD and 






Authors assert the 
There was 
possible bias in 




unable to be 
analyzed (from 
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
Duodenal biopsy 
among children with 
PD or growth 
problems 
abdominal pain, 
PD, short stature, 
FTT, GI bleeding, 
or anemia. The 
subjects of 
interest for this 
review were those 
with PD or growth 
problems. 
visualization, and findings did 







endoscopy, due to 
lack of correlation 





















not by condition 
or by patient, so 
specific results 
could not be 
interpreted in 
regards to this 
review.  
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Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
2007 
 
Jain S et al. 
 
Fecal occult blood 




Fecal occult blood 
among severely 
malnourished children 





































Fecal occult blood test was 
positive in 30/50 (60%) cases 
and 0/30 controls.  
 
Among cases positive for 
fecal occult blood, 20 (66.7%) 
were found to have 
hemoglobin <8 g/dL.  
 
Enteric infections: 
• Parasitic infections were 
detected in 14/50 (28%) of 
cases, 12 (85.7%) of whom 
tested positive for fecal 
occult blood.  
• Bacterial infections were 
detected in 18/50 (36%) of 
cases, 13 (72.2%) of whom 
tested positive for fecal 
occult blood. 
• Of the remaining 18 for 
whom an enteric pathogen 
was not identified, 5 
(27.8%) tested positive for 
fecal blood. 
 
Among the 30 cases with 
fecal occult blood, 16 were 
breastfed, 11 were fed cow’s 
milk, and 3 were fed formula.  
 
A high proportion of 
severely 
malnourished 
children had a 
positive fecal occult 
blood test, 
compared with no 
positives among 











of those without an 
identifiable 
pathogen also 
tested positive.  
 
Presence of fecal 
blood did not 
appear to vary by 
feeding mode (e.g. 
breast milk, cow’s 



































scheme was not 
defined. 
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
2002  
 














New Delhi, India 
 












n=3 <5 yr old 
Tc-99m dextran 
scintigraphy 
Abnormal Tc-99m dextran 
uptake was positive in one 
child found to have subtotal 
villous atrophy on biopsy 
and another thought to have 
abdominal tuberculosis. 
  
The child with the negative 
scan had marasmus and 











This pilot study had 
a small sample 
size of 8 children, 
and only 3 were 












duodenal fluid and 
serum among 
children with PD 
and Giardia 
infection compared 
to those without 
diarrhea  
New Delhi, India 
 
<12 yr olds 
admitted to 
hospital with PD 
and Giardia.  
 
Controls had no 




Most cases were 
<7 yr old, with 
n=19 <3 yr old. 
Ages of controls 





n=30 cases with 




















Higher mean concentrations 
of IgM were found in 
duodenal aspirates of cases 
compared to controls 
(p<0.05).  
 
Mean concentrations of 
duodenal IgA and IgG did 















The number of 
controls was small 



















<36 mo old inner-
city residents 
recruited from the 






n=49 cases with 
Cryptosporidium 
infection  




Serum MBL concentrations 
were lower in cases than in 
healthy controls (p=0.002) 














was defined as 
concentrations <70 
ng/mL. 
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 






lectin as a marker of 
innate immune 
response among 





or from GHESKIO 
HIV Center37.  
 













• 9.8% healthy controls 
• 0 diarrhea controls 
 
Cryptosporidiosis was 
associated with MBL 
deficiency (odds ratio=22.4; 
CI: 3.1, 160.838). 
 
Among cases, the 
proportion of those with PD 
was nearly double among 
those with MBL deficiency 
compared to those without 
MBL deficiency, but these 
results were not significant 
(p=0.13). MBL deficiency 
was not associated with 
duration of diarrhea 
(p=0.37) among those with 
cryptosporidiosis nor with 
anthropometric status 
among either cases or 
controls. 
associated with 
mean duration of 
diarrhea or history 
of PD.  
2006 
 









Fecal cytokines and 
lactoferrin as 










healthy controls.  
 
Subjects were 
followed-up at 6 





















• IL-4  
• IL-8  
• IL-10 
Proportion lactoferrin-
positive at enrollment: 
• Cases: 51.2% 
• Controls: 4.0%  
 
Cases had higher 
concentrations of TNF-α 
than controls at enrollment 
(p=0.04), but no difference 
was observed at follow-up. 
 
Controls had almost 2x 
higher fecal IFN-γ at 
enrollment (p=0.1); the 
Lactoferrin was 
present among 








Fecal TNF-α was 
higher among 
cases at 
enrollment but did 
Cut-off values for 
lactoferrin positivity 
were not provided.  
 
Breastfed children 
(>85% of cases 
and controls) were 
included in testing. 
Proportions at 
follow-up were not 
reported.  
 
The association of 
fecal cytokines and 
                                                          
37 The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections. 
38 Reported results were adjusted for confounding variables, unless otherwise noted. 
39 The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections. 
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
mucosal 
inflammation among 




infection resolved.  
 
HIV status of 
subjects varied.  
 
There was a high 
prevalence of 
malnutrition in the 
study population. 
negative magnitude of difference 
increased (to almost 3x) and 
was statistically significant 
at the 6- and 9-month 
follow-up (p=0.01 and 
p=0.03, respectively). 
 
No differences in fecal 
concentrations of TGF-β, IL-
8, IL-4, or IL-10 were noted 
between groups. 
not persist when 





higher fecal IFN-γ 













and controls.  
lactoferrin with 
growth parameters, 
history of PD, and 
HIV status were 
not reported, nor 
was their 
association with 
each other.  
 










not reported.  
2002 
 



















<18 mo olds from 
a low SES setting 
recruited from the 
















n=17 cases with 
Cryptosporidium 
and diarrhea (5 





• 17 with diarrhea 
(5 with PD)  



















Proportion RS-positive:   
• 33.3% cases 
• 64.7% diarrhea controls 





• 83.3% cases  
• 60.0% diarrhea controls 
• 28.6% healthy controls, 
(p=0.01) 
 
IFN-γ was not recovered in 
any stools. 
 










While some fecal 
cytokines were 
detected in as 
many as 40% of 
healthy controls 






were not stratified 










children who were 
breastfeeding were 
not tested for 
lactoferrin.  
 
                                                          
40 The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections. 
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 










compared to diarrhea and 
healthy controls.  
 
Additionally, TNF-α receptor 
I, IL-8, and IL-13 were found 
in diarrhea and healthy 
controls, while IL-4 and IL-
10 were not.  
 
Fecal lactoferrin was 
associated with the 
presence of TNF-α receptor 
I (point estimate not 
provided, p=0.03). 
 
Mean WBC counts were 






















Fecal lactoferrin as 









favela in Fortaleza, 
Brazil 
 
All newborns from 
an urban 
shantytown were 
recruited at birth 
and followed for up 
to 4 yr. Those with 
Giardia recovered 
from stools were 


















Stool Test:  
Lactoferrin 
Proportion of positive 
lactoferrin results decreased 
with each new Giardia 
infection, p=0.015: 
• 1st infection: 74.0% 
(15.2% of those testing 
positive had high titers)  
• 2nd infection: 40.0% (5.3% 
of those testing positive 
had high titers)  
• 3rd infection: 1 (20.0%) 
tested positive (at a high 
titers) 
 
Increasing titers of 
lactoferrin were associated 
with longer duration of 
diarrhea, p=0.017: 
• Negative: 2.2 days 
• Low: 9.7 days 













these results were 
not presented 





might be useful in 
predicting 
Lactoferrin results 





following scale was 
used: 
• High = positive 
at 1:400-1:3200 
dilution  
• Low = positive at 
1:25-1:200 
• Negative = no 
reaction at 1:25 
 
Stools from 
children who were 
breastfeeding were 
not tested.  
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
 
Lactoferrin results did not 
differ between symptomatic 
and asymptomatic children 
at first infection, but those 
with symptoms had positive 
results with recurrent 
infections with greater 









Data were part of a 
larger study; similar 
data on lactoferrin 
in Cryptosporidium-
infected children 
were published by 
O.Y. Bushen, et al. 
(also included in 
this review); 
however, Bushen 
et al. used a 
slightly different 
grading scale for 
reporting lactoferrin 
results [108].  
2003 
 




oxide production in 









Nitric oxide (NO) as 





ratio (L:R) as a 
marker of intestinal 





1-6 yr old 
Aboriginal and 
non-Aboriginal 





1. Children with 
AD 
2. Children with no 
diarrhea but with 
non-GI infectious 
conditions  
3. Children without 












• 73 with non-GI 
infections (49 
Aboriginal)  


















(169 cases tested)  
 
 
* NO is an unstable 
free radical and is 
converted to nitrite 
and nitrate. Urine 
nitrate (NO3)+ nitrite 
(NO2) was expressed 
as a ratio with urine 
creatinine (NO2 + 
NO3:Cr) in order to 
account for 
NO among Aboriginal 
children with diarrhea was 
>3x higher than any other 
group and >5x higher than 
in non-Aboriginal controls. 
• NO was >3x and >2x 
higher among Aboriginal 
than non-Aboriginal 
children in the diarrhea 
(p<0.001) and no 
infections groups 
(p<0.001), respectively, 
but there was no 
difference between them 
in the non-GI infections 
group.  
• NO was >3x and ~2x 
higher in the diarrhea 
compared to the no 
infections group among 
Aboriginals (p<0.001) and 
non-Aboriginals (p<0.03), 
respectively.  
• NO was virtually the same 
among the Aboriginal non-
GI infections and no 
NO2 + NO3:Cr 




was used as a 
marker of gut 
permeability and 
inflammation, with 
an attempt to 
identify how much 
more it reflects as 
response to 
inflammation from 







the same among 
those with 
diarrhea and non-
GI infections (and 
higher compared 
Positive stool RS 
was defined as 
>0.5%.  
 
Abnormal L:R was 
defined as >7.6; no 
reference or 
derivation was 




appears to be the 
same as in another 
Kukuruzovic, et al. 
study also included 
in this review which 
assessed serum 
lactulose:rhamnose 
as a marker of 
intestinal 
permeability [58].  
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(as a surrogate of 
iron deficiency), and 
stool reducing 
substances among 
children with and 
without diarrhea  
differences in urine 
concentration. 
 
** Measured only 
among children with 
profuse diarrhea. 
 
infections groups, as well 
as among the non-
Aboriginal diarrhea and 
non-GI infections groups.  
 
112/152 (74%) and 31/169 
(18%) of children with AD 
had abnormal L:R ratios and 
positive stool RS, 
respectively. 
 
NO and L:R were measured 
at “convalescence” on Day 
5 among those with 
diarrhea: the mean 
improvement in NO was 
21.7% compared with 
54.6% for L:R (p=0.01). 
 
NO and L:R were correlated 
(n=193, r=0.37, p<0.001)41; 
the correlation was stronger 
for lactulose (effect 
ratio=1.47, p<0.001) than 
for rhamnose (effect 
ratio=0.80, p=0.0242).  
 
NO was not correlated with 
stool RS43 or MCV, but was 
correlated with lower WAZ 
score (effect ratio=0.88, 
p=0.05). 
to controls). NO 




compared to any 
other group. 
Authors suggest 











controls in this 
study. 
 
NO appeared to 
decrease 
significantly more 




NO was found to 
correlate with L:R. 





                                                          
41 Reported results appear to have been adjusted for age and race. 
42 Reported results were adjusted for age and race. 
43 Reported results among children with diarrhea were adjusted for age and race. 
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2002 
 
Kukuruzovic RH et 
al. 
 
Milk formulas in 
acute gastroenteritis 




ratio (L:R) as a 












<3 yr old with AD 
and/or WAZ score 
<-2. 
 
60% of subjects 
had low WAZ 



























free formula  







L:R testing was 
repeated in 150 
subjects at day 5: 
• De-Lact: n=48  
• O-Lac: n=52 
• Alfaré: n=50 
Baseline mean44 L:R (CI) in 
De-Lact group was 14.9 
(10.4, 21.5), with no 
difference between groups. 
 
The mean improvement* in 
L:R (CI) was 13.0 (9.3, 16.6) 
with some significant 
differences between the 
various formulas: 
• De-Lact: 18.6 (10.6, 26.6)  
• O-Lac: 12.0 (7.5, 16.6), 
p=0.15 compared to De-
Lact  
• Alfaré: 8.5 (2.1, 14.9), 




* Improvement in L:R was 
calculated as baseline L:R 





with all of the low-
lactose formulas 
studied resulted in 
improved L:R 
among this 





most marked with 






did not appear to 











The study did not 
include a control 
arm (of standard 
care) to which 





the advantages of 
serum over timed 
urine collection for 
assessment of L:R 
as discussed in 
another publication 
in this review [125]. 
                                                          
44 Geometric mean. 
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2002 
 












lactose, and stool 
reducing 
substances as 












































• L:R  
• Hemoglobin  









L:R testing was 
repeated on day 5 for 
a subset of Aboriginal 
subjects: 
• 174/264 admissions 
for acute diarrhea  




* Measured only 




tested not provided. 
 
 
27/75 (36%) of Aboriginal 
controls and 0 non-
Aboriginal controls had 
abnormal L:R ratios. 
 
Mean46 L:R at baseline: 
Cases: 
• Aboriginal: 16.4  
• Non-Aboriginal: 7.9, 
p=0.002 compared to 
Aboriginal cases 
Controls: 
• Aboriginal: 4.6 
• Non-Aboriginal: 2.5, 
p=0.02 compared to 
Aboriginal controls  
 
Mean improvement47 in L:R 
(CI) at day 5 among those 
with repeat testing: 
• Aboriginal cases: 14.6 
(11.2, 18.0)  
• Aboriginal controls: -0.63 
(-4.0, 2.7)  
 
Mean lactulose recovery48: 
• Cases day 1: 0.085 
(0.070–0.103)  
• Cases day 5: 0.039 
(0.033–0.046) 
• Controls: 0.024 (0.019–
0.029) 
All 3 values significantly 
differed from one another. 
 
Mean rhamnose recovery: 




double those of 
non-Aboriginal 
children both 



















had higher mean 
L:R. 
 
Higher case L:R 
was driven more 
by high lactulose 




Positive stool RS 
was defined as 
>0.5%.  
 
Abnormal L:R was 
defined as >5.6, 
derived from 2 SD 
above the 
arithmetic mean for 
non-Aboriginal 
controls in this 
study. The 
rationale for the 
choice of 2 SD 
above the 
arithmetic, instead 
of the geometric, 





were not reported. 
 
Analysis included 







analysis methods.  
 
Repeat L:R testing 
was conducted on 
                                                          
45 Lactulose and rhamnose results were expressed as % of dose administered. 
46 Geometric mean. 
47 Improvement in L:R appears to have been calculated as baseline L:R minus repeat L:R, as described in another publication in this review; however, this was not expressly stated. 
Reference 134. Kukuruzovic, R.H. and D.R. Brewster, Milk formulas in acute gastroenteritis and malnutrition: a randomized trial. J Paediatr Child Health, 2002. 38(6): p. 571-577. 
48 Figures reported parenthetically after the mean percent recoveries of lactulose and rhamnose were not specified as ranges or CIs. 
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• Cases day 1: 0.479 
(0.424–0.542) 
• Cases day 5: 0.555 
(0.498–0.616) 
• Controls: 0.585 (0.500–
0.685) 
These values did not 
significantly differ from one 
another. 
 
Confidence intervals (CIs) in 
the authors' graphical 
representation of mean L:R 
at admission did not 
overlap, and the difference 
in means was particularly 
evident between Aboriginal 
and non-Aboriginal subjects.  
 
Factors associated with L:R 
among cases were49:  
• Acidosis (p=0.007) 
• Hypokalemia (p=0.035) 
• Diarrhea severity 
(p=0.001)  
 
Age and malnutrition were 
not associated with L:R. 
 
38% and 27% of Aboriginal 
cases had positive serum 
lactose and stool RS, 
respectively. 12% of 
Aboriginal and non-
Aboriginal controls 
combined had lactosemia.  
 
Presence of lactosemia was 
associated with L:R, 
L:R among cases 




Stool RS and 
serum lactose 










controls of both 
racial groups, but 





This study appears 
to report on the 
same population as 
in the Kukuruzovic, 
et al. 2003 
reference also 







the advantages of 
serum over timed 
urine collection for 
assessment of L:R, 
as discussed in 
another publication 
in this review [125]. 
                                                          
49 Reported results were adjusted for confounding variables, unless otherwise noted. 
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adjusted relative risk 
(CI)=1.06 (1.03, 1.10)50. 
Stool RS, anemia, and MCV 
were not associated with 
L:R.  
                                                          
50 Reported results were adjusted for severity of diarrhea, acidosis, hypokalemia, and age. 
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2004 
 





antibodies in the 
diagnosis of celiac 
disease in children: 




among patients with 








symptoms of CD 
(not specified).  
 
Subjects of interest 
for this review 
were those who 
tested negative for 
CD-specific 
serology and who 
did not meet the 
study diagnostic 
criteria for CD--
subtotal or total 
villous atrophy 
consistent with 




aged 3 mo-17 yr 












Of 99 subjects not meeting 
diagnostic criteria for CD, 
endoscopic biopsies 
revealed: 
• 76 had normal 
morphology of the 
intestinal mucosa 
• 7 had elevated densities 
of intraepithelial 
lymphocytes  
• 10 had partial villous 
atrophy (Marsh stage 2)  
• 6 had various other 
conditions such as 
giardiasis or gastritis 
Among 169 
children with 
symptoms of CD, 
41% had subtotal 
or total villous 








Article in French. 
 
Prevalence of CD 
antibodies did not 
clearly align with 
case/control 
designation. 
Because of the 
way the results 
were reported, we 
could not extract 
data on those who 
tested negative for 
CD-specific 
serology and who 
had Marsh stages 






while results and 
conclusion sections 
specify that jejunal 
specimens were 
obtained. 
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2006 
 











Small intestinal and 
rectal biopsy to 
assess morphology 





Sao Paulo, Brazil 
 
5 mo-12 yr old 
(median 24 mo) 
HIV-infected 
subjects recruited 
from a hospital and 
clinic. 
 
All subjects had 







n=5 patients with 




n=6 patients with 











Biopsy of small 










100% had low D-xylose 
absorption: 
• Mean: 15.6 mg/dL 
• SD: 5 
• Range: 8.9-24.4 
• Median: 14.2  
 
Small intestinal biopsy:  
• 100% had some degree 
of villous atrophy based 
on a I-IV grading system: 
• Grade I: 3 
• Grade I/II: 2  
• Grade II: 1 
• Grade II/III: 1 
• Grade III/IV: 1 
• 2 samples were too 
superficial to assess 
• Intraepithelial 
lymphocytes were 
increased in half of the 
biopsies. 
• Lymphocytic and 
polymorphonuclear 
(PMN) infiltration of the 
lamina propria were 




• 100% had normal 
architecture 
• Lymphocytic and PMN 
infiltration were present in 
6/6 and 4/6, respectively. 








diarrhea status.  
 
All patients also 
had cellular 
infiltration of the 
lamina propria 
and varying 
degrees of villous 
atrophy. 
 
There was no 
correlation 
between D-xylose 
and degree of 
villous atrophy on 
biopsy.  
Portuguese 
language article.  
 
D-xylose <25 
mg/dL was defined 
as indicative of 
malabsorption. 
This value is higher 
than what some 
references have 
noted as a cut-




system of grading 
villous atrophy.  
 
Results were not 
presented by 
diarrhea status, 
perhaps due to 
small sample size. 
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2010 
 
Lima AA et al.  
 




total parasitic, and 
specific Giardia spp 
infections in 






L:M as a marker of 
intestinal barrier 










vitamin A or placebo  
Fortaleza, Brazil 
 
2 mo-9 yr olds 
(mean 43 mo) from 
an impoverished 
urban community, 
eligible if HAZ 
score was 







































Median L:M at baseline was 
0.089. There was no 
significant change in L:M at 
4 mo follow-up within either 
treatment group.  
 
No significant difference in 
L:M was observed between 
treatment groups. 
 
Both median lactulose and 
mannitol excretions 
decreased at 4 mo follow-up 
among the vitamin A 
compared to the placebo 
group: 
• Lactulose: 0.21 to 0.74, 
p=0.042  
• Mannitol: 3.06 to 8.25, 
p=0.008  
 
Overall proportion of 
lactoferrin was 23% initially. 
At 1 mo follow-up, there was 
no difference in prevalence 
between vitamin A (33%) 
and placebo (31%) groups. 
 
Cytokine concentrations did 
not significantly differ 
between placebo and 















excretion, with no 











Authors did not 













Cut-point values for 
lactoferrin positivity 








participation due to 
assessment of 
stool lactoferrin. 
                                                          
51 For lactulose and mannitol results, excretion measurement was not specified. 
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2005 
 
Lima AA et al. 
 
Intestinal barrier 








L:M as a marker of 
intestinal 
permeability and 
various stool tests 
among children with 
malnutrition or PD 
who received either 
glycine or glutamine 
supplemented 
formula or placebo 
Fortaleza, Brazil 
 
2-60 mo olds 
hospitalized with 
WAZ score <-2, 
~70% of whom 
had PD.  
RCT 
 





• 27 with glycine 















• Lactoferrin  
• Leukocytes  





* n=80 tested at 
enrollment, n=65 
tested at day 10. 
 
** n=60 tested. 
Mean53 L:M (SE):  
• Glutamine group: 
• Baseline: 0.31 (0.10) 
(similar in all three 
groups) 
• Day 10: 0.10 (0.02); 
significant decrease, 
(p=0.01) 
• No significant decrease in 
L:M in glycine and 
nonsupplemented formula 
groups at day 10 
 
Mean lactulose (SE):  
• Glutamine group: 
• Baseline: 0.97 (0.46) 
(similar in all three 
groups) 
• Day 10: NS decrease 
in all 3 groups 
 
Mean mannitol (SE):  
• Glutamine group: 
• Baseline: 3.42 (0.64) 
(similar in all three 
groups) 
• Day 10: NS decrease 
in all 3 groups 
 
Proportion of stool markers 
at baseline among all 
subjects:  
• Lactoferrin: 53.3% 
• Leukocytes: 11.7% 
• RS: 3.3% 
• Occult blood: 5.0%  
L:M significantly 









RS, and occult 
blood were 





markers and L:M 
was not reported.  
 
Data were not 
stratified by history 
of PD. 
 
Fecal fat was 
assessed, but 
results were not 
reported. 
 














                                                          
52 Lactulose and mannitol results were expressed as % of dose administered. 
53 Type of mean not specified. 
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2007 
 


























6 mo-8 yr olds 
(mean age 3.5 yr) 
from an urban 
setting with HAZ, 


















• L:M  
 
L:M median (range) at 
baseline: 
• Treatment: 0.0385 
(0.8922 [sic])  
• Placebo: 0.0302 (5.5812 
[sic]) 
 
Lactulose and mannitol 
excretion both significantly 
decreased in the treatment 
group only (p=0.05 for both 
sugars)55. L:M did not 
change significantly within 
or across groups days after 
treatment. 
 
Lactulose excretion was not 
associated with WHZ, WAZ 
or HAZ scores in either 
group56. Mannitol was not 
associated with growth 
parameters in the control 
group, but was associated 
with WHZ (r2=-0.386, 
p=0.027) and WAZ (r2=-
0.385, p=0.027) scores in 
the supplemented group. 
Data for L:M and growth 













mannitol and L:M 
did not change 
significantly in the 
placebo group. 
Authors state that 
L:M median and 
range values were 
within the 
confidence interval 
for values of 









chronic diarrhea in 
their methods, they 
did not report data 
stratified according 
to these conditions. 
 
Authors provide 




results; these likely 




Long KZ et al. 
 
The effect of vitamin 
A supplementation 




All 5-15 mo olds 
within a periurban 
community were 













Positive tests for fecal 
cytokines: 
• IL-4: ~55% 
• IFN-γ: ~50% 
• IL-6: ~40%  
 




due to vitamin A 
supplementation 
were observed 




were not reported. 
Differences in fecal 
cytokines between 
all subjects with 
                                                          
54 For lactulose and mannitol results, excretion measurement was not specified. 
55 Reported results were adjusted for age and season. 
56 Reported results were adjusted for age and season. 
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immune response in 





Fecal cytokines as 
markers of intestinal 
mucosal immune 
activation in children 
with and without GI 
pathogens receiving 




















was tracked and 
stool samples 
were tested. 
differences in proportions of 
these fecal cytokines 
between vitamin A-




children with diarrhea had 
lower median IFN-γ 
concentrations (odds 
ratio57=0.51; CI: 0.26, 0.99) 
and higher IL-4 
concentrations (odds 
ratio=2.14; CI: 0.94, 4.87) 
compared to children with 
diarrhea in the placebo 
group in a nonrandomized 
analysis. IL-6 
concentrations did not differ 
in this analysis. There were 
no differences between the 
two groups among those 
without diarrhea. 
 
Differences in median 
concentrations of fecal 
cytokines by types of enteric 
pathogens were also 
observed.  
of subjects with 
GI infection or 
diarrhea.  
and without GI 
infections or history 




described in terms 




López de Romaña 









3-4 yr olds residing 
in a poor 
community at the 
periphery of Lima 
with stunting and 
moderate anemia 
as a surrogate risk 





both initial and 
follow-up 
absorption assay 




Zinc excretion to 
measure fractional 
absorption of zinc 
(FAZ) and total 
absorbed zinc (TAZ) 
following radiolabeled 
zinc administration  
 
Mean zinc parameters (SD) 
at initial assessment: 
• FAZ:  
• Group 1: 0.34 (0.11) 
• Group 2: 0.24 (0.05) 
• Group 3: 0.13 (0.04) 
• TAZ (mg/d):  
• Group 1: 0.71 (0.18) 
• Group 2: 1.11 (0.21) 
• Group 3: 1.34 (0.47) 
Despite a 










could play a role in 
zinc (or other 
micronutrient) 
absorption; such 
factors were not 
explored in this 
study. 
 
The principal aim 
                                                          
57 The odds ratios represent odds that a cytokine (categorized into three levels: undetectable, <median, >median) will have a higher value among vitamin A-supplemented children. 
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products fortified 
with iron only or iron 






receiving zinc as 

















wheat flour with 
iron and 3mg 





n=15 wheat flour 
with iron and 9mg 







Neither mean FAZ nor TAZ 
changed significantly at 
subsequent assessments in 
any treatment group. 
 
In both the initial and 
subsequent assays, mean 
TAZ from zinc-fortified 
meals increased with 
increasing amounts of 
fortification (p< 0.001). 
However mean FAZ was 
inversely related to zinc 
intake from these meals 
(p<0.001). 
 
Nonfortified dinner FAZ and 
TAZ were significantly lower 
in the group receiving the 
most zinc-supplementation 
at the initial assay (p=0.015 
and p=0.012, respectively) 
despite no difference in zinc 
intakes from the unfortified 
dinner by treatment group. 
This relationship between 
groups was not observed at 
the second assay; however, 
a significant decrease of 
16% in mean FAZ and TAZ 
from the unfortified dinners 
was observed between 
initial and subsequent 
assays (p<0.001).  
Mean plasma zinc 
concentrations did not differ 
between treatment groups 
throughout the study period. 
The proportion with low 








be due to factors 








zinc from the zinc-
fortified breakfast 
and lunch meals 
absorbed less 
zinc from the 
unfortified 




of this study was to 
determine 
appropriate extent 
of zinc fortification 
of a staple food in 
a specific 
community; we 
present only results 
relevant to this 
review. 
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was lower at the end of the 
study (3.3% vs. 20.5% 
initially, p=0.046).  
2001 
 




clinical risk factors 
for developing 
persistent diarrhea 
among infants in a 
rural community of 
Egypt 
 
Stool IgE as a 
marker of 
gastrointestinal 
allergy and its 
association with 






recruited at birth 
from a rural village 
and followed for 






diarrhea, 41 (11%) 




control within a 










* Stool samples 
from each PD 
episode were 
counted as a 
case for analysis 
and compared to 
randomly 
selected AD 







Fecal IgE was detected 
more frequently in stools 
from episodes of PD 
compared to episodes of 
AD: odds ratio (CI)58=3.3 
(1.0, 10.9). 
 
Fecal IgE was detected 
more frequently in stools 
from episodes of PD than in 
stools from children without 
diarrhea: odds ratio 
(CI)=4.84 (1.1, 21.7).  
 
Fecal IgE was 
detected 3 times 
more frequently 
during episodes 
of PD than AD 
and 5 times more 
frequently in PD 
stools than in 




based on episodes 
of diarrhea within a 




than one diarrheal 
episode. 
Additionally, it 
appears that an 
individual could 
also have been 
included as a case 
of PD, a control 
with AD, or a non-
diarrhea stool 




appears to be the 
same as in another 
Mahmud, et al. 
study also included 
in this review which 
reported the 
prevalence of fecal 
IgE by gender and 




Mahmud MA et al. 
 
Bilbeis, Egypt         
 
Newborns 









Overall incidence of fecal 
IgE: 0.39/child-year 
 
By age group:  
Substantial 
incidence of fecal 
IgE was observed 
in this setting in 
Study population 
appears to be the 
same population as 
in another 
                                                          
58 Reported results were adjusted for confounding variables, unless otherwise noted. 
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Increased fecal IgE 
among infants in a 
rural community of 
Egypt: an analysis 
of associated risk 
factors 
 
Fecal IgE as a 




from a rural village 
and followed for 














• < 3 mo: 0.28/child-yr  
•  3-6 mo: 0.42/child-yr  
•  6-9 mo: 0.16/child-yr  
• >9 mo: 0.12/child-yr  
 
Relative risks (CI): 
• 3-6 compared to >9 mo 
olds : 3.28 (1.03, 13.60)  





peaked at 3-6 mo 
of age. 
 
Male gender was 
associated with 
fecal IgE. 
Mahmud, et al. 
reference also 




between fecal IgE 
and PD [142]. 
2002 
 
Manary ML et al. 
 






Zinc absorption in a 








2–5 yr olds (mean 
age 43.6 mo, SD 





There was a high 
prevalence of 
stunting and low 














Zinc excretion to 
measure fractional 
absorption (FAZ) and 






• FAZ: 0.24 (0.04) 
• TAZ (mg/d): 1.30 (0.33)  
• EFZ (mg/d): 1.15 (0.33) 
 
Language in the discussion 
section strongly suggests, 
but does not explicitly state, 
that TAZ and EFZ were not 
correlated. Correlation 
analysis for these 
parameters was not 
reported. 
  
EFZ was higher 
than would be 
expected for a 
zinc deficient 
cohort, and EFZ 
was not 
correlated with 




leading to poor 
zinc absorption 
might explain 
these findings, the 
authors note that 
in a previous 
study (among a 
somewhat older 
age group) there 
were no 




diets [187]. They 
note that such 
perturbations in 
EFZ have also 
Authors note that 
the lack of 
comparable 
data from children 
of the age range in 
this study limits 
data interpretation. 
They also provide 
results per body 
weight due to 
presumed 
relationship; 
validity of such 




that the methods 




accurate, but quite 
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Sample Size  Biomarker Results Conclusion Comments 
been reported in 
children with 
enteropathy due 
to cystic fibrosis 
[188] and suggest 
that a similar 
process could be 
going on in these 
Malawian children 
due to TE.  
2001 
 


















1-5 yr olds with PD 
selected randomly 
from an outpatient 
population in an 
urban setting. 
 
A high proportion 
of the children had 

















7 (23.3%) had grossly 
abnormal endoscopic 
findings: 
• 5 (16.7%) with chronic 
duodenitis  
• 1 with duodenitis with 
multiple erosions  
• 1 with duodenitis with 
hemorrhagic gastritis  
 
22 (73.3%) had abnormal 
histopathology: 
• 17 (56.7%) with villous 
atrophy with mononuclear 
cell infiltration  
• 1 (3.3%) with villous 
atrophy and eosinophilic 
infiltration  
• 2 (6.7%) with villous 
atrophy and mononuclear 
and eosinophilic 
infiltration 




Mean duration of diarrhea 
(SD) was not associated 


















had >1 month 
longer duration of 
diarrhea than 










WFA were not 








Number of patients 




infiltration was very 
small (n=2), yet 
authors report a 
significant 
difference in their 
duration of diarrhea 
relative to those 
with normal 
histopathology. 
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findings but did vary by 
histopathology: 
• Normal histopathology: 
9.0 wk (6.0), n=8 
• Mononuclear cell 
infiltration: 9.0 wk (6.0), 
n=2 
• Villous atrophy with 
mononuclear cell 
infiltration: 14.9 wk (5.3), 
n=17, p<0.02 compared 
to normal histopathology 
• Villous atrophy with 
mononuclear and 
eosinophilic infiltration: 
21.5 wk (2.1), n=2, 
p<0.02 compared to 
normal histopathology 
• Villous atrophy with 
eosinophilic infiltration: 
6.0 wk, n=1 
 
No consistent pattern was 
observed between gross 
endoscopic findings or 
histopathological lesions 
and age, degree of 
malnutrition, or type of 
enteropathogen recovered 








Mittal SK et al. 
 
Tropical sprue in 
north Indian children 
 
D-xylose and 




0-15 yr old 
gastroenterology 







(38 with repeat 
biopsies) 
 










• D-xylose*  
 
36 (38.3%) were diagnosed 
with TS including 14/44 
(31.8%) who were under 5 
years of age.  
 
18 (19.1%) were diagnosed 
with CD.  
 
Degree of villous atrophy 
More than half of 
the GI clinic 
patients with PD 
had some degree 
of villous atrophy.  
 
More than one-
third and almost 
one-fifth of 
Biopsy results were 
not provided for 
patients without TS 
or CD.  
 
It was unclear if 
there were patients 
with abnormal D-
xylose and 
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D-xylose test, and 
clinical response to 
antibiotics were 
diagnosed as 








with CD. We 
include data on 






* Not specified 
whether from urine or 
serum, and units of 
measurement not 
provided. 
among TS vs. CD patients:  
• Mild in 8/36 (22.2%) vs. 0 
• Moderate in 23/36 
(63.9%) vs. 4/18 (22.2%) 
• Severe in 5/36 (13.9%) 




among TS patients was 8.3 
g/dL (5.5-11) and did not 
differ from values of those 
with CD.  
 
Among the 22 TS patients, 
repeat biopsies showed: 
• 16 with normalization 
• 5 with improvement  




The D-xylose test was 
abnormal in all TS patients 
by diagnostic definition. 
subjects were 
diagnosed with 





definition, all TS 
patients improved 
with treatment.  







23% had partial 
improvement and 




histology who did 
not respond to 
antibiotic therapy 
and therefore were 
not diagnosed with 
TS. 
 
Cut-off points used 
to define abnormal 
D-xylose tests 























criteria of no GI 
symptoms, no 
antibiotics in the 
preceding 3 wk, 
and no SBBO by 
















• Lactose HBT  







* Reported as parts 
per million (ppm) post-
substrate ingestion 
after subtraction of 
baseline, pre-
Mean lactose HBT (SE): 
• Cases pre-treatment: 3.6 
(0.75) ppm  
• Cases post-treatment:  -
0.85 (0.75) ppm (p<0.05 
compared to pre-
treatment) 
• Controls: 0.19 (0.81) ppm 
(p<0.05 compared to pre-
treatment cases) 
 
Mean xylose HBT (SE): 
• Cases pre-treatment: 2.2 














to controls and 
Statistical methods 
might not have 




the same group of 
subjects (cases) 




wished to exclude 
children with 
                                                          
59 D-xylose results were expressed as % of dose administered. 
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Lactose hydrogen 
breath test (HBT) as 
a marker of lactose 
absorption, and 
xylose breath test 
and urinary 
excretion as 


























positive HBT is 
considered to be a 
rise of >20ppm in 




** Investigators did 




characteristics lead us 
to assume that it was 




• Cases post-treatment:   -
4.16 (0.69) ppm (p<0.05 
compared to pre-
treatment) 
• Controls: 1.13 (0.74) ppm 
(NS compared to pre-
treatment cases) 
 
Mean urinary excretion of 
xylose (SE) among cases 
pre-treatment and post- 
treatment was 34% (3) and 
46% (11), respectively (NS), 
well above cut-offs 
indicative of malabsorption. 
 







relevance of such 
mildly elevated 
HBT results in 
asymptomatically 
infected children 
is unclear.  
 




either urinary or 
breath measures 
among any group. 
While urinary 
results did not 
differ before and 
after treatment, 






such results is not 
apparent. 






production of H2 
following ingestion 




The number of 
children excluded 
due to failure to 
meet these criteria 












5-23 mo olds 
admitted to the 
Tropical 
Metabolism 
Research Unit of 







divided into 3 
groups of 8 
Stool Tests: 
• Total and 
fractionated 13C 
following ingestion 
of one of three 13C 
labeled triglycerides 
(TG): trilaurin, 
triolein, or trilinolein* 
Median total stool excretion 
of 13C in phase 1 was 9% 
(range: 1%-29%) and did 
not vary between TG 
groups.  
Median 13C excretion 
dropped 33%-99% in phase 
2 and 86%-95% in phase 3 
High 
concentrations of 
13C (compared to 
healthy UK 
children) [190] 
were observed in 
half of the 
subjects at 
Authors state that 
the study was not 
powered to 
compare the 
different TGs, but 
they contend that 
medium chain 
trilaurin did not 
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malnutrition 
 
Stool recovery of 
radiolabeled 
products as markers 
of lipid digestion and 
absorption, and bile 
salt deconjugation 
as a marker of 
SBBO among 















collected in three 
separate phases 
as described 
above in JL 
Murphy et al. 
2001 [149].  
• 13C stool assay 
following 
administration of 




* To assess fat 
excretion as a % of 
dose administered. 
Also assessed 
proportion of 13C in 
triglyceride (TG) and 
fatty acid (FA) 
fractions to distinguish 
excretion caused 
impaired digestion 
(presence of TG) vs. 
poor absorption 
(presence of FA). 
 
** To assess bile salt 
deconjugation in the 
bowel caused by 
SBBO; conducted 
after the TG 
assessment and a 3 
day washout period. 
 
 
compared to phase 1 
(p<0.05 each). 
 
Over the study period, there 
were significant 
associations between total 
lipid and the amount of 13C 
labeled TGs in stool for 
some groups, but not for 
others. 
 
Median 13C in TG and FA 
was similar across TG 
groups in all phases. 13C 
FA recovery was similar and 
reduced by ~2/3 compared 
to Phase 1. 13C TG was not 
detectable in Phases 2 or 3. 
Statistical comparisons 
between phases were not 
reported.  
 
13C after radiolabeled 
glycocholate administration 
was detected in stool at 
quantities considered to be 
in excess of the 7% 
recovery of dose 
administered upper limit of 
normal in U.S. adults in 
[189]: 
• Phase 1: 13/24 (54%) 
• Phase 2: 5/24 (20.8%)  







or absorption.  
 
The differences in 
stool 13C were 
wide but not as 
extreme as in a 
previous study by 
same 
investigators (also 
examined in this 





13C excretion did 
not significantly 






Similar to their 
previous study, 
significantly more 
13C in stool was 








in their previous 
study, there was 
evidence of 
SBBO as 
appear to be 
processed 
differently than the 




Authors did not 
describe the 
method used to 




While it was noted 
that some subjects 
had positive stool 
cultures, details 
were not provided 
on the nature of the 
enteric infections. 
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measured post-



















breath tests as 
markers of lipid 
digestion and 
absorption and bile 
salt deconjugation 
as a marker of 
SBBO among 







7-23 mo olds with 
malnutrition 
admitted to the 









collected in three 
separate phases 
(each lasting 9 
days): 
1. Within 48 
hours of 
admission 
2. During early 
rehabilitation 




• Fecal fat* 






















* In 72 hour stool 
collection (measured 
as total grams and as 
% of dietary fat 
intake). 
 
** To assess fat 
excretion as a % of 
dose administered. 
Also assessed 
proportion of 13C in 
triglyceride (TG) and 
fatty acid (FA) 
fractions to distinguish 
Mean fecal fat (SD): 
• Phase 1: 2.4 g/day (3.6) 
or 5.9% (9.4) of dietary 
lipid intake 
• Phase 2: 1.7 (0.9) g/day, 
or 3.3% (2.4) of intake  
• Phase 3: 0.9 (0.6) g/day, 
or 1.4% (0.7) of intake 
• Differences between 
phases were not 
statistically significant. 
 
Total excretion of 13C in 
stool also varied widely 
across patients (0%-44%) 
and did not differ between 
study phases.  
 
Correlation between fecal 
fat and 13C (r=0.48; p<0.05) 
was observed.  
 
Lack of lipid digestion and 
absorption were assessed 
by measuring TG and FA 
fractions, respectively. 
Mean 13C TG recovery (SD) 
(% of administered dose), 
number of patients excreting 
TG: 
• Phase 1: 0.7% (1.6), n=3 
• Phase 2: 0.9% (2.8), n=1  
• Phase 3: no recovery 
from any subjects, 
differences between 
phases were NS 
 
13C FA fraction in stool 
Mean fecal fat 
was not elevated 
compared to 
published norms 
[191, 192] during 
any study phase.  
 
There was wide 
variation in fecal 
fat at 
presentation, and 
wide variations in 
stool 13C across 
subjects. Authors 
indicate that this 




studies on healthy 
children from the 
UK demonstrated 
average excretion 
of 6% [190]. 
 
The majority of 
excreted 13C was 
in the form of FA 
rather than TG. 
Authors 
interpreted this to 
reflect failure of 
lipid absorption in 




form (FA and TG) 
Statistical methods 
might be 
inappropriate for a 
small sample. 
 





SBBO; this might 
have affected GCA 
testing. 
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excretion caused by 
impaired digestion 
(presence of TG) vs. 
poor absorption 
(presence of FA). 
 
*** To assess bile salt 
deconjugation in the 
bowel caused by 
SBBO; conducted 
after the TG 
assessment and a 3 
day washout period. 
 
**** Expressed as a 
percentage of 
absorbed label (dose 
administered - label 
recovered in stool) to 
assess oxidation for 






Mean 13C FA recovery (SD): 
• Phase 1: 6.0% (7.3)  
• Phase 2: 4.8% (3.7)  
• Phase 3: 3.3% (3.8),  
differences between 
phases were NS 
  
Mean FA values were ~9x 
(NS), 5x (p<0.001), and 3x 
(p<0.05) higher than mean 
TG values in Phases 1, 2, 
and 3, respectively. 
  
Following administration of 
labeled TP, absorbed 13C 
label by breath analysis was 
~5% (range 0%-21.2%) and 
similar across study phases.  
 
Following the administration 
of labeled GCA, there was 
either no or minimal 
recovery of 13C in stool and 
13CO2 on breath (as % of 
dose administered) in all 
phases.  
was found in 
decreasing values 








did not differ 
significantly.  
 
Fecal fat was 
correlated with 
concentrations of 
13C in stool.  
There was no 
evidence of 

















that this breath 
test has not been 
widely used, but 
that healthy UK 
children have 
breath excretion 
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values from 15%-
43% [190], 
compared to a 
mean of 5% and 
range 0%-21% in 
this cohort; the 
latter findings 
were more similar 








Nichols B et al. 
 
Contribution of 
villous atrophy to 
reduced intestinal 











maltase and villous 
atrophy and other 
mucosal intestinal 
markers indicative 
of loss of 
enterocytes and 
enterocytic function.  
 













age 3.6 mo, SD 
1.0) with HAZ and 













n=24 cases  
 














• Maltase activity  























Mean villous atrophy score 
(SD): 
• Cases: 2.6 (0.8) 
• Controls: 1.2 (0.5), 
p=0.006) 
 
WAZ score was correlated 
with villous atrophy (r=0.65, 
p- value not reported).  
 
13/25 [sic] cases and 0/5 
controls had subnormal 
(defined as <94 U/g protein) 
of maltase activity; mean 
maltase was 34% lower 
among cases (p=0.11). 
Maltase activity did not 
appear to decrease with 
WAZ score (further details 
not provided). 
 
However, in sub-analyses 
among those samples with 
an adequate β-actin, a 
housekeeping gene 
message, (n=10 cases, n=9 





atrophy than the 
younger controls. 
 
Among the subset 
tested for mRNA 
messages, 
maltase activity 
as well as the 
mRNA 
abundances for 

























they mocked up ex 
vivo mucosal 
biopsies in these 
controls, resections 




compared to cases’ 
samples derived 
from mucosal 
biopsies. While this 
probably doesn’t 
affect histology, it 
might affect 
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* Mucosal atrophy 
was scored on a scale 
of 1 (absence of 
atrophy compared to 
an organ donor) to 4 
(similar to children 
with active CD). 
 
Histology among 




expressed as a mean 
percent of controls' (SD) 
included: 
• Villous length (reciprocal 
of atrophy score): 38.9 
(41.6), p=0.004 
• Maltase activity: 37.1 
(23.2), p=0.001 
• MGA mRNA: 45.1 (36.4), 
p=0.016 
• Villin mRNA: 52.5 (22.6), 
p=0.003 
• SGLT mRNA: 66.6 (23.1), 
p=0.057 
• β-actin: 88.2 (15.8), 
p=0.189 
 
Both villous length and 
maltase activity in a subset 
of cases were less than 
40% of control values.  
 
MGA, villin, and SGLT 
mRNA abundances were 
correlated with villous 
atrophy score (r=0.73), 
(r=0.76), and (r=0.54), 
respectively (p-values not 
reported)60.  
 
MGA mRNA abundance 







that these are the 
first results that 
directly support 
the hypothesis 
that reductions in 
maltase activity 
are due to villous 
atrophy. This 












will bring in more 
diverse populations 
of cells; only some 
of them might have 
transcripts of 
interest. However, 
the bias is likely in 
a direction that 
would reduce effect 
size. 
 
It was unclear if 
control inclusion 
criteria included 
absence of atrophy 





might not have 
adequately taken 
into account the 




Subsets of subjects 
were investigated 
for various tests. 
For example, 10 
cases had mRNA 
analyses based on 
β-actin adequacy. 
Another instance of 
                                                          
60 Villin and SGLT1 were assessed as a ratio with housekeeper gene β-actin. 
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selected testing 
was the subset of 
22 and 15 cases 
that had WAZ 












CA et al. 
 
Anthelmintic 
treatment of rural 
Bangladeshi 





L:M as a marker of 
intestinal 
permeability, and α 
1-antichymotrypsin 
as a marker of 
inflammation and 










2-5 yr olds from 
poor rural villages, 
sampled randomly 






















* Randomized at 







• Albumin  







Among 93 subjects 
with L:M at baseline:  
• 46 received 
treatment 
• 47 received placebo 
 
Among 66 subjects 
with repeated L:M 
testing: 
• 34 received 
treatment 
• 32 received placebo 
 
Mean L:M61 at baseline: 
• Treatment: 0.22 
• Placebo: 0.25 
 
Seasonal variation in L:M 
was observed, with highest 
values following the 
monsoon season.  
 
Within-subject L:M analysis 
showed no significant 
association with intestinal 
helminthiasis and no 
significant improvement in 
treatment or placebo groups 
over 1 yr. L:M was generally 
not associated with 
giardiasis (with the 
exception of one group at 
one study interval). 
 
L:M was inversely 
correlated with ∆HAZ and 
∆WAZ scores at some of 
the follow-up intervals (r=-
0.22, p<0.02 and r=-0.21, 
L:M ratios were 






L:M values did not 
change 
significantly over 

















data were lost, so 
analysis began 
with samples taken 
at month 2. 
 
The relationship 





                                                          
61 Geometric mean. 
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p<0.05, respectively, at 12 
mo follow-up visit).  
 
Mean serum ACT, albumin 
and total protein were within 
normal ranges and were not 
associated with growth 
parameters. ACT and 
albumin concentrations did 
not significantly change with 
treatment, whereas total 




in these markers 
was a decrease in 
















Panter-Brick C et al. 
 
Pathways leading to 
early growth 
faltering: An 










ratio (Lactose:Cr) as 





3-18 mo olds in 
two cohorts: 
1. All children in 















n=48 in squatter 
cohort  
 










Mean62 Lactose:Cr (CI): 
• Squatter: 0.14 (0.12, 
0.16) 
• Middle Class: 0.08 (0.07, 
0.10) 
• Statistically significant 
difference between the 2 
groups among the 6-12 
mo olds (p=0.007) and 
18-24 mo olds (p=0.002), 
but not among 12-18 mo 
olds.  
• For both SES groups, 
Lactose:Cr values 
decreased with increasing 
age (p<0.001). 
 
HAZ, WAZ, WHZ, and 
∆WAZ scores were strongly 
associated with mean 
Lactose:Cr (p<0.001 each) 
Authors speculate 
that Lactose:Cr 










that impact the 
nutritional status 
of children with 
lower socio-





to control for 






not be as accurate 





compared to L:M, 
requiring only spot 
urine collection and 
no substrate 
                                                          
62 Geometric mean. 
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IgG as markers of 
immunostimulation. 
The latter were also 
assessed for their 
relationship to 
nutritional status.  
as was ∆HAZ score 
(p=0.004); ∆WHZ score was 
not. The strength and 
magnitude of association 
between ∆WAZ score and 
Lactose:Cr was most 
pronounced among the 
wealthier cohort and there 
was no association between 
∆HAZ score and Lactose:Cr 










L:M was not 
assessed in this 
study; direct 
comparison of the 





inversely related to 
Lactose:Cr, testing 
for associations of 
other measured 
blood markers 






Perin NM et al. 
 
Intestinal absorption 
of D-xylose in 
children infected 




D-xylose as a 
marker of intestinal 
absorption among 
HIV-infected 






18 mo-14 yr old 
HIV-infected 
children with GI 
and non-GI 
symptoms of HIV 
infection recruited 
from a pediatric 






Prevalence of an abnormal 
D-xylose result was 7.7%.  
 
Mean D-xylose (SD, range): 
42.8mg/dL (14.4mg/dL, 16-
73 mg/dL)  
 
D-xylose was not 
associated with age. 
 
Of the 8 children with 
abnormal results, 1 had 
diarrhea. Of 19 with 
diarrhea, 1 had an abnormal 
result. 
 
Of those with abnormal 
results, 50% had 
Cryptosporidium infection. 
Of the 33 subjects with 
Cryptosporidium infection, 4 











mg/dL was defined 
as indicative of 
malabsorption. 
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intestine biopsy in 




6 mo-5 yr old 
inpatients from an 
urban setting who 
underwent biopsy 
as part of a work-
up for PD. 
 
There was a high 
proportion of 
children with 







biopsies, site and 





(62 tested):  
• Villous height 












• Brush border 
height  
• Stereological 











measures were similar to 
those by micrometer and 





enterocyte brush border, 
and enterocyte nucleus 
height correlations:  
• WAZ score: r=0.25 
(p=0.038), r=0.26 
(p=0.03), and r=0.24, 
(p=0.05), respectively  
• WHZ score: r=0.29 
(p=0.02), r=0.27 (p=0.03), 
and r=0.16 (p=0.19), 
respectively 
• HAZ score: r=0.16 (0.18), 
r=0.23 (p=0.06), r=0.23 
(0.06)  
 
There was no correlation 
between mucosal surface 





with WAZ and 
WHZ scores, but 
not with HAZ 
score. However, 











Poddar U et al.  
Chandigarh, India 
 







Duodenal biopsy of those 





Authors did not 
report the biopsy 
findings in the TS 
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best for diagnosing 






in controls with 
giardiasis, TS, and 
SBBO 
6.9 yr) presenting 
with symptoms 
consistent with CD 




for CD were of 
interest for this 
review. 
• 22 with 
giardiasis  
• 1 with TS 
• 5 with SBBO 
inflammation of lamina 
propria; there was no 




or SBBO patients. 
2002 
 
Poddar U et al. 
 
Celiac disease in 
India: Are they true 




xylose, and fecal fat 
in children with 
symptoms of CD but 
normal mucosal 
biopsy results  
Chandigarh, India 
 
18 mo-14 yr olds 
with PD, FTT, or 







on biopsy were of 















* In 72-hour stool 
collection. 
 
** Not specified 
whether from urine or 





38% had chronic 
inflammatory cell infiltrates 
in the lamina propria.  
 
55% had abnormal D-xylose 
concentrations. 
 
20% had abnormal fecal fat 
test. 
 
No results beyond 
proportion positive were 







biopsy, more than 
one-third had PD. 
 
D-xylose and 
fecal fat might not 




between fecal fat, 
D-xylose and 
biopsy results were 
not reported. 
 
While 38% of 
controls had PD, 
results for the 
markers studied 
were not stratified 
by PD for this 
group.  
 
Seven children with 
biopsies consistent 
with CD did not 
respond to gluten-
free diet and were 
excluded from the 
study.  
 
Cut-off points used 
to define abnormal 
D-xylose tests 
were not provided. 
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2000 
 
Quadro L et al. 
 
Retinol and retinol-





L:M as a marker of 
small intestinal 
permeability, and its 
correlation with 




favela in Fortaleza, 
Brazil 
  
1-9 yr olds with 
mild malnutrition 
selected from a 
large cohort of 
children from an 
urban slum. They 
were recruited at 
birth and followed 
longitudinally. 
 
19 (63%) had 
some degree of 
vitamin A 
deficiency—all of 
these had mild 
deficiency, except 









 Urine Tests: 
• Lactulose63 
• Mannitol 






80% of subjects had 
abnormal L:M, defined as 
>=0.030.  
 
Serum retinol was:  
• Inversely correlated with 
L:M (r=0.46, p=0.012) 
• Directly correlated with 
mannitol (r=0.66, p<0.01)  
• Not correlated with 
lactulose (data not 
reported) 
Children with low 







The L:M normal 
cutoff was defined 
lower than for most 
other L:M studies, 
as 0.030. The 
authors reference 
several studies 
regarding use of 
this cut point. 
                                                          
63 Lactulose and mannitol results were expressed as % of dose administered. 
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Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
2004 
 
Rabbani GH et al. 
 
Green banana and 
pectin improve small 
intestinal 
permeability and 





L:M as a marker of 
intestinal 
permeability among 
infants with PD who 
are treated with 
green banana, 





5-12 mo old males 
admitted to the 
hospital of the 
International  
Centre for  
Diarrhoeal Disease 
Research with PD 





























Mean L:M65 (SD) by 
treatment group, pre- and 
post-treatment:  
• Banana: pre=0.50 (0.14), 
post=0.21 (0.12), p<0.01 
• Pectin: pre=0.54 (0.17), 
post=0.23 (0.09), p<0.01 
• Placebo: pre=0.41 (0.11), 
post=0.45 (0.13), p>0.6 
 
Lactulose and mannitol 
excretion did not differ 
between groups at baseline.  
 
Lactulose excretion was not 
significantly reduced after 
intervention in the placebo 
group. Mean (SD): 
• Pre-treatment: 1.45 (0.12) 
• Post-treatment: 1.35 
(0.15) 
 
Both treatment groups had 





increased in all groups 
compared to their pre-
treatment values, but only 
significantly so in the 
banana and pectin groups 
(p<0.05).  
 
Mean mannitol % excretion 
(SD), pre- vs. post-
treatment:  
• Banana: 1.82 (0.13) vs. 
L:M values were 
high at baseline 
among the study 
population of 
inpatient young 
children with PD. 
Mean L:M 
significantly 
improved with the 
green banana or 
pectin intervention 
but were still 
above normal 
range following 7 
days of treatment. 
The 
improvements in 
L:M were driven 
by both mannitol 
and lactulose, 
with the latter 








of green banana 
in reducing 
diarrheal fluid loss 








                                                          
64 Lactulose and mannitol results were expressed as % of dose administered. 
65 Type of mean not specified. 
Appendix 7. Evidence table of all studies included in the review.
 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
3.21 (0.16) 
• Pectin: 1.91 (0.12) vs. 3.2 
(0.18) 
• Placebo: 2.10 (0.11) vs. 
2.33 (0.18) 
 
The banana and pectin 
groups stopped having 
diarrhea more often 
compared to controls (e.g. 
p<0.01 by day 4). Among 
the banana and pectin 
groups, stool reductions 
were associated with 
percent change in L:M 
before and after treatment 
(R2=0.84 for pectin and 
R2=0.86 for banana; p<0.05 
for each). 
short-chain fatty 
acids in the colon, 
stimulating 
colonic salt and 
water absorption. 
Pectin is thought 




suggest that short 














Rabbani GH et al. 
 
Increased nitrite and 
nitrate 
concentrations in 
sera and urine of 
patients with cholera 
or shigellosis 
 
To assess and 
compare nitric oxide 
as a marker of 
intestinal 
inflammation among 




2-6 yr olds with 
cholera or 
shigellosis 




recruited from the 
healthy attendants 
of patients or from 
children of hospital 
staff. 
 






• 24 with cholera 
















• Nitrite (NO2) 
• Nitrate (NO3) 







* Nitric oxide (NO) is 
an unstable free 
radical that is 
In children with shigellosis, 
median serum NO was ~8x 
higher at baseline than in 
controls and significantly 
differed from convalescent 
concentrations (p<0.01). 
Concentrations declined by 
52% of baseline during the 
recovery period but did not 
return to values found in the 
controls (measure of 
statistical significance not 
reported).  
 
In children with cholera, 
median serum NO 
concentrations at baseline 
NO as measured 
by both serum 








to 7-10 days after 
hospitalization in 
both cholera and 
shigellosis.  
 
Median serum NO 
concentrations in 
Some values 
reported in table 
format conflict with 
the text; columns of 
data appear to be 
transposed. 
 
Assessment for NO 
correlation with 
fecal leukocyte 
counts was not 
reported, nor was 
the correlation 
between urinary 
NO and total blood 
WBC. 
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
or shigellosis or 
healthy controls. 
Evaluated to assess 
nitric oxide 
production during 
infection of small 
bowel without 
inflammatory lesion 








cases: 3.8 (1.2) 
• Cholera cases: 
4.2 (1.4)  





7-10 days of 
treatment). 
 
converted to nitrite 
and nitrate. Urine NO2 
+ NO3 were 
expressed as a ratio 
with urine creatinine in 
order to account for 
differences in urine 
concentration. 
 
were ~4x higher than in 
control subjects. Recovery 
concentrations decreased 
52% from baseline (p<0.01); 
convalescent values did not 
differ from the values in 
controls (p<0.4).  
 
Median urinary NO ratios 
were similar among those 
with Shigella and V. 
cholerae infection, both 
upon admission and 
discharge. Initial values 
were ~2x higher than upon 
discharge (p<0.05 and 0.01, 
respectively). Control 
median NO was of an 
intermediate concentration 
between cases’ admission 
and discharge median 
concentrations; the 
difference between control 
and case admission values 
was NS. 
 
Mean blood WBC counts 
(SD): 
• Shigellosis: 19.6 (3.3)  
• Cholera: 8.3 (2.8) 
• Controls: 7.1 (1.8) 
 
Mean fecal WBC/high 
power field (SD): 
• Shigellosis: 38 (17) 
• Cholera: 5 (2) 
• Controls: 3 (1)  
 
Serum NO correlated with 
blood WBC count in 
shigellosis cases at baseline 
(r2=0.92, p<0.01), but only 
cholera patients 







were much higher 











total blood WBC 
in shigellosis 
cases.   
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
to a slight degree upon 
discharge (r2=0.26, no p-
value reported) and there 
was no correlation among 
the cholera cases. Serum 
NO correlated with stool 
volume at presentation 
(r2=0.85, statistically 
significant per authors, p-
value not reported).  
2009 
 
Ritchie BK et al. 
 
13C-sucrose breath 






Sucrose breath test 
(SBT) as a marker 
of small bowel 
mucosal damage vis 
a vis sucrase 




































cases with AD 
 
n=25 controls: 







(32 Aboriginal cases 
and controls tested) 
• C-reactive protein 
(CRP) 










20/32 (63%) of Aboriginal 
children had abnormal L:R 
ratios. 
 
Mean66 L:R (CI): 
• Diarrhea cases: 31.8 
(24.9, 40.7)  
• Aboriginal controls 
without diarrhea: 11.4 




SBT Mean (CI): 
• Diarrhea cases: 1.9% 
(0.9, 3.0), p<0.0001 
compared to non-
Aboriginal controls and 
p=0.004 compared to 
Aboriginal controls 
• Aboriginal controls: 4.1% 
(3.0, 5.2), p=0.032 
compared to non-
Aboriginal controls 
• Non-Aboriginal controls: 
6.1% (4.8, 7.3) 
Significant differences were 
observed between all three 
groups.  
SBT values were 
significantly lower 





















clinically silent TE 






ratios were defined 
as >16; no 
reference or 
derivation was 
provided for this 
cut-point.  
 







was based on data 
for Aboriginal 
cases and controls 
combined; stratified 
analysis was not 
reported and could 
be of interest 
considering the 






                                                          
66 Geometric mean. 
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Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
 
SBT results were not 
associated with wasting or 
with patient age or 
breastfeeding status. 
 
SBT and L:R were inversely 
correlated (r=0.67; CI: 0.42, 
0.62; p<0.0001). L:R 
explained 45% of the 
variance in SBT; diarrhea 
explained 28% of variance. 
 
SBT was associated with 
increased MCV, relative risk 
(CI)=3.9 (2.8, 5.0). SBT was 
not associated with 
hemoglobin or CRP. 
correlated with 
L:R.  
MCV, CRP, and 
hemoglobin with 
SBT after adjusting 
for potentially 
confounding 










A longitudinal study 




L:M as a marker of 
gut mucosal 
integrity and urinary 
neopterin excretion 
as a marker of cell-
mediated immunity 




1, 6, and 14 wk old 









• L:M  
• Neopterin  
Mean68 L:M (CI): 
• HIV-infected subjects: 
• 1 wk: 0.12 (0.06, 0.27)  
• 6 wk: 0.24 (0.15, 0.38) 
• 14 wk: 0.24 (0.14, 
0.44) 
• Uninfected subjects:  
• 1 wk: 0.13 (0.09, 0.19) 
• 6 wk: 0.08 (0.06, 0.11) 
• 14 wk: 0.09 ( 0.07, 
0.13) 
 
HIV-infection by 14 wk of 
age was significantly 
associated with increased 
L:M. 
 
A non-significant, positive 
trend in neopterin excretion 
was observed among HIV-
L:M was generally 
normal (compared 




















between L:M and 
neopterin was not 
reported. 
                                                          
67 Lactulose and mannitol results were expressed in mg. 
68 Geometric mean. 
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
without HIV infection infected infants.  Higher neopterin 
excretion by HIV-
infected infants 
was observed but 












timing for improving 
biochemical and 








serum α-1 acid 
glycoprotein, and C-
reactive protein as 
markers of 
inflammation among 

































either on the day 
of 







• L:M  




• C-reactive protein 
(CRP) 
• α-1 acid 
glycoprotein (AGP) 
 
49 subjects received 
urine testing: 
• Group 1: n=25 
• Group 2: n=24  
 
 
Blood and urine were 




• Group 1:  
• Day 0: ~1.8 
• Day 3: ~2.4  
• Group 2:  
• Day 0: ~1.2 
• Day 3: ~0.7 
 
There were no differences 
in mean L:M between 
groups or within groups 
between days 0 and 3, 
although there was a 
significant difference in 
paired analysis within 
individuals at the two time 
points (data not presented, 
and direction, magnitude 
and degree of significance 
not reported). 
  
Lactulose and mannitol 
excretion were assessed 
only in the paired analysis. 
Lactulose excretion 
decreased between days 0 
and 3 (magnitude of effect 
and degree of significance 
not reported), while mannitol 
excretion showed no 
change.  
Mean L:M ratios 
were very high 
(~10x) (at 
baseline and at 
day 3 in both 
groups) compared 
to other studies in 





that this could 
have been due to 
the severity of 








not result in 
significant 
improvement in 
L:M, neopterin, or 
AGP regardless 
of timing of 
vitamin A 
administration.  
Urine testing could 
only be conducted 
in the laboratory on 
certain days; hence 
only a subset of 
subjects underwent 
those tests.  
 




WBCs and AGP, 




compared to group 
1 at baseline. 
Authors note that 
these parameters 
suggest that Group 
2 patients might 
have been more ill 
at baseline. For the 
subset of 49 
patients 
undergoing urine 
testing, the mean72 
L:M and neopterin 
concentrations 
                                                          
69 For lactulose, mannitol, and neopterin results, excretion measurement was not specified. 
70 Geometric mean. 
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
 
Mean71 neopterin and AGP 
concentrations did not differ 
between groups or within 
groups on the different 
study days or in the paired 
analysis. When initial CRP 
(~2x higher in Group 2 
compared to Group 1, 
p<0.004) was taken into 
account, mean CRP on day 
3 did not differ between the 
2 groups. However in the 
paired analysis, CRP 
concentrations were 
significantly different 




were lower among 
Group 2 than 
Group 1 subjects 
(NS). However, 
baseline 
differences in acute 
phase and vitamin 
A markers at 
baseline were not 
reported separately 
for these 49 
subjects. 
 
Data for lactulose 
and mannitol 





of these molecules 
expressed as ratios 
with creatinine was 
not explained.  
 
Authors suggest 
that their 3-day 
testing period 
(based on their 
previous work in a 
different setting 
[207] might have 
been too short to 
identify effect as 
demonstrated by 
McCullough et al. 
at 10 days after 
presentation [208]. 
                                                                                                                                                                                                                                                                                               
72 Geometric mean. 
71 Geometric mean. 
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Location and 
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Design and 
Sample Size  Biomarker Results Conclusion Comments 
2006 
 








school children and 
hospital patients in 




Stool lactoferrin as a 
marker of intestinal 
inflammation among 
hospitalized patients 









diarrhea or other 
GI complaints as 





n=26 <5 yr old: 
• 22 hospital-
based subjects 




16/22 patients and 0/4 
students were lactoferrin 
positive. 
 
While examination of 
lactoferrin association with 
history of diarrhea or with 
Cryptosporidium infection 
was not reported, only 3/22 
and 16/22 hospitalized 
patients and 2/4 and 3/4 
school children were 
positive for Cryptosporidium 
and had a history of 













not found among 
school-recruited 
children, most of 
whom did have a 
history of 
diarrhea. Two of 




Among the entire 
study cohort of all 
ages, lactoferrin 




status (influence of 





frequently found to 
be positive among 
those infected with 
Cryptosporidium; 
statistical testing 
was not reported. 
 
Lactoferrin results 




dilution and was 
considered 
negative if there 




were breastfed and 















Iron (absorption test) 
Mean73 iron absorption from 
ferrous (Fe) sulfate and Fe 
fumarate:  
• Uninfected children: 
Iron absorption 
from Fe fumarate 
was significantly 
lower than from 
Data on iron 
absorption among 
2-5 yr olds are 
limited, making 
                                                          
73 Geometric mean. 
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Study Outcomes of 
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Location and 
Target Population  
Design and 










among children with 
iron deficiency 
anemia with and 
without H. pylori 
infection 
apparently healthy 
children from a 
periurban setting, 
screened for iron 
deficiency and H. 
pylori. 
n=13 cases 
infected with H. 
pylori 
 
n=12 controls not 
infected with H. 
pylori 
15.6% and 5.4%, 
(p<0.001) 
• Infected children before 
treatment: 19.7% and 
5.3%, (p<0.0001)  
• Infected children after 
treatment: 22.5% and 
6.4%, (p<0.0001)  
• H. pylori treatment did not 
significantly affect 






Results do not 
support the 















Sheng XY et al. 
 
Major variables of 
zinc homeostasis in 
Chinese toddlers 
 
Differences in zinc 
absorption in 
healthy toddlers with 
a high prevalence of 
zinc deficiency.  




19-25 mo olds 
recruited from a 
remote small town 
and 2 surrounding 
rural villages.  
 
48% of children 




zinc intake was 
low.  
 














Zinc excretion to 
measure fractional 
absorption of zinc 
(FAZ) and total 
absorbed zinc (TAZ) 
following radiolabeled 
zinc administration  
  
Mean (SD): 
• FAZ: 0.35 (0.12) 
• AZ (mg/d): 0.63 (0.24) 
• EFZ (mg/d): 0.67 (0.23) 
 
The quantity of absorbed 
zinc was lower than 
physiologic requirements. 
 
There was no statistically 
significant difference in any 
laboratory value between 
the town and village groups. 
 
Zinc absorption was ~80% 
of estimated physiologic 
requirement and equivalent 
to the amount of 
endogenous zinc excreted 
via the intestine; it was 
expected that absorbed zinc 
would exceed excreted zinc 
[144, 187, 194, 195]. 
Zinc absorption 
was lower than 
physiologic 
requirements and 
EFZ was higher 
than expected. 
 
The authors note 
that the results 
are difficult to 
explain and 
specifically state 





prevalent in the 
population and 
therefore could 






Sherwani K et al. 
 
Aligarh, India  
 
1-12 yr olds (mean 






method not specified: 
Histopathology 
Six patients had partial 
villous atrophy and non-






The 6 children with 
partial villous 
atrophy were 
thought to have 
Appendix 7. Evidence table of all studies included in the review.
 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
Prevalence of iron 
deficiency anemia in 
chronic diarrhoea 
and celiac disease - 
A western UP 
experience 
 
Duodenal biopsy in 
patients with PD  
an urban setting 
with PD recruited 
from pediatric 
outpatient and 




up were subjects 
of interest for this 
review. 
of patients who 
did not have CD, 
but did not identify 
PD etiology in the 
remainder who 
did not have CD. 











mixture in acute and 
persistent diarrhea 
in infants and its 
impact on nutritional 
status 
 
Blood cell and 
albumin markers 
among infants with 
acute, persistent or 
no diarrhea, and 
effects on these 





vitamin A, zinc and 
other 
micronutrients) 
among subjects with 











5/6 PD cases and 
10/14 AD cases 
had some degree 
of malnutrition.  
 
Infants with PD 
had significantly 
lower vitamin A 
and zinc stores 
compared to 
controls. Those 
with AD had 
significantly lower 






• 6 with PD 











• Complete blood 
count and 
differential 


















Mean baseline hemoglobin 
was significantly lower in 
infants with AD and PD 
(p<0.05 for each group) 
than in controls  
 
Mean MCV and MCH were 
lower in those with AD 
(p<0.025 and p<0.01, 
respectively) and PD 
(p<0.01 for both markers) 
compared to controls.  
 
Mean lymphocyte counts 
among PD cases were low 
compared to those of 
controls (p<0.01). 
 
Other markers did not vary 
significantly at baseline. 
However, among infants 
with PD, mean albumin was 
abnormally low, although it 
was not significantly 
different compared to 
controls or those with AD. 
Mean albumin (g/dL) (SE): 
• PD: 2.9 (0.27)  
• AD: 3.29 (0.25)  
• Controls: 3.37 (0.21) 
Albumin and 
many hematologic 





those with PD, 
compared to 
those without 














were not specified. 
 





for PD cases (n=6). 
Controls were 
reported to have 
been matched to 
cases, yet there 
were half the 
number of controls 
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 





lymphocyte counts and 
albumin increased in both 
diarrhea groups to 
concentrations on par with 
control baseline 
concentrations (albeit 
increases were NS except 
within the PD group). MCH 
improved to concentrations 
on par with the control 
group only among the 
infants with AD.  
2003 
 
Tassara O et al. 
 
Gastrointestinal 
diseases in children 










0-12 yr old 
(median 9 mo) 
HIV-infected 
children treated in 
hospital. A high 

















changes were observed on 
endoscopy in the 
esophagus, stomach or 
duodenum in 2 subjects.  
 
Biopsies of esophagus, 
stomach or duodenum 
showed inflammatory 
changes of varying degree 













in the digestive 
system were not 












Thurnham DI et al. 
 
Innate immunity, gut 
integrity, and 
vitamin A in 
Gambian and Indian 
Orissa State, India 
 
Subjects were 











• 31 received 






subjects, L:M was 
assessed at baseline, 
discharge from 
Mean L:M was ~3-fold 
higher among hospitalized 
compared to clinic patients 
at baseline. Within the 
allocation groups, mean 
baseline L:M did not differ 
for either the hospitalized or 
clinic subjects. 
Mean L:M values, 
including post-
intervention 
values, were 2-5 
times higher than 
those observed in 
the UK [209]. 
 
Precise numerical 
values were not 
reported, rather 
L:M results were 
portrayed in figures 
with units 
expressed in mg, 
making it difficult to 
Appendix 7. Evidence table of all studies included in the review.
 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
infants 
 
L:M as a marker of 
intestinal integrity 
among children 










not specified  
 
1 
• 32 received 
vitamin A at 
discharge (up to 
day 5) 










receive vitamin A 
weekly for 8 wk 
or placebo.  
 
 
* Number of 
subjects in each 
treatment group 




hospital, and 10 or 30 
days after discharge. 
 
For clinic-based 
subjects, L:M was 
assessed at baseline, 
4, and 8 wk. 
 
Among the hospital cohort, 
mean L:M declined 
significantly in the two 
vitamin A groups compared 
to the placebo group, and 
remained lower at day 30 
among the treatment 
groups, but the difference 
was no longer significant 
compared to the placebo 
group. 
 
Among the clinic cohort, 
mean L:M reduction was 
accelerated in vitamin A-
supplemented children. 
However, mean L:M did not 
significantly differ between 
treatment groups at any 
time point.  
 
The rate of decline in L:M 
was most steep among the 
vitamin A-treated 
hospitalized patients, in 
whom the mean L:M value 
decreased by 63% over 30 
days, followed by placebo-
treated hospitalized 
patients, with a decrease of 
38% over 30 days. Mean 
L:M decreased by 57% in 
the vitamin A-treated clinic 
patients, while there was no 
change in L:M among the 
clinic placebo group. 
L:M reduction was 
accelerated 








in either the clinic 





results to those of 
other studies.  
 
Information on 





The article also 
reported re-
analyzed data from 
a 1991 report from 
The Gambia [209]. 
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2009  
 





trial of rifaximin, a 
nonabsorbable 
antibiotic, in the 













rifaximin or placebo  
Limela, Malawi 
 
All 3-5 yr olds from 















It was presumed 
that if SBBO is 










• Sucrose (SUC) 
• Sucralose (SCL) 




ratio (SCL:L)  
 
 
Subjects were tested 
before and after 
treatment. 
At enrollment: 
• Mean mannitol (SD):  
• Treatment: 9.57 (5.24)  
• Placebo: 10.29 (6.62) 
• Mean lactulose (SD): 
• Treatment: 0.30 (0.18) 
• Placebo: 0.34 (0.25) 
• Mean SUC (SD):  
• Treatment: 0.062 
(0.04)  
• Placebo: 0.074 (0.058) 
• Mean SCL (SD):  
• Treatment: 0.51 (0.29)  
• Placebo: 0.58 (0.53) 
• Mean L:M75 (SD): 
• Treatment: 0.18 (0.12) 
• Placebo: 0.17 (0.09) 
• Mean SUC:L (SD): 
• Treatment: 0.50 (0.34) 
• Placebo: 0.64 (0.90) 
• Mean SCL:L (SD): 
• Treatment: 0.42 (0.32) 
• Placebo: 0.39 (0.23) 
• For both groups 
combined:  
• 76% had L:M >0.10 
• 34% had L:M >0.20 
 
No significant post- 
intervention differences 
were observed in any 
fractional sugar excretion or 
dual sugar test, including 




There was a high 
proportion with 
elevated L:M 
















SCL excretion in 
this population 
was similar to that 





lower (0.8) and 
driven by 
lactulose [210]. 
SCL:L might be a 
better marker of 
colonic 
permeability [211-









testing, in particular 
for SCL excretion, 
might account for 
some differences in 
values compared 
to other studies.  
 
This was the first 
use of SCL for site-
specific absorption 
testing in a 
developing country 
setting.  
                                                          
74 Lactulose, mannitol, SUC, and SCL results were expressed as % of dose administered. 
75 Type of mean for sugar ratios not specified. 
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Design and 




Few data exist on 
SUC excretion. 
Results in this trial 
are similar to 











[210, 212].  
2008 
 
Vieira MM et al. 
 
Carotenoids, retinol, 
and intestinal barrier 









markers of intestinal 
inflammation, and 





2 mo-9 yr olds 




eligible if HAZ 



























48.5% had abnormal L:M.  
 
L:M and excretion of each 
sugar separately did not 
vary with retinol 
concentration. 
 
L:M was associated with 
levels of common dietary 
carotenoids, primarily driven 
by lactulose. However, the 
association was not always 
statistically significant, and 
the direction of association 
varied depending on 
precursor.  
 
40% of stool samples were 
positive for lactoferrin. 
 
Almost half of 
subjects had 
increased L:M, 













that these retinol 
precursors might 
be more sensitive 
predictors of 
L:M threshold for 
abnormal values 
was defined as 
>0.0864 [214]. Cut-














between L:M and 
lactoferrin or fecal 
                                                          
76 Lactulose and mannitol results were expressed as % of dose administered. 
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children with varying 
vitamin A status  
1% of stool samples were 
positive for fecal leukocytes. 
 
30% of stool samples were 
positive for parasites but 
this had no impact on L:M 
results, lactoferrin, or acute 










leukocytes as well 
as those between 
retinol or 
carotenoids and 
lactoferrin or fecal 
leukocytes were 





















L:M and plasma 
immunoglobulins 







enrolled in a 
glutamine trial 
 
West Kiang region, 
Gambia 
 
4-10 mo olds from 
a rural area 
followed during the 
5-month rainy 









amino acids was 
orally 
administered 
twice daily during 
























Mean77 L:M (CI):  
• Baseline:  
• Glutamine group: 0.33 
(0.25, 0.43) 
• Placebo group: 0.33 
(0.26, 0.41) 
• Post-intervention: 
• Glutamine group: 0.29 
(0.23, 0.35) 
• Placebo group: 0.26 
(0.21, 0.32) 
 
Mean excretion of lactulose 
(CI):  
• Baseline:  
• Glutamine group: 0.21 
(0.16, 0.28) 
• Placebo group: 0.20 
(0.15, 0.26) 
• Post-intervention: 
• Glutamine group: 0.17 
(0.13, 0.21) 
• Placebo group: 0.14 
L:M values were 
elevated in this 
population, with 
no significant 
change after the 
intervention.  
 







either at baseline 










between L:M and 
growth parameters, 
immuno-globulins, 
and acute phase 
proteins were not 
reported. 
                                                          
77 Geometric mean 
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Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
 (0.11, 0.18) 
 
Mean excretion of mannitol 
(CI):  
• Baseline:  
• Glutamine group: 2.65 
(2.02, 3.48) 
• Placebo group: 2.50 
(1.87, 3.36) 
• Post-intervention: 
• Glutamine group: 2.48 
(1.99, 3.11) 
• Placebo group: 2.14 
(1.62, 2.82) 
 
L:M values did not differ 
significantly between 
treatment groups before or 
following intervention. 
However, a repeated 
measures ANOVA showed 
that during supplementation, 
L:M values were borderline 
elevated among the 
glutamine-supplemented 
group relative to the placebo 
group (p=0.05), counter to 
expectation. 
 
Neither ACT, CRP, albumin, 
nor immunoglobulins IgA, 
IgG, or IgM differed 
significantly between 
treatment and placebo 
groups, either at baseline or 
at the end of 
supplementation. 
 
Mean levels of IgA and IgG 
increased during the study 
(p <0.001), while IgM levels 
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
did not. Concentrations of 
each of these 
immunoglobulins did not 
differ between treatment 
and placebo groups. 
 
Plasma albumin, ACT, 
and CRP values showed no 
change over the course of 
the study. 
 
Proportions of children with 
elevated CRP ranged from 
30-41% at different 
collection time points. The 
glutamine intervention had 
no effect on proportion of 
children with elevated CRP. 
 
Treatment and placebo 
groups experienced 
decreases in WAZ, HAZ, 
and MUAC coinciding with 
the rainy season; however, 
there was no significant 
difference observed 
between the groups for any 
of these parameters.  
 
Treatment and placebo 
groups did not differ in 
morbidity indices (i.e. 
percentage of time reported 




Willumsen JF et al. 
 
Subclinical mastitis 

















There was no significant 
association between L:M 
and subclinical mastitis as 




mastitis was not 
associated with 
magnitude of L:M. 
 
Actual L:M values 
were not reported 
but are found in a 
companion study, 
also included in 
this review [119]. 
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 Reference and 
Study Outcomes of 
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Target Population  
Design and 




L:M as a marker of 
infant intestinal 




infants followed up 




clinic via a vitamin 
A supplementation 




n=104 mothers  
 
n=108 infants (4 
pairs of twins), 
(26 were HIV-
infected by 3 mo 
of age) 
The study group in 
Willumsen, et al. 
represents a 
subsample of the 
study population 








permeability test in 
children with 














0-36 mo olds with 
watery diarrhea 
admitted to oral 







• 15 with C. 
parvum alone 
• 7 with rotavirus 
alone 
• 7 with bacteria 













convalescent (at day 
20) L:M ratios were 
assessed. 
Mean78 L:M (SE) at day 1, 
day 20: 
• Rotavirus only: 0.67 
(0.38), 0.19 (0.09) 
• Cryptosporidium only: 0.76 
(0.43), 0.28 (0.14) 
• Bacterial infection: ranged 
from 0.2-0.87, 0.11-0.99 
• Unknown etiology: 0.26 
(0.12), 0.29 (0.18) 
 
Mean L:M ratios 
significantly differed 
between the unknown 
etiology and both the 
rotavirus (p< 0.01) and 
Cryptosporidium groups 
(p<0.05) at baseline, but 
not at day 20.  
 
Mean L:M ratios decreased 
between baseline and day 




Among the group of 
subjects with enteric 
bacterial infections, the 
















Mean L:M did not 
change 
significantly 
among those with 
diarrhea of 
unknown 








                                                          
78 Arithmetic mean. 
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 Reference and 
Study Outcomes of 
Diagnostic Interest 
Location and 
Target Population  
Design and 
Sample Size  Biomarker Results Conclusion Comments 
causative agents identified 
and mean L:M ratios 
(baseline, day 20) were: 
Campylobacter jejuni and 
rotavirus infection (0.86, 
0.18), C. jejuni and 
Cryptosporidium infection 
(0.87, 0.53), Salmonella sp. 
(0.2, 0.11), C. jejuni (0.69, 
0.99), and Aeromonas sp. 
(0.38, 0.11). The L:M ratios 
of this group of seven 
infants were not included in 
the statistical analyses. 
similar to those 






Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. Where these 
studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s. 
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting. 
Further details on L:M studies can be found in Table 14.  
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval, 
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins, 
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G, 
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent 
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium 
99, T3=triiodothyronine, T4 = thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score), 
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s) 
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